
==== Front
Signal Transduct Target Ther
Signal Transduct Target Ther
Signal Transduction and Targeted Therapy
2095-9907
2059-3635
Nature Publishing Group UK London

37945593
1649
10.1038/s41392-023-01649-4
Review Article
Nuclear transport proteins: structure, function and disease relevance
Yang Yang 1
Guo Lu 1
Chen Lin 1
Gong Bo 23
http://orcid.org/0000-0002-2205-1998
Jia Da Jiada@scu.edu.cn

4
Sun Qingxiang sunqingxiang@hotmail.com

15
1 grid.54549.39 0000 0004 0369 4060 Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
2 grid.54549.39 0000 0004 0369 4060 The Key Laboratory for Human Disease Gene Study of Sichuan Province and Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
3 https://ror.org/01qh26a66 grid.410646.1 0000 0004 1808 0950 Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, China
4 grid.461863.e 0000 0004 1757 9397 Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Pediatrics, West China Second University Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China
5 grid.13291.38 0000 0001 0807 1581 Department of Pathology, State Key Laboratory of Biotherapy and Cancer Centre, West China Hospital, Sichuan University, and Collaborative Innovation Centre of Biotherapy, Chengdu, China
10 11 2023
10 11 2023
2023
8 4259 4 2023
13 9 2023
14 9 2023
© The Author(s) 2023
2023
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Proper subcellular localization is crucial for the functioning of biomacromolecules, including proteins and RNAs. Nuclear transport is a fundamental cellular process that regulates the localization of many macromolecules within the nuclear or cytoplasmic compartments. In humans, approximately 60 proteins are involved in nuclear transport, including nucleoporins that form membrane-embedded nuclear pore complexes, karyopherins that transport cargoes through these complexes, and Ran system proteins that ensure directed and rapid transport. Many of these nuclear transport proteins play additional and essential roles in mitosis, biomolecular condensation, and gene transcription. Dysregulation of nuclear transport is linked to major human diseases such as cancer, neurodegenerative diseases, and viral infections. Selinexor (KPT-330), an inhibitor targeting the nuclear export factor XPO1 (also known as CRM1), was approved in 2019 to treat two types of blood cancers, and dozens of clinical trials of are ongoing. This review summarizes approximately three decades of research data in this field but focuses on the structure and function of individual nuclear transport proteins from recent studies, providing a cutting-edge and holistic view on the role of nuclear transport proteins in health and disease. In-depth knowledge of this rapidly evolving field has the potential to bring new insights into fundamental biology, pathogenic mechanisms, and therapeutic approaches.

Subject terms

Cell biology
Oncogenesis
Neurological disorders
Molecular biology
Structural biology
https://doi.org/10.13039/501100001809 National Natural Science Foundation of China (National Science Foundation of China) 82273850 Sun Qingxiang issue-copyright-statement© West China Hospital, Sichuan University 2023
==== Body
pmcIntroduction

Eukaryotic cells store genetic material in the nucleus and separate it from other cellular components using a double-layered membrane called the nuclear envelope (NE). This compartmentalization allows for complex and specialized cellular activities while simultaneously posing challenges for the exchange of materials between the nucleus and the cytoplasm. The vast majority of material exchange occurs through nuclear pore complexes (NPCs), which form channels in the NE. The transport of molecules into and out of the nucleus determines the subcellular localization of many macromolecules, e.g., transcription factor, and is fundamental in the regulation of gene expression, cell division, and other critical cellular functions.1

To facilitate nuclear transport (or nucleocytoplasmic transport), human cells dedicated approximately 60 different proteins to constitute the nuclear transport system (NTS).2 Each of these nuclear transport proteins (NTPs) has a defined function. One component of the NTS is the NPC, which is formed by nucleoporin proteins and presents a selective barrier to free diffusion of macromolecules into and out of the nucleus.3 The karyopherin family proteins, such as importins, exportins, and bidirectional transporters (biportins), act as molecular shuttles to transport macromolecules through NPCs.4 The small GTPase protein Ran and accessory factors regulate the transport direction and accelerate transport speed.5 In addition, proteins involved in nuclear transport have been demonstrated to have nontransport functions, including roles in mitosis, regulation of transcription, and regulation of biomolecular condensates.6,7 It is often possible to distinguish the contribution of canonical and noncanonical functions of NTPs in a certain cellular process. Due to these important cellular functions, dysregulation of the NTS is implicated in a range of human diseases, including cancer, neurodegenerative disorders, and viral infections.8,9

While different NTPs are often tightly linked in many cellular processes, most previous reviews have not included all three NTP classes: karyopherins, nucleoporins, and Ran system proteins. A holistic view of the NTS could facilitate the understanding of relevant phenomena and guide the development of therapies for diseases. In this review, we will explore the structure, function, and disease relevance of individual NTPs, with a focus on their interaction mechanism and networks, underlying principles, and potential therapeutic targets. We will draw on key foundations dating back decades as well as recent literature to summarize and discuss the vast body of knowledge acquired, and hopefully bring new perspectives to future research.

Retrospective summary of research milestones

Due to their large size, cylindrical nuclear pore complex penetrating the nuclear envelope were discovered under electron microscopy as early as 1959 (Fig. 1).10,11. The first nuclear localization signal, which localizes yeast ribosomal protein L3 to the nucleus, was reported in 1985.12 Although the existence of nuclear import receptors was suspected at the time, first import receptor, p97 (now known as importin β1), was identified about a decade later.13,14 Shortly after, the first nuclear export signal and the first nuclear export receptor CRM1 were also identified.15–17 Ran-mediated regulation of nuclear cytoplasmic transport was discovered slightly earlier, but its role in nuclear transport was not well-understood until 1999.18 In the same year, the report of Ran-Importin β1 crystal structures marked that the field of nuclear transport entered the structural era.19,20 Using a collection of biophysical and proteomic techniques, the first molecular architecture of yeast NPC was built in 2007.21 Thereafter, with the development of cryo-EM and cryo-ET (electron tomography), the resolution of NPC structures has gradually increased to the current subatomic level.22,23 In the 1990s and 2000s, it was demonstrated that these NTS proteins also regulate mitosis, biomolecular condensates, and gene transcription, and are therefore implicated in various human diseases, including cancers, although many of the underlying mechanisms have not been revealed until recently.24–27 A drug targeting CRM1 was approved to treat two types of relapsed or refractory hematological cancers in 2019.28Fig. 1 Research milestones in the field of nuclear transport

Components of the nuclear transport system

The 60 NTPs can be classified into three groups: the nucleoporins that form the nuclear membrane-embedded NPC, the karyopherins that bind and ferry cargoes through NPCs, and the Ran system proteins that determine transport directionality and efficiency.2 In this section, we will discuss the structure and function of each NTP class.

Nucleoporins that form the nuclear pore complex

The NE consists of two lipid bilayer membranes—the inner and outer nuclear membranes - with NPCs embedded in NE pores where the inner and outer bilayers are curved and fused. A typical mammalian cell has approximately 2000–5000 NPCs.29 Each NPC can be visualized as a hollow cylinder with an outer diameter of ~1200 Å, a height of ~800 Å, and a total weight of ~120 MDa.30,31 The NPC can be divided into three parts: a central core that binds to the membrane and forms a diffusion barrier, eight thin filaments that bind to the central core and extend to the cytoplasm, and an additional eight thin filaments that form a basket-like structure on the nuclear side (Fig. 2a). All three parts of the NPC exhibit eightfold rotational symmetry along the channel axis, with all nucleoporins present as a multiple of eight in each NPC. The central core has an additional twofold symmetry between the cytoplasmic and nuclear halves.30 Therefore, each symmetric core nucleoporin (or symmetric nucleoporin) is present in at least a multiple of 16 in each NPC.32Fig. 2 Carton representation of the nuclear pore complex. a The nuclear pore complex can be divided into three parts: the central core, the cytoplasmic filaments, and the nuclear basket. The central core can be further divided into four rings surrounding the central channel: the inner ring, the cytoplasmic ring, the nuclear ring, and the luminal ring. b Inner ring viewed in the direction of transport. The inner ring consists of eight loosely associated subunits surrounding the central channel. The central channel is filled with disordered FG repeat polypeptides that inhibit free diffusion across the nuclear envelope. c Architecture of the outer ring. The two outer rings (the cytoplasmic and nuclear rings) are highly similar, and only one outer ring is drawn for clarity. Each outer ring contains 16 copies of the Y complex, arranged in two concentric rings and stabilized by linker nucleoporins. The Y complex consists of 10 nucleoporins, which can be divided into three regions: the stem, the short arm, and the long arm. d Architecture of the luminal ring. Thirty-two copies of Pom210 connected end-to-end surround the NPC and interact with the inner ring on the other side of the nuclear envelope. The parallelogram architectural features of Pom210 allows deformation that contract (left panel) or dilate (right panel) the central channel

Each NPC is constructed from approximately 1000 protein subunits, made up of multiple copies of approximately 34 unique nucleoporins encoded by the human genome. Approximately ten nucleoporins contain long stretches of FG repeats that are disordered and rich in FG dipeptides.33 These FG repeats are critical for passive diffusion barrier formation and karyopherin binding. The most prevalent domains are α-helical solenoids and β-propellers, which form the relatively rigid NPC scaffold. Nucleoporins have diverse functions, with some anchoring the NPC in the membrane (transmembrane nucleoporins), some forming the skeleton or scaffold of NPC (scaffold nucleoporins), some linking different scaffolds together (linker nucleoporins), some forming a diffusion barrier and/or interacting with different transport factors (FG nucleoporins), and some having mixed domains and functions. In this review, we introduce different nucleoporins according to their location within the NPC (Table 1). However, it should be noted that some nucleoporins are not restricted to a single location, especially those linking different parts of the NPC.Table 1 The organization of nucleoporins in NPCs

		Name (copy number)	Main domain features	Functions in NPC architecture and transport	
Central Core	Inner ring	Nup188 (16)	α-solenoid	Scaffold	
Nup205 (16)	α-solenoid	Scaffold	
Nup93 (32)	α-solenoid, disordered	Scaffold, linker	
Nup155 (48)	β-propeller, α-solenoid	Scaffold, linking to outer rings, membrane binding	
NDC1 (16)	Transmembrane, pore domain	Membrane anchoring, interacting with ALADIN	
ALADIN (16)	β-propeller	Membrane binding, scaffold	
Nup54 (32)	FG repeats, coiled-coil	Anchor the diffusion barrier to the NPC lumen	
Nup58 (32)	FG repeats, coiled-coil	Anchor the diffusion barrier to the NPC lumen	
Nup62 (32)	FG repeats, coiled-coil	Anchor the diffusion barrier to the NPC lumen	
Nup35 (32)	Disordered	Linker	
Nup98 (32)	FG repeats, disordered	Linker, diffusion barrier	
Cytoplasmic ring	Nup75 (16)	α-solenoid	Y short arm component, scaffold	
Nup43 (16)	β-propeller	Y short arm component, membrane binding	
Seh1 (16)	β-propeller	Y short arm component, membrane binding	
Nup160 (16)	β-propeller, α-solenoid	Y long arm component, scaffold, membrane binding	
Nup37 (16)	β-propeller	Y long arm component, membrane binding	
ELYS (8)	β-propeller, α-solenoid, disordered	Y long arm component, scaffold, membrane binding	
Sec13 (16)	β-propeller	Y stem component, membrane binding	
Nup96 (16)	α-solenoid, disordered	Y stem component, scaffold	
Nup107 (16)	α-solenoid, disordered	Y stem component, scaffold	
Nup133 (16)	β-propeller, α-solenoid	Y stem component, scaffold, membrane binding	
Nup205 (16)	α-solenoid	Linker	
Nup93 (16)	α-solenoid, disordered	Linker	
Nuclear ring	Nup75 (16)	α-solenoid	Y short arm component, scaffold	
Nup43 (16)	β-propeller	Y short arm component, membrane binding	
Seh1 (16)	β-propeller	Y short arm component, membrane binding	
Nup160 (16)	β-propeller, α-solenoid	Y long arm component, scaffold, membrane binding	
Nup37 (16)	β-propeller	Y long arm component, membrane binding	
ELYS (16)	β-propeller, α-solenoid, disordered	Y long arm component, scaffold, membrane binding	
Sec13 (16)	β-propeller	Y stem component, membrane binding	
Nup96 (16)	α-solenoid, disordered	Y stem component, scaffold	
Nup107 (16)	α-solenoid, disordered	Y stem component, scaffold	
Nup133 (16)	β-propeller, α-solenoid	Y stem component, scaffold, membrane binding	
Nup205 (8)	α-solenoid	Linker	
Nup93 (8)	α-solenoid, disordered	Linker	
Luminal ring	Pom210 (32)	Ig-like domains, transmembrane	Scaffold, membrane anchoring	
Pom121 (8)	Disordered, transmembrane	Linker, membrane anchoring	
Cytoplasmic filaments	Nup358 filament	Nup358 (40)	α-solenoid, coiled-coil, disordered, RBDs	Outer ring anchoring, homopentamerization, docking platform for Ran and transport factors	
Nup214 complex	Nup214 (16)	β-propeller, coiled-coil, FG repeats	Complex with Nup62/88, transport factor binding	
Nup62 (16)	FG repeats, coiled-coil	Complex with Nup214/88, transport factor binding	
Nup88 (16)	β-propeller, coiled-coil	Membrane binding, complex with Nup214/62	
Nup98 (16)	FG repeats, disordered, GLEBS	Transport factor binding, linker, RAE1 binding	
Nup42 (16)	FG repeats, Gle1 binding motif	Transport factor binding, bind and regulate Gle1	
Gle1 (16)	Coiled-coil, α-helical	DDX19 activation	
RAE1 (48)	β-propeller	Membrane binding	
DDX19 (16)	RecA-like domain	Bind mRNA and dissociate mRNA export factors	
Nuclear basket		Nup153 (32)	Disordered, ZnF, FG repeats	Basket anchoring, Ran and transport factor binding	
	Nup50 (16)	FG repeats, RBD	Ran and transport factor binding	
	TPR (32)	Coiled-coil, FG repeats	Scaffold, transport factor binding	
RRM RNA recognition motif, RBD Ran binding domain, GLEBS Gle2-binding sequence

Symmetric core nucleoporins

The symmetric core can be further divided into four concentric rings: an inner ring which lines the central channel and forms the NPC diffusion barrier, two outer rings (nuclear ring and cytoplasmic ring) which dock the cytoplasmic filaments and the nuclear basket, and a luminal ring in the NE lumen surrounding the NPC (Fig. 2a).34 The inner ring and outer rings are connected by eight filaments on each side of the NPC. The filaments limit the movement of the inner ring towards outer rings but permit dilation or constriction in the NE plane. NPCs are conserved across diverse species from yeast to humans, but the degree of conservation for different parts are not the same: the inner ring, out rings, and other regions are in descending order of conservation. The inner ring thus represents the most critical part for NPC functions, especially nuclear transport.

Nucleoporins forming the inner ring

The inner ring is divided into eight subunits by eightfold symmetry, and each subunit is symmetrical on both the nuclear and cytoplasmic sides. When viewed from the direction of transport, each subunit resembles an eighth slice of pizza with the center portion cut away (Fig. 2b).35 The inner ring subunits are porous, plastic, and weakly connected to one another, allowing them to deform and change pore size in response to stimuli.36–38 The inner ring subunit can be further divided into three layers based on the distance to the transport axis: a middle layer of nucleoporins that form the central scaffold, an outer layer of coat nucleoporins that associate with the membrane, and an inner layer of nucleoporins that form the diffusion barriers.39,40

The central scaffold of each subunit is composed of two copies of Nup188, two copies of Nup205, and four copies of Nup93.41 These scaffold nucleoporins are mainly α-helical solenoids that intercalate extensively. The relatively rigid scaffold prevents excessive shrinkage of nuclear pores when subjected to compression force from the membrane.42 The coat nucleoporins include Nup155 (6 copies), NDC1 (2 copies), and ALADIN (2 copies). Nup155 contains a β-propeller domain as well as an α-helical solenoid. Four copies of Nup155 use α-helical solenoid domains to form a cushion for the central scaffold and use β-propeller domains to contact the membrane. The interaction between the inner ring and membrane is strengthened by ALADIN and NDC1. ALADIN is a β-propeller fold that interacts with the membrane and the pore domain of NDC1. NDC1 contains an additional transmembrane domain anchoring the inner ring to the NE. The two ALADIN-NDC1 heterodimers also interact with two other copies of Nup155 that contact the two outer rings.

The barrier nucleoporins, also known as the channel nucleoporin heterotrimer (CNT),43 include Nup54, Nup58, and Nup62 (four copies each) and are anchored by the N-terminal SLiMs of Nup93.44 Each of these nucleoporins contains a C-terminal coiled-coil domain bundled alongside the other coiled-coil domains of the heterotrimer, as well as an N-terminal FG repeat domain extending into the central transport channel to form the diffusion barrier. These FG repeats are depleted of charged amino acids and, at high concentrations, can self-assemble into a hydrogel-like condensate, which allows the diffusion and transport of FG-interacting karyopherins but prevents the passage of other macromolecules, biophysically similar to the NPC barrier.45,46 FG repeats in two disordered inner ring nucleoporins, Nup98 and Nup35 (also known as Nup53), can simultaneously bind several α-solenoid nucleoporins, which are structurally related to karyopherins, through interactions resembling those found in FG-karyopherins.47 In this way, these linker nucleoporins thread together all three layers, stabilize the NPC, and play a role in recruiting inner ring nucleoporins during NPC biogenesis.39,48

Nucleoporins forming the outer rings

Outer rings refer to the cytoplasmic outer ring (cytoplasmic ring) and the nuclear outer ring (nuclear ring). These two rings are largely identical, except for copy number differences of select components (ELYS, Nup205, and Nup93).49 Copy number differences for these proteins are also observed between species or even within a single cell, however, the functional difference remains poorly understood.50 Remarkably, the human outer rings contain twice as many Y-shaped structures (knowns as Y complexes or coat nucleoporin complexes, 32 vs. 16) as yeast.51 The outer rings bind and curve the membrane, connect the inner ring through Nup155, and form docking sites to recruit asymmetric nucleoporins (e.g., Nup358).52 Several asymmetric nucleoporin domains are firmly bound to outer rings and are sometimes regarded as a portion of the outer rings. For simplicity, we consider those domains to be part of the cytoplasmic filaments or nuclear baskets and will discuss asymmetric nucleoporins separately in later sections.

In each outer ring, the Y complexes are arranged head-to-tail and form two concentric rings, each containing eight copies of Y complexes (Fig. 2c). The human Y complex is composed of 10 nucleoporin proteins that form a short arm (Nup75, Nup43, and Seh1), a long arm (Nup160, Nup37, and ELYS), and a stem (Sec13, Nup96, Nup107, and Nup133), together resembling the ‘Y’ shape (Fig. 2c).50,53 These nucleoporins contain either α-helical solenoid domains, β-propeller domains, or both, and membrane contact is primarily mediated by the β-propeller domains at the tips of the long arm and the stem. ELYS is not considered as a component of the Y complex by some groups because it is not uniformly present in all Y complexes. In X. laevis, the cytoplasmic ring has eight copies of ELYS, whereas the nuclear ring contains 16 copies.49 The extra copies of ELYS in the nuclear ring are well-exposed, functioning in chromatin binding, decondensation and gene transcription.50,54,55

The cytoplasmic ring can be divided into eight identical subunits, each containing two copies of Y complexes, one proximal and one peripheral (Fig. 2c). Except for the extensive interface between the two Y complexes, two linker nucleoporins, Nup205 and Nup93, connect and stabilize the two Y complexes. In addition, these two nucleoporins mediate inter-subunit interactions in a head-to-tail fashion, strengthening the outer ring scaffold. In Xenopus laevis, the cytoplasmic ring contains two copies of Nup205 and Nup93, while the nuclear ring subunit contains only one copy each of Nup205 and Nup93.49,56 Unlike the inner ring, the outer rings have extensive intersubunit interactions and rigid linkers, thus not allowing intersubunit movements. Stable outer rings are capable of restricting the inner ring movement through the Nup155 filament.38

Nucleoporins forming the luminal ring

The luminal ring (also known as the membrane ring) is within the perinuclear lumen of the NE and equatorially encircles the NPC.57 The luminal ring may sense membrane tension, set the NPC dilation limit, and buffer collisions with adjacent NPCs.34,37,58 The luminal ring appears as eight arches connected end to end and can be conceptualized as 16 parallelograms joined on their short sides (Fig. 2d).58,59 Since the luminal ring is connected to the inner ring via NDC1, the deformation of parallelograms can contract or dilate the associated inner ring. The deformation of parallelograms is likely passive, allowing the NPC to adapt to membrane tension and transport demands. The luminal ring contains Pom121 and Pom210 in vertebrates, both possessing a single-pass transmembrane region.42,57 Pom210, which contains 16 immunoglobulin-like domains, is responsible for the CryoEM density of the luminal ring, since each Pom121 contributes merely ~30 residues to the luminal ring.58 The pore side of Pom121 is largely unstructured and directly binds the β-propeller domains of Nup155 (the inter-ring filament) and Nup160 (Y complex component), thereby anchoring the cytoplasmic ring to the membrane.60,61 Whether and how Pom121 directly bind Pom210 are currently unclear.

The cytoplasmic filament nucleoporins

The cytoplasmic filaments are anchored to the cytoplasmic outer ring and possess long, flexible filamentous extensions into the cytoplasm. The exact architectural details of these extensions are not fully understood due to their conformational heterogeneity. These filaments are composed of less conserved accessory nucleoporins, being cell-type specific and modifiable by cellular processes.62,63 Nevertheless, cytoplasmic filaments play a crucial role in the recruitment of transport factors and the final step of protein and mRNA export.64 Nup214, Nup358, Nup98, and Nup42 are the main contributors to cytoplasmic FG repeats.33

Most of the molecular mass of the cytoplasmic filament is contributed by Nup358, which is large in size (358 kD) and high in copy number (five copies per filament).52 Five Nup358 molecules form a homopentameric complex using the coiled-coil domains and assemble onto the stems of two Y complexes using the N-terminal α-helical solenoid domains.52 Nup358 assembly in turn can stabilize the Y complex rings.65 The remaining domains of the five Nup358 molecules are entangled and flexibly extend into the cytoplasm, forming the observed 50 nm filamentous structures.66 The extended region of Nup358 contains four dispersed RanBP1-like Ran binding domains, a tandem array of eight zinc-finger RanGDP-binding domains, a binding site for the SUMO E2 ligase Ubc9 and RanGAP1, many FG repeats, and a catalytically active cyclophilin domain.67 These domains are involved in RanGTP hydrolysis, RanGDP recycling, and karyopherin docking.68–71

Alongside Nup358, the cytoplasmic ring is decorated with 16 copies of Nup214 complexes.50 This complex is constructed by eight nucleoporins including Nup214, Nup62, Nup88, Nup98, Nup42, Gle1, RAE1, and the ATP-dependent DEAD-box RNA helicase DDX19, although some of these proteins are not constitutively associated with NPCs.51 An earlier study showed that Nup358 assembly is dependent on the Nup214 complex, but the reverse is not true.72 Nup214, Nup88, and Nup62 uses the coiled-coil domains to form a heterotrimeric complex similar to the one observed in CNT. This complex is anchor to the short arm of the Y complexes and to the membrane, forming a multivalent interaction hub.50,52 Two other subcomplexes, Nup98/RAE1 and Nup42/Gle1/DDX19, are recruited to the vicinity using long linkers. The Nup214 complex thus localize critical factors to remove mRNA from its export factors in the final step of mRNA export.73 Unlike Nup358-mediated protein export termination, this process is independent of Ran and occurs closer to the central channel, but the biological significance is unclear.

Nuclear basket nucleoporins

In humans, the nuclear basket is made up of three nucleoporins: Nup50, Nup153, and Tpr. Tpr is the major structural component of the basket, as it has a large coiled-coil domain which allows for homo-oligomerization.74 Prior studies have demonstrated that Nup153 is responsible for tethering Nup50 to the nuclear pore and post-mitotic recruiting of Tpr to NPC, but not for stabilizing Tpr that is already anchored within the NPC.75–77 Unlike the cytoplasmic face, the nuclear face of NPC had minimal electron density beyond the symmetric core nucleoporins, indicating that the basket is anchored by short linear motifs.49,50,78 In agreement with this, depletion of multiple Y complex components, e.g., Nup75 (a Y short arm component) and Nup133 (a Y complex stem component), perturbed nuclear basket formation.59,79 Amphipathic helices from Nup1 (Nup153 orthologue) in yeast can induce membrane curvature and stabilize the nuclear ring.75,80 Nup50 and Nup153 forms a cargo disassembly station for nuclear import due to containing high affinity FG repeats interaction sites for importins.78 Besides nuclear transport, the nuclear basket is critical for cellular processes such as mRNA production and quality control, chromosome organization, and DNA damage repair,75,81,82 but how and why these processes occur at this location are largely unknown.

Karyopherins responsible for ferrying cargo across the nuclear pore complex

Karyopherins are molecules that ferry cargoes across NPCs either into or out of the karyo-compartment (the nucleus). These proteins are conserved from yeast to humans and are important in many cellular processes.83 Typical karyopherins are divided into three groups: importins, which import cargoes into the nucleus; exportins, which export cargoes to the cytoplasm; and biportins, which transport cargoes in either direction.4 These karyopherins rely on the GTPase RanGTP for cargo binding and dissociation.84 They are large in size (~ 1000 residues), forming alpha-helical solenoid structures.20 Generally, the highly acidic concave surface is used for interactions with RanGTP and cargo, and the convex surface presents hydrophobic pockets to interact with the FG repeats of the NPC. There are several small size transport factors that are not known as karyopherins, but similar to karyopherins, they can transport cargo through NPCs.85 On the other hand, a group of transport adaptor molecules (alpha karyopherins) are known as karyopherins, but they cannot independently transport cargo.86 In this section, each of these factors is explained in terms of the cargoes it recognizes, the mode in which cargoes are recognized, the cellular pathways in which it may specialize, and the associated diseases (Table 2).Table 2 Members of broad sense karyopherins

	Name (abbrv)	Synonyms	Cargo examples	Binding motif/domain	Cargo clustering	
Importin	Importin β1 (Impβ1/Impβ)	KPNB1, Kapβ1,	Many cargoes through the adaptors Impα1 and Snurportin, SREBP-2, NFκB, TFEB, PD-L1	A basic helix by IBB, globular domains	DNA synthesis, DNA repair, gene expression regulation	
Transportin 1 (TNPO1/TRN1)	Kapβ2	hnRNP A1, TDP-43, FUS, β-catenin, BAP1	Linear PY-NLS, RGG domain, poly PR peptide	RNA processing, nuclear division, tRNA ligases	
Transportin 2 (TNPO2/TRN2)	IPO3, Imp3	hnRNP A1, TDP-43, FUS	Linear PY-NLS,	RNA processing, DNA repair, HMG proteins	
Transportin 3 (TNPO3)	TrnSR2, TNPO-SR	ASF/SF2, CPSF6, CIRBP, HIV virus,	Linear motif R(pS/D/E)R(pS/D/E)	Transcription elongation, mRNA splicing and export	
Importin 4 (IPO4/Imp4)	RanBP4	Histones H3 and H4, Vitamin D Receptor, CEBPD	LPPRS(G/P)P linear motifs, histone H3-H4 globular domain	DNA metabolic processes, chromosome organization	
Importin 5 (IPO5/Imp5)	RanBP5, KPNB3	Ribosomal proteins, histone H3, influenza A virus RNA polymerase subunit PB1, DSCAM	Linear motif KP(K/Y)LV	Ribosomal biosynthesis	
RanBP6		STAT3			
Importin 7 (IPO7/Imp7)	RanBP7	Histone H1, HIV reverse transcription complex (RTC), Smad1, Yap1, DNA plasmids	Disordered histone tail	mRNA splicing factors, snRNPs, HMG proteins	
Importin 8 (IPO8/Imp8)		Smads, eIF4E, microRNAs		mRNA splicing factors, ribosomal proteins	
Importin 9 (IPO9/Imp9)	RanBP9	ARID3A, PFKP, histones H2A and H2B.	Histone H2A-H2B globular domain	Ribosomal proteins or mRNA splicing factors.	
Importin 11 (IPO11/Imp11)		BZW1/2, β-catenin, PTEN.		Developmental processes	
Exportin	Exportin 1 (XPO1, Exp1)	CRM1	p53, FOXO, Survivin, TFEB, cGAS.	Linear NES motif Φ-X1–3-Φ-X1–3-Φ-X1–3-Φ.	A broad spectrum of cargoes	
Exportin 2 (XPO2)	CAS, Cse1, Cse1L	Impα1–7	Globular domain	Impα only	
Exportin t (XPOT)		Mature tRNA	tRNA stem and two ends	Mature tRNA only	
Exportin 5 (XPO5)		Pre-miRNA, tRNA, hairpin RNA, RNA coexported proteins	The stem and 3’ overhang	Some double-stranded RNAs	
Exportin 6 (XPO6)		Actin			
Biportin	Importin 13 (IPO13)		Import GR, Mago-Y14, Ubc9, PDCD5, export eIF1A	Globular domains of Mago-Y14, Ubc9, and eIF1A	Chromatin modification, chromatin remodeling, and transcription.	
Exportin 4 (XPO4)		Sox2, SRY, PKM2, Smad, eIF5A, a subset of circRNAs in metazoans	Globular domains of eIF5A	RNAP II elongation factors, mRNA processing factors.	
Exportin 7 (XPO7)		RhoGAP1, 14-3-3sigma, p65	Basic folded domains	Diverse functions.	
RanBP17					
Smaill size	NTF2		Ran, CapG	GDP-bound Ran	Import of Ran and piggyback proteins	
NXF1 family	TAP	mRNA, piRNA		Nuclear export of different RNAs	
Hikeshi		Hsp70	Full length protein	Only Hsp70 import	
Adaptor	Importin α family	KPNA1/Impα5,

KPNA2/Impα1,

KPNA3/Impα4,

KPNA4/Impα3,

KPNA6/Impα7,

KPNA7/Impα8,

	NFκB, STATs, eVP24, PB2	Classical NLS containing one or two stretch(s) of polyK/R sequences	Broad range of cargoes	
Snurportin	Snurportin 1	m3G-capped U snRNPs		m3G-capped U snRNPs	
The name and synonyms include only those that have been used in recent years

The importins that import cargoes into the nucleus

Humans possess ten verified importins.87 The function of RanBP6 is unclear, but it is classified as an importin because it has high sequence homology (80% identity) to Importin 5. Importins bind to cargoes in the cytoplasm and release cargoes within the nucleus upon encountering the GTP-bound form of the GTPase Ran (Fig. 3). Generally, cargo binding and RanGTP binding are mutually exclusive, but RanGTP binds with a greater affinity and is thus able to dissociate cargoes.4 A proteomics study demonstrated that each importin recognizes a set of cargoes, although many of these interactions require further verification.88 Importins recognize cargoes in diverse ways, but all rely on positively charged amino acids in cargoes.4 This may explain why many cargoes are able to enter the nucleus using multiple importins.89,90Fig. 3 Model of protein nuclear import and export. Imported cargoes containing nuclear localization signals (NLSs) form complexes with importins in the cytoplasm, enter the nucleus through the NPC, and are dissociated from the importins with the aid of RanGTP. Nuclear export of cargoes starts with the formation of trimeric complexes consisting of exportin, nuclear export signal (NES)-containing cargo, and RanGTP. The trimeric complex transits through the NPC and is dissembled in the cytoplasm upon the hydrolysis of RanGTP. Certain species of RNA utilize protein adaptors to cross NPCs

Importin β1

The most widely studied importin is Importin β1 (Impβ1, also known as Importin β, karyopherin β1, or by its gene name KPNB1). Impβ1 acts as a transporter in classical nuclear import, wherein it recruits the adaptor protein Importin α (Impα, containing 7 isoforms) that directly binds to the cargo protein. The N-terminal Importin Beta Binding Domain (IBB) of Impα is basic and forms an α helix upon binding to Impβ1.91 Likewise, Impβ1 imports m3G-caped U snRNA by binding to the IBB of the adaptor snurportin.92 The use of adaptors enhances the diversity of cargoes recognized by Impβ1 and allows for fine regulation of nuclear import.93 Impβ1 may also directly recognize and import cargo without adaptors, for example, binding globular domains of the cholesterol metabolism transcription factor SREBP-2 to mediate its nuclear import.94 As a major import receptor, Impβ1 imports many cargoes, including the NF-κB subunit p65, autophagy transcription factor TFEB, and programmed cell death ligand 1 PD-L1.95–97 Most Impβ1 cargoes play a role in DNA synthesis and repair, as well as gene expression regulation.88 Impβ1 abnormalities are present in several diseases, such as upregulation in cancers and downregulation in neurodegenerative diseases.83,98

Transportin 1 and Transportin 2

Transportin 1 (TNPO1, also known as karyopherin β2) and Transportin 2 (TNPO2, also known as Importin 3) are highly homologous (85% sequence identity) and well-characterized importins that bind the PY (proline-tyrosine) nuclear localization signal (NLS) of cargo proteins.99 A typical PY NLS is disordered and contains two patches, an N-terminal positive/basic patch and a C-terminal [+]-X2–5-P-ϕ motif ([+], positively charged residue; ϕ, any hydrophobic residues including Y).99 In addition to the PY NLS, these importins bind arginine-glycine-glycine (RGG) domains in RNA binding proteins such as hnRNP A1, FUS, and the proline-arginine (PG) poly-dipeptides from C9orf72.100–103 As such, impairment of TNPO1 and TNPO2 causes those proteins to aggregate and condense in neuron cells, contributing to neurodegenerative diseases.83 Furthermore, TNPO1 imports the Wnt signaling effector β-catenin as well as the tumor suppressor BAP1, and many viruses exploit TNPO1 for nuclear entry and replication.104–107 Proteome analysis indicated that proteins related to nuclear division and tRNA ligases are preferentially cargoes of TNPO1, while proteins related to DNA repair and HMG proteins are preferentially imported by TNPO2.88 Interestingly, TNPO2 enhances export of a large proportion of mRNAs through the formation of a complex with RanGTP and the mRNA export factor NXF1,108 suggesting that it may be appropriate to classify TNPO2 as a biportin.

Transportin 3

Transportin 3 (TNPO3, also known as Transportin-SR or Transportin-SR2) specifically binds cargoes containing an arginine/serine (RS) domain.109 Counter intuitively, serine phosphorylation of TNPO3 cargoes reduces net positive charges but enhances TNPO3 binding.110 Structural analysis has demonstrated that TNPO3 uses a unique arginine-rich helix for interaction with phosphorylated serine residues, in addition to the common acidic patches that interact with positively charged residues in importin cargoes.111 Examples of TNPO3 cargoes include the alternative splicing factor/splicing factor 2 (ASF/SF2), cold-inducible RNA-binding protein (CIRBP), and polyadenylation specificity factor 6 (CPSF6).101,111 Many TNPO3 cargoes are RS-rich splicing factors.88 The HIV virus utilizes TNPO3 to facilitate its nuclear import and replication, and a natural TNPO3 mutation that causes limb girdle muscular dystrophy also provides strong resistance against HIV-1 infection.112,113 Refer to the Supplemental File for reviews on other importins.

The exportins that export cargoes to the cytoplasm

The human genome encodes five exportins to conduct the export of cellular proteins and RNAs. Unlike importins, exportins display low affinities to either RanGTP or the cargo, typically in the micromolar range. However, exportins can cooperatively bind cargoes and RanGTP and form nanomolar affinity complexes in the nucleus. After translocating through NPCs to the cytoplasm, the complex is disassembled via RanGTP hydrolysis.114 Each exportin recognizes cargo by a different mechanism, and there is no common rule for cargo recognition.115

Exportin 1

Exportin 1 (XPO1, Exp1, also known as chromosomal region maintenance protein 1, CRM1) is the best characterized exportin.115 There are approximately 200 validated XPO1 protein cargoes, including p53, FOXO, Survivin, TFEB, and the cyclic GMP-AMP synthase cGAS.116–118 XPO1 cargoes are often involved in translation, cytoplasmic mRNA metabolism, vesicle coat complexes, and centrosome proteins.119,120. XPO1 interacts with leucine-rich nuclear export signals (NES), which are typically made up of four large hydrophobic residues separated by 1–3 linker residues (conforming to a Φ-X1–3-Φ-X2–3-Φ-X1–3-Φ motif).121 These hydrophobic residues are arranged linearly and bind in a long groove on the convex side of XPO1.122 The groove opens and closes dynamically, and RanGTP binding to the concave side stabilizes the open groove conformation.123 On the other hand, cargo binding displaces a loop on the concave side (H9 loop) and prepares XPO1 for RanGTP binding. Utilizing different protein adaptors, XPO1 can also export a variety of RNA molecules.124,125 XPO1 is frequently overexpressed in cancers and impairs the function of many tumor suppressors by exporting them to the cytoplasm.126

Exportin 2

Exportin 2 (XPO2, cellular apoptosis susceptibility, CAS, or chromosome segregation 1-like, Cse1, Cse1L) is a dedicated nuclear export factor for the classical nuclear import adaptor Impα, which is unable to traverse NPCs alone.127 By wrapping around RanGTP and Impα and folding the IBB in the NLS binding sites of Impα, XPO2 ensures cargo dissociation from Impα before export.128 XPO2 depletion alters the localization of multiple silencing factors and reactivates many repressed genes, due to its indispensable role in classical nuclear import.129 As Impβ1, XPO2 is overexpressed in many cancers.130,131

Exportin 5

Exportin 5 (XPO5) exports pre-miRNA, and this step is necessary for proper miRNA maturation.132,133 The crystal structure illustrates that Exp-5:RanGTP recognizes the 2-nucleotide 3’ overhang structure and the double-stranded stem of pre-miRNA.134 Likely through the same RNA interface, XPO5 exports tRNA and other double-stranded RNA molecules, as well as co-exports proteins bound to these RNAs.135–138 Impaired miRNA maturation due to XPO5 dysregulation such as genetic mutation and phosphorylation-mediated inhibition has been observed in several cancers.139,140 However, XPO5 was reported to be expressed in colorectal cancer that promotes the expression of oncogenic miRNA, but how this is selective for oncogenic miRNA but not tumor-suppressive miRNA is not clear.140 Exportin 6 and Exportin t are reviewed in the Supplementary File.

Bidirectional transporters

Biportins can function as importins to import cargoes or as exportins to export cargoes. There are three verified biportins in humans, and RanBP17 is classified as a biportin due to its high sequence homology to the biportin Exportin 7. The use of dedicated importins and exportins may allow for more diverse cargo recognition modes and more specific pathway control. On the other hand, using biportins in transport is likely more economical than using importins and exportins separately.

Importin 13

Importin 13 (IPO13) is a well-characterized biportin which imports glucocorticoid receptor GR, the exon junction complex components Mago-Y14, the E2 SUMO-conjugating enzyme Ubc9, programmed cell death 5 PDCD5, while exporting translation initiation factor 1 A eIF1A.141–143 A proteomic study demonstrated that IPO13 binds to many cargoes functioning in chromatin modification, chromatin remodeling, and transcription.88,144 Crystal structures of IPO13 in complex with Mago-Y14, Ubc9, and eIF1A have illustrated the mechanism by which this importin uses different surfaces to interact with different cargoes and how it plastically changes conformation upon binding to different cargoes.142,145 IPO13 overexpression plays a role in several cancers, and loss-of-function mutations cause defects in eye morphogenesis,146–148 but which cargo(es) mediate these pathological consequences are unknown.

Exportin 4

Exportin 4 (XPO4) mediates nuclear import of transcription factors Sox2 and SRY, the glycolytic enzyme PKM2, as well as mediates nuclear export of Smad proteins, the hypusine-containing translation factor eIF5A, and interestingly, a subset of circRNAs.149–152 Many XPO4-imported cargoes identified by mass spectrometry are RNAP II elongation factors and mRNA processing factors.88 The export cargo eIF5A is bound to the convex and concave surface of XPO4, with the hypusine bound in an acidic pocket.152 It is unclear how XPO4 recognizes other cargoes, but its plasticity may play a role in binding to different cargoes. Reduced expression of XPO4 due to copy number variation sustains nuclear Smad levels and TGFβ signaling, thereby enhancing the severity of fibrosis in patients with metabolic-associated fatty liver disease.153

Exportin 7 and RanBP17

Exportin 7 (XPO7) was initially identified as an exportin for RhoGAP1 and 14-3-3sigma.154 It was then demonstrated that XPO7 could also recognize positively charged folded domains and mediate the nuclear import of NFκB/p65.155 A recent proteomic study showed that XPO7 may import and export hundreds of cargoes with diverse structures and functions.156 How XPO7 recognize cargoes has not been reported. Depletion of XPO7 correlates with poor overall survival in several cancer types due to lack of oncogene-induced senescence caused by insufficient nuclear localization of p21 transcription factor TCF3.157 RanBP17 is 67% identical to XPO7 but little is known about this protein.

Smaller size transport factors

There are a few smaller-sized transport factors that do not form α-solenoid. However, they function as karyopherins and are capable of recognizing cargoes and translocating through NPCs.158 Unlike typical karyopherins, they are very specific in cargo recognition, do not rely on the RanGTP for cargo binding and dissociation, and contain fewer FG pockets.159

Nuclear Transport Factor 2

One ‘small karyopherin’ is Nuclear Transport Factor 2 (NTF2), which contains only 127 amino acids. NTF2 is a dedicated RanGDP nuclear import factor that recycles inactive RanGDP to the nucleus.160 NTF2 forms a homodimer and uses a distinct hydrophobic cavity for recognition of RanGDP.161,162 Two identical FxFG binding sites within the dimer are used for FG binding and NPC translocation.158 How NTF2 is dissociated from RanGDP in the nucleus is unclear, but NTF2 inhibits the guanine nucleotide exchange activity of RCC1 on Ran.163 Nuclear translocation of Ran may simultaneously import ankyrin repeat proteins and the filamentous actin capping protein CapG via a piggyback mechanism.162,164,165

NXF1 family

The nuclear RNA export factor 1 (NXF1, also known as TAP) family of proteins possesses an NTF2 domain capable of FG repeat binding and interacts with NTF2-like export factor 1 (NXT1) to form a heterodimer reminiscent of the NTF2 homodimer.166,167 This heterodimer binds to FG repeats but not RanGDP.166 NXF1 facilitates mRNA nuclear export since it also contains several other domains that interact with RNA and other mRNA processing factors, such as the TREX complex.168 Unspliced RNAs are generally not exported, but type-D retroviruses use a ∼130 nucleotide RNA called the constitutive transport element (CTE) to bind NXF1-NXT1 without protein adaptors (e.g., TREX) to export their unspliced genomic RNA.169 Structural analysis shows that this CTE-RNA forms a symmetrical stem-loop motif that binds to a symmetrical site formed by two copies of NXF1-NXT1 dimers.167 In humans, NXF1 is a major mRNA export factor, but there are a few other less-understood NXF family export factors, such as NXF2 and NXF3.170,171 NXF2 appears to be a tissue-specific mRNA export factor.171 Interestingly, NXF3 lacks FG binding pockets and instead relies on binding to XPO1 to translocate through NPCs, illustrating the diversity of RNA export.125,172

Hikeshi

The heat shock nuclear import factor Hikeshi contains 197 a.a. and is structurally unrelated to NTF2. Under conditions of heat shock, importins are globally downregulated and Hikeshi mediates nuclear import of molecular chaperone Hsp70 to counteract heat-shock damage and increase cell viability.173 Hikeshi contains an FG-binding N-terminal domain (NTD) and a C-terminal dimerization domain, and forms an asymmetric dimer that recognizes the full-length ATP-bound Hsp70.174 Interestingly, an loop in NTD contains a FG motif that can dock into its own FG pocket, thereby autoinhibits its interaction with FG nucleoporins and nuclear import function. How this autoinhibition is lifted under heat shock, how Hikeshi recognizes Hsp70, and whether Hsp70 is exported by Hikeshi after completing its nuclear function are unclear.175

The transport adaptor molecules

The transport adaptor itself does not have NPC translocation capabilities; however, it can bind karyopherin and cargo at the same time, thereby facilitating cargo transportation. They play important roles in nuclear transport, and in fact, alpha karyopherins are the first ‘karyopherins’ identified.176 Any protein that contains an NES or NLS and forms a tight complex with another protein/RNA is a potential nuclear transport adaptor. Because the list of adaptors is very long, except for the few examples shown above, two classes of well-studied adaptors with broad utility are reviewed here.

Importin α family

The importin α (Impα, or karyopherin α) family of adaptors functions in classical nuclear import, and it recognizes classical NLS signals. A classical NLS contains one or two stretches of polyK/R (2-4) sequences which bind to one or two acidic patches in the concave surface of Importin α.177 Impα contains an N-terminal Importin beta binding (IBB) domain that directly binds to Impβ1.178 This IBB can also bind to its own NLS binding sites, playing an autoinhibitory role so that cargo binding only occurs in the presence of Impβ1.179 In humans, there are seven Impα family members (Impα1 - Impα7) that are ~ 50%–80% identical in sequence and completely identical in the NLS interaction surface.180 These members are not entirely redundant, as they differ in cargo specificity and tissue- or developmental-stage-specific functions.181–184 Impα binds to a broad range of cargoes, including NFκB, STAT transcription factors, Ebola virus VP24 protein (eVP24), and influenza Polymerase PB2, thereby often involved in different cancers and viral infections.185–188

Snurportin

Snurportin (also known as Snurportin 1, SNUPN) is the nuclear import adaptor for m3G-capped U snRNPs, which participate in pre-mRNA splicing.92 Similar to Impα, Snurportin uses an IBB domain to interact with Impβ1.189 SNUPN contains an NES and is recycled to the cytoplasm via XPO1.190 Structural analysis has revealed that SNUPN binds to XPO1 in a manner incompatible with snRNP binding, thereby ensuring cargo unloading prior to nuclear export.191

Ran system proteins determining transport direction and speed

The transport directionality of importins, exportins, and biportins relies on an elaborate RanGTP system.5 This system generates the RanGTP gradient, strictly partitioning RanGTP in the nucleus and RanGDP in the cytoplasm.192 This RanGTP gradient is maintained by the nuclear-specific distribution of Ran guanine nucleotide exchange factor (GEF) RCC1 and the cytoplasm-specific localization of the GTPase-activating protein (GAP) RanGAP1 (Fig. 4).193 RanGDP, which is continuously generated throughout transport, is recycled to the nucleus by the aforementioned NTF2. In addition to these essential factors, four Ran binding proteins (RanBP1, RanBP2, RanBP3, and Nup50) regulate the interaction between RanGTP and karyopherins, accelerating transport speed.194Fig. 4 The RanGTP system and regulatory proteins. Ran is predominantly GTP-bound in the nucleus and GDP-bound in the cytoplasm. RanGTP is exported to the cytoplasm in complexes with karyopherins (either importins or export-cargo-bound exportins). In the cytoplasm, RanBP1 or RanBP2 (Nup358) promotes the dissociation of RanGTP from karyopherin complexes, allowing RanGAP1-mediated GTP hydrolysis. RanGDP is recycled back to the nucleus by NTF2, dissociated from NTF2, and reloaded with GTP by chromatin-bound RCC1 (GEF). RanBP3 enhances the recruitment of RanGTP to exportins

Ran

The Ras-related nuclear protein Ran contains a typical small GTPase domain and a C-terminal flexible tail that interacts with Ran-binding domains (RBD).195 Ran is active when it is GTP-bound and inactive when it is GDP-bound. RanGTP typically binds importins with nanomolar to picomolar affinities, and its binding either directly clashes with the cargo or induces an importin allosteric change to induce cargo dissociation.196,197 The binding affinity between an exportin and its cargo is usually higher than micromolar; however, RanGTP and the cargo cooperatively bind to the exportin at an affinity of tens to hundreds of nanomolar.198 In the cytoplasm, RanGTP in the export complex (either RanGTP-importin or RanGTP-exportin-cargo) is hydrolyzed to RanGDP through the cooperative action of RanGAP1 and RanBP1/2.67 In mitotic cells, RanGTP production is localized to chromosomes to promote local spindle assembly and at a later stage, local NE and NPC assembly.199–201

RCC1

Regulator of chromosome condensation (RCC1) contains an NLS that mediates its nuclear import and binds chromatin in the nucleus.202 RCC1 directly binds nucleosomal DNA via its N-terminal tail and a DNA binding loop, and it binds nucleosomal histones via a switchback loop.203,204 It collapses the P-loop of Ran to release bound nucleotides, and increases guanine nucleotide dissociation by over five orders of magnitude.205,206 GTP/GDP exchange catalyzed by RCC1 is indiscriminate, but due to the greater abundance of GTP compared to GDP in cells, nuclear Ran is eventually charged with GTP.205 Because NTF2 inhibits RCC1-mediated nucleotide exchange, an unknown ATP-dependent factor dissociates RanGDP from NTF2 to allow for RCC1-catalyzed guanine nucleotide exchange.163,207 Chromatin-bound RCC1 is responsible for local production of RanGTP in mitotic cells.

RanGAP1

RanGAP1 (RanGAP) is a cytoplasm-localized Ran-specific GAP recruited to the cytoplasmic filament protein Nup358 when SUMOylated.69,208,209 RanGAP1 does not use an arginine finger but positions Ran’s catalytic glutamine in the active conformation to trigger hydrolysis.210 RanGAP1 is anchored to the kinetochore and mediates chromatid segregation during mitosis, and depletion of RanGAP1 drives chromosome instability and tumorigenesis.211,212

RanBP1, RanBP2, RanBP3, and Nup50

RanGTP is tightly wrapped within karyopherins and is inaccessible to RanGAP1 when nuclear export complexes (RanGTP-importin or RanGTP-exportin-cargo) enter the cytoplasm.213,214 RanBP1 is a coactivator of RanGTP hydrolysis that increases the rate of RanGAP1-mediated RanGTP hydrolysis by an order of magnitude.215 This is achieved through its Ran-binding domain (RBD), which tightly binds to RanGTP and increases the rate of karyopherin-RanGTP dissociation.127,216 RanBP1 contains an NES and is located exclusively in the cytoplasm.217 RanBP2 (also known as Nup358) contains four RBDs functioning similarly to RanBP1, namely, in dissociating RanGTP from karyopherins and allowing RanGAP1-mediated GTP hydrolysis.218 In contrast, RanBP3 is a nuclear-localized RBD-containing protein that promotes nuclear export cargo assembly.219 RanBP3 contains several FG sequences that can form high-affinity anchors with exportins and an RBD domain, facilitating recruitment of RanGTP to exportins.220 This lowers the entropic barrier for RanGTP loading, as exportins typically have low affinity for RanGTP.221,222 Basket-localized Nup50 contains a high-affinity importin-binding FG domain and a C-terminal RBD that can recruit RanGTP to accelerate cargo dissociation from importins.223,224 These domain features of Nup50 enable it to increase the rate of nuclear import complex disassembly and, ultimately, nuclear import.

RanBP2, SUMOylated RanGAP1, and Ubc9 together form the NPC-localized SUMO E3 ligase, thus potentially linking SUMOylation and nuclear transport.225–227 SUMOylation of sites within or adjacent to the NES or NLS can disrupt karyopherin binding or alter the binding partner of modified proteins to render them inaccessible to karyopherins, thereby altering protein localization.228,229 SUMOylation of a protein may also enhance its nuclear import or export, but the mechanisms are largely unknown.230 On the other hand, nuclear transport also regulates protein SUMOylation. The nuclear import of many proteins, such as Sp100 (a component of the PML nucleosome), is critical for their SUMOylation.231,232 Although these proteins may undergo SUMOylation during nuclear entry, their SUMOylation may also occur inside the nucleus by other SUMO E3 ligases. In fact, most SUMO-modifying enzymes and SUMOylated proteins, including many kinetochore proteins, are found in the nucleus.233,234 For example, the kinase Aurora B, a key regulator of mitosis, is SUMOylated at the centromere in early mitosis by SUMO ligases including the RanBP2 complex.235 Interestingly, NPC also binds to deSUMOylase. The major de-SOMOylating enzyme SENP2 localizes to NPCs by binding to Nup153 and is critical for the de-SUMOylation of ribosomal precursors and their subsequent nuclear export.236,237 Removal of the highly hydrophilic SUMO groups may reduce energy required to penetrate the hydrophobic NPC barrier, which is especially important for translocation of large cargoes such as ribosomal precursors. Exported proteins could theoretically be SUMOylated by the RanBP2 complex, but reports on this are limited.67 Among many SUMO-regulated processes, gene expression, DNA damage response, and immune response can occur in the vicinity of NPCs, and future discoveries on how NPC-mediated SUMOylation participates in these processes to impact diseases such as tumors and infections are anticipated.238,239 It remains largely unclear what determines whether a translocating cargo is SUMOylated and how SUMOylation and nuclear transport cooperate in specific pathways.

Translocating across the NPC barrier

Nucleoporins, karyopherins, and Ran system proteins work together to transport cargo through the NPC. Each NPC can transport cargo at a staggering rate of ~ 1000 molecules per second, especially considering that it simultaneously prevents non-specific passive diffusion.240 The passive diffusion size limit is reported to be 40 kD, but few macromolecules employ passive diffusion to cross NPC due to low efficiency.241 Although much is known about the individual NTPs, we remain uncertain how NPC simultaneously achieve such a high level of transport efficiency and selectivity. Both the barrier and its interaction with karyopherin are highly dynamic and complex, making them difficult to study with most existing techniques.242 The variety of different models that have been proposed highlights our current lack of consensus in this regard.243–247

The nature of the barrier is highly debated. For example, whether the barrier is cohesive or non-cohesive, or in simpler terms, whether the barrier is formed of highly condensed “hydrogels” or more dynamic and loosely packed “polymer brushes”.248,249 GLFG repeats containing nucleoporins such as Nup98 are highly cohesive and form hydrogels in vitro at physiological concentration, but charged FG nucleoporins are less cohesive and do not naturally form hydrogels.250,251 The hydrogels formed in vitro exhibits many characteristics similar to the NPC barrier.252 It is not difficult to imagine that by anchoring in the relatively rigid NPC scaffold, the GLFG repeats are locally enriched,253 thereby forming a hydrogel barrier in NPC.244,254 However, this raises the question of whether and how karyopherins can rapidly melt and thus pass through cross-linked gels as rapidly as observed. Furthermore, high-speed atomic force microscopy revealed that the center of the barriers was entangled but ‘did not condense into a tightly cross-linked network’.255 Another model proposed that the highly dynamic FG repeats prevent the passage of non-interacting macromolecules by means of entropic exclusion, i.e., FG repeats exclude passive diffusion by forming a non-cohesive and highly entropic ‘virtual gate’.22,256 Invasion of inert macromolecules limits the entropy of the FG nucleoporins, thus being energetically unfavorable. Regardless of the debates, it is now known that the FG domains account for only ~ ¼ of the molecular mass of the NPC lumen, with the other ¾ being karyopherins and the cargoes they carry.257 A number of studies have highlighted a ‘karyopherin-centric’ model whereby karyopherins are integral constituents of the barrier and are critical for preventing NPC leakage.258–260 This model could complement both the hydrogel model (to reduce cohesiveness) and the virtual gating model (to outcompete non-specific diffusion).259,261 Although NPCs are somewhat heterogeneous in composition, it is unlikely that different gating mechanisms exist in different NPCs, but more likely that they coexist in all NPCs.262

Another controversy concerns the process of translocation, i.e. how karyopherins (with or without cargo) translocate from one side of NPC to the other.263 One of the earlier models proposed that certain FG nucleoporins bind karyopherins on one side of the NPC, escort them across the barrier, and release them on the other side.224,264 However, data generated later showed that the interaction between FG repeats and karyopherins is rather dynamic: FG pockets rapidly binds, dissociates, and rebinds other FGs in vicinity.265 Thus, rather than remaining tightly bound to FGs of one nucleoporin throughout transport, it is more plausible that karyopherins rapidly “slide” on the FG repeats of different nucleoporins to move forward.266 The ‘Brownian motion’ model suggest that the translocation process in the barrier is energy-independent and directionless.267–269 However, this model does not account for two important facts: (1) the distribution of different types of FGs, i.e., XXFG, GLFG, and FXFG, is asymmetrical in NPCs,270,271 and (2) cargo-loaded karyopherins always have a stronger affinity for the FG type on their destination side.272–275 Further, uncontrolled movement of karyopherins may cause traffic congestion and reduce transport efficiency, especially for large cargoes. Therefore, an ‘affinity gradient’ model demands that, besides RanGTP control of transport direction outside the barrier, the trafficking inside the barrier is constrained to a single direction, with the asymmetrically distributed FG types establishing an affinity gradient for karyopherins and luring it towards the high affinity end.273,274 Here, we further add that different FG types can be abstracted as hydrophobic balls of different sizes, with FXFG, GLFG, and XXFG representing large (2 F), medium (1.5 F), and small (1 F) balls, respectively (two Fs in FXFG or LF in GLFG are held together when inserted into FG pockets, as illustrated by different crystal structures, Fig. 5). RanGTP and cargo binding regulate the FG pocket size of karyopherin, shaping it selective for certain size balls, as observed in the ‘reversible collapse’ model where Importin β1 but not Importin β1-RanGTP can bind and collapse FXFG containing Nup153.249 Take importin as an example, after cargo binding, its FG pocket enlarges to bind 2 F balls and move along the 2 F gradient to the basket side. In the nucleus, RanGTP binding reshapes the importin FG pocket to select for 1 F balls and drive the importin to the cytoplasmic side. Free importins tend to stay in one compartment (cytoplasm for most importins) since it is energetically unfavorable to move against the affinity gradient. This prevents energy wasting, since GTP is consumed during transport (via RanGTP hydrolysis) even when there is no cargo. Furthermore, this model could explain why more karyopherins are required for large cargoes to cross the NPC:276 more karyopherins provide more energy (moving down the affinity gradient yields energy) or traction force to overcome the energy required for penetration of large cargoes. The affinity gradient can provide each karyopherin with energy equal to that generated by RanGTP hydrolysis in one round of import and export, if not considering any energy loss. Along this thread, the cytoplasmic filament and nuclear basket can use the affinity gradient to select export complexes and import complexes, and only at these exposed locations, these complexes are terminated by RanGTP hydrolysis and RanGTP binding, respectively. Without these cytoplasmic and nuclear extensions, these import and export complexes may spend a longer time in the transport channel where RanGTP and RanGAP are excluded, and ultimately ruduce transport efficiency. This model could better explain the observed high efficiency of NPC transport.Fig. 5 Model of uni-directional translocation within NPCs. In NPC, XXFG (small ball), GLFG (medium ball), and FXFG (large ball) repeats are not uniformly distributed but exist in concentration gradients. NLS binding to importin in the cytoplasm rearranges importin HEAT repeats to generate large pockets with high affinity for FXFG repeats, thereby moving importin and the bound cargo toward the nucleus with the aid of the FG gradient. Nuclear RanGTP binding renders importin surface pockets small and selective for XXFG repeats, driving the export of the complex. Exportin can also take advantage of this FG concentration gradient. Concentration gradients of different FG repeats provides a traction force and restrains directionality, thereby contributing to the high transport efficiency of NPCs. This model also explains the biological significance of the cytoplasmic filaments and the nuclear basket in nuclear transport (see text)

Nuclear transport-independent functions of nuclear transport proteins

In interphase cells, NTPs play an important role in mediating the nuclear import and export of macromolecules. In mitotic cells, these proteins continue to regulate aspects of mitosis through fundamental principles of nuclear transport.277 Many NTPs act as molecular chaperones for highly basic cargoes to prevent aggregation and cellular degradation or form biomolecular condensates through phase separation.278 Some NTPs also interact extensively with chromatin, regulating its structure and transcription.279 Readers are redirected to these works for other atypical NTP functions such as cilia transport and nuclear sizing.280–283

Mitosis

In mitotic cells, the RanGTP system signals the location of chromosomes as a global positioning system (GPS). The RanGTP system cooperates with karyopherins to modulate key mitotic factors that are usually cargoes of karyopherins. Many nucleoporins are also critical players in mitosis and are highly involved in different stages of mitosis. These NTPs orchestrate many aspects of mitosis, and their defects may lead to genetic instability and tumorigenesis through different mechanisms. Although less studied, meiosis is also regulated by NTPs due to its similarity to mitosis.284,285

The role of RanGTP, Impβ1, and Impα1 in mitosis

In mitotic cells, RCC1 is constantly bound to chromosomes, continues to generate RanGTP surrounding the chromosome and promotes local mitotic spindle assembly and functioning.286 Defects in RCC1 localization or function perturb the RanGTP gradient, resulting in chromosomal misalignment, abnormal spindle pole number, abnormal chromosome segregation, and genome instability.287 RanBP1 can form a tight complex with RCC1/RanGTP and inhibit RCC1 function, thereby regulate spatial distribution and magnitude of mitotic Ran-GTP production at different stages.288 Many spindle assembly factors (SAFs), including NuMA, HURP, TPX2, and APC, are classical nuclear import cargoes, and a high concentration of RanGTP in the vicinity of the chromosome releases SAFs from Impβ1 and Impα1 (Fig. 6a).277 These released SAFs participate in microtubule nucleation, growth, stability, and organization.289 In the cortical region, Impβ1 and Impα1 inhibit the mitotic function of SAFs by binding to the NLS of these SAFs. NLS binding by Impβ1 and Impα1 often sterically masks the functioning region of an SAF, e.g., the microtubule-binding region of NuMA.290 This intricate system prevents spindle assembly at nonchromosomal locations. RanGTP regulation of spindle assembly is not a switch but rather a gradient from the chromosome to the cell cortex where importins and SAF activities are gradually tuned.291Fig. 6 Role of nuclear transport proteins in mitotic spindle assembly and chromatid segregation. a Chromosome-bound RCC1 catalyzes the production of RanGTP around chromosomes. RanGTP near the chromosomes dissociates spindle assembly factors (SAFs) from bound importins, and the released SAFs promote spindle assembly. In the cortical region of the cell, spindle assembly is inhibited by excess importins. b The Y complex nucleoporins are critical for the recruitment of γ-TuRC, which induces k-fiber formation (kinetochore-initiated spindle microtubules). XPO1 is recruited to the Y complex and strengthens the connection between the k-fiber and the kinetochore. RanBP2 and RanGAP1 are recruited by XPO1 and mediate chromatid segregation at anaphase

In addition to spindle assembly, the RanGTP-Impα1/β1 system regulates many other events in mitosis. For example, Impα directly competes with p115, a vesicle-tethering factor, for the interaction with the Golgi matrix protein GM130, inhibits p115/GM130-mediated vesicle fusion, and promotes Golgi disassembly in the early stages of mitosis.292 During anaphase, the TPX2 NLS is phosphorylated, and the bound importin α and β1 are dissociated, allowing Eg5 recruitment to promote centrosome separation.293 The formation of NE in late mitosis requires Lamin B-coated NE precursor vesicle-vesicle fusion at the vicinity of chromatin, a process possibly induced by local dissociation of Impβ1 from Lamin B receptor, which then simultaneously binds chromatin and NE vesicles.294 Likewise, nuclear pore assembly is also regulated by RanGTP and classical nuclear import karyopherins.295,296 These studies collectively highlight a model in which RanGTP regulates the activity of many mitotic factors through Impα1/β1 at different mitotic stages to ensure proper chromosome segregation.

The role of other karyopherins in mitosis

In addition to Impβ1/Impα1, TNPO1, TNPO2, and potentially other importins, are involved in mitosis.277 For example, TNPO1 is known to inhibit recruitment of the Y complex to kinetochores and suppress mitotic spindle assembly, a process that is counteracted by RanGTP.297 Furthermore, inhibiting TNPO1 induces the formation of microtubule asters in the mitotic cytosol, while cells depleted in TNPO1 display defects in spindle and cytokinesis.298 Other importins are rarely reported in mitosis regulation, but their importance should not be neglected because they can also bind many mitotic factors.88

As anticipated, exportins are involved in mitosis. In particular, exportin XPO1 is recruited to kinetochores via RanGTP- and NES-binding and is required for stabilizing the connection between kinetochores and k-fibers (kinetochore-initiated spindle microtubules).299 XPO1 is also present at centrosomes, recruiting pericentrin and γ-tubulin ring complex (γ-TuRC) to nucleate spindles from the centrosome.300 In addition, centrosome-localized XPO1 may also recruit other NES proteins such as NPM, p53, BRCA1, and cyclin B, to ensure the mitotic fidelity and prevent genomic instability.301 For example, XPO1-RanGTP controls the spatial/temporal recruitment of NES-containing NPM to prevent centrosome reduplication.302 Generation of the microtubule organizing center (MTOC) at the NPC in yeast requires Nup159 (human Nup214), XPO1, RanGTP, and the MTOC protein Mto1, where XPO1 simultaneously binds the Nup159 FG domain and the Mto1 NES to link them together.300 The E3 ligase Nup358/RanGAP1/Ubc9, which is recruited to kinetochores by XPO1, SUMOylates and recruits TopoIIσ to decatenate sister centromeres prior to anaphase onset.299,303 Nup358 haploid mice develop cells with anaphase bridges and severe aneuploidy, and are highly susceptible to tumor formation.257

The role of nucleoporins in mitosis

As shown in Fig. 6b, some of the dismantled NPC parts, especially the Y complex, are recruited to kinetochores and centrosomes, where they continue to function during mitosis.304 The recruitment of the Y complex to the kinetochore occurs through its component ELYS, and this process is inhibited by Impβ1 and TNPO1 that compete with kinetochores for ELYS binding.297,305 The kinetochore Y complex recruits γ-TuRC which induces k-fiber formation.285,306 The presence of the Y complex at kinetochores is required for the recruitment of XPO1 as well as chromosome passenger complex (CPC) proteins, a critical factor in chromosome alignment and segregation.307,308

Moreover, the proper expression levels of Nup98/Nup88/RAE1/Tpr/Nup153 are critical for spindle polarity, preventing aneuploidy and tumorigenesis.309 Mechanistically, Nup98 and RAE1 form a complex with the anaphase-promoting complex/cyclosome (APC/C) to inhibit premature progression into anaphase through inhibition of APC E3 ligase activity.310 Sequestration of Nup98/RAE1, by RAE1/Nup98 haploinsufficiency or overexpression of Nup88, can activate APC/C and induce degradation of the mitotic kinase PKL1, disrupt normal centrosome separation, and lead to aneuploidy.311 The spindle assembly checkpoint (SAC) proteins Mad1 and Mad2 associate with Tpr at NPC in interphase cells and are recruited to kinetochores in mitotic cells without Tpr, signaling to inhibit APC function until all kinetochores are attached to spindles.312 Cyclin B1-CDK1 is targeted to NPC at early mitosis and mediates Tpr phosphorylation to release Mad1 so that it can be recruited to kinetochore.313–315 In conclusion, studies have shown that NTS proteins play an indispensable role in mitosis, and that their dysfunction can distort mitosis and lead to genomic instability and cancers by different mechanisms. More studies are needed to reveal the complex spatiotemporal interactions and regulation mechanisms of NTPs in mitosis.

Disassembly and reassembly of NPC during mitosis

During mitotic entry, NPCs break down into subcomplexes within approximately 5 min and disperse to different regions of the cell.316 Phosphorylation of several nucleoporins is a decisive event for NPC disassembly and subsequent entry into mitosis.317,318 The responsible kinases include cyclin-dependent kinase 1 (CDK1), polo-like kinase 1 (PLK1), and NIMA-associated kinases (NEKs) NEK6/7.317,318 The CNT complex can recruit PLK1 to NPCs during mitosis in C. elegans.319 These kinases primarily hyperphosphorylate two nucleoporins, Nup98 and Nup35.318 Hyperphosphorylation of more than 15 sites in the Nup98 C-terminal domain dissociates Nup98 from NPCs and is the rate-limiting step in mitotic NPC disassembly.317 Nup98 and Nup53 are linker nucleoporins linking different NPC subcomplexes, and hyperphosphorylation of the intermolecular interaction sites disrupts their linker function, leading to their dissociation from NPC, dissociation of threaded subcomplexes such as the CNT complex, and exposure of more nucleoporins to be phosphorylated and disassembled.38,318 Y complexes are not further dissembled, but released into the mitotic cytoplasm, or recruited to kinetochores and assist in spindle assembly, or retained in the membrane with transmembrane nucleoporins to serve as templates for later reassembly.320 These studies highlight the role of hyperphosphorylation and inactivation of key linker nucleoporins in NPC disassembly.

It takes ~10 min to reassemble the NPC after anaphase onset.321 To start, the Y complex binds to chromatin via the C-terminal disordered region of ELYS.322 ELYS also recruits the phosphatase PP1, which dephosphorylates phosphorylated nucleoporins to allow their assembly.323,324 Chromatin-bound RCC1 and a high concentration of RanGTP in vicinity are critical in this process, since RanGTP relieves the inhibition of several importins on chromatin-Y complex interaction.277 Nup50 can bind and stimulate the activity of RCC1 and is also critical for NPC assembly.223 Mitotic NPC assembly and NE assembly are tightly coupled, possibly through the transmembrane nucleoporins.325 Membrane-embedded Pom121 can interact with the Y complex, allowing the nuclear membrane to form around newly formed (partial) NPCs.61,326,327 Another transmembrane nucleoporin, NDC1 is also critical for anchoring NPCs to membranes, since it interacts with (dephosphorylated) Nup35 which stabilize the inner ring subcomplexes.328 The recruitment of Nup98 to the inner ring and the Y complex may further stabilize the NPC scaffold.48 EM studies show that the cytoplasmic ring is assembled after the nuclear ring and inner ring.329 The mitotic reassembly of NPC described above is largely the reverse process of disassembly, but studies suggest that there may exist multiple reassembly pathways, e.g., cytoplasmic assembly of NPC precursors.330–332 More studies are needed to determine the proportion and detailed steps of different assembly pathways.

Regulation of biomolecular condensates

Owing to their acidic surface properties, karyopherins, especially importins, interact with many highly basic cargoes (HBCs).333 This interaction not only plays a role in the nuclear import of these HBCs but also prevents their binding to other cellular targets and sometimes their cellular degradation.278 A special group of HBCs is the RNA binding proteins (RBPs), including FUS, hnRNP A1, and TDP-43. These proteins contain intrinsically disordered regions that can phase separate within the cytoplasm to form membraneless liquid droplets or β-amyloid-like solid fibers.278 The chaperone activity of importins also disaggregates already oligomerized RBPs and may be exploited to halt or reverse neurodegeneration. In contrast, many FG nucleoporins can phase separate to form hydrogel-like permeable barriers or aggregate with other cellular condensates, playing key roles in physiological or pathological processes.

Ability to function as a molecular chaperone

Many highly abundant HBCs, such as histones and ribosomal proteins, readily aggregate with cytoplasmic polyanions such as RNAs.25 As early as 2002, Jakel et al. demonstrated that several importins, such as IPO4, IPO5, IPO7, IPO9, and Impβ1, can serve as chaperones for these HBCs. The chaperone activity of these importins requires their large acidic surfaces, which shield the basic patches in HBCs and thereby prevent the ionic aggregation of HBCs with cellular polyanions. This is conceptually similar to canonical chaperons that prevent hydrophobic aggregation of proteins with large hydrophobic surfaces. This chaperone activity not only prevents aggregation but also protects the HBCs from proteasome-mediated degradation, since aggregated proteins are prone to aggregation.334,335 Recent studies have confirmed and expanded upon this role.336,337 It has been shown that the disassembly of the IPO9-H2A-H2B complex requires the presence of DNA in addition to nuclear RanGTP.338 This stricter dissociation mechanism may also allow for the storage of unused histones.338 The chaperone function is not limited to importins, as it has shown that XPO4 can bind to the export cargo eIF5A and inhibit its undesired interactions before entering the cytoplasm.152

Ability to disaggregate RBPs

Some importin-chaperoned HBCs are the neurodegenerative disease-associated RBPs, including FUS, TAF15, hnRNP A1/A2, and TDP-43.278 These RBPs are typically larger and contain RNA recognition motif (RRM) domains, intrinsically disordered low complexity (LC) regions, and arginine-glycine-glycine rich (RGG) domains. These domains contain weak and multivalent interaction sites, predisposing these RBPs to undergo phase separation with or without RNA. Phase-separated RBPs can further form amyloid fibers under certain conditions.339 Importins, in contrast, inhibit their self-association and even dissolve aggregated RBPs (Fig. 7a).340 For example, TNPO1 inhibits and reverses fibrils formed by PY-NLS-containing FUS, TAF15, hnRNPA1, and hnRNPA2. Similarly, Impα and Impβ1 prevent and reverse TDP-43 fibrillation.341,342Fig. 7 Role of nuclear transport proteins in regulating biomolecular condensates. a Importins can act as molecular chaperons for highly positively charged cargoes, such as many RNA binding proteins. The interaction between importin and cargo inhibits cargo aggregation and disaggregates biomolecular condensates (including fibers) formed by cargo. Purple dots represent nuclear localization signal of cargo proteins. b Many FG nucleoporins can form biomolecular condensates either on their own and/or coaggregate with other biomolecular condensates, such as TDP-43 droplets and stress granules. Red dots represent FG dipeptides

The mechanism of importin-mediated RBP disaggregation is starting to be unveiled. First, an intact NLS in the cargo is required for the chaperone activity of importins. Equimolar importin are often required to fully dissolve the preformed hydrogels or fibrils.342 Second, binding to NLS alone is not sufficient to inhibit aggregation, since an antibody against FUS NLS did not inhibit FUS self-association.343 Similarly, XPO1 did not inhibit FUS aggregation when the NLS of FUS was replaced with an NES.344 This suggests that TNPO1 forms additional contacts with FUS in addition to its NLS interactions. However, these interactions are very weak, dynamic, and difficult to visualize using typical structural biology approaches.344 These interactions likely involve the acidic surfaces of importins and positively charged residues in the RRM/RGG domains of cargoes, as well as the FG pockets of importins and the FG dipeptides (or FG-like hydrophobic residues) of cargoes.278 For example, FUS contains two FG dipeptides and 19 FG-like YG dipeptides, and TDP-43 contains 8 FG dipeptides. Therefore, through NLS binding, importins may reduce the phase separation ability of RBPs by sequestering key elements that drive phase separation.345

Ability to form biomolecular condensates

FG domains are intrinsically disordered and contain weak multivalent interaction sites, such as positively charged residues and F/Y residues that can form π-cation interactions, and thus capable of phase separation like other intrinsically disordered domains. FG nucleoporins can be found in various cellular condensates, including amyloid-like fibers (Fig. 7b).346,347 Within the nuclear pore, the concentrated FG domains may aggregate into a condensed phase to form the selectively permeable barrier, although this is under debate.348,349 Karyopherins, which can form multivalent interaction with FG domain through FG pockets, coexist in these FG condensates and can fortify the NPC barrier to prevent NPC leakage. Additionally, many FG nucleoporins can phase-separate with other aggregation-prone proteins.248,350,351 Direct interaction between Nup98 and Tau is observed to promote phase separation of each other in vitro.352,353 Furthermore, fragments of Nup98 and Nup214, when fused with other DNA binding domains, can phase separate at chromosomal regions, a process that induces chromosomal looping and regulates transcription.354,355

Transcription regulation

As nuclear transport impacts the localization of different transcription factors, nuclear transport is naturally a critical step in transcription regulation.356 However, mounting evidence suggests that many nucleoporins can directly regulate transcription, independent of their function in nuclear transport.279,357 These nucleoporins can interact with transcription factors at promoters and enhancers.358 The end result may be either transcriptional activation or inhibition, and this regulation does not necessarily occur at the NPC locus.359 These activities are cell-type specific, and their dysregulation may drive the initiation and progression of different tumors.360,361

Transcription activation

More transcriptionally active genes are localized to NPCs from yeast to humans.362 Recruitment of active genes to NPCs may facilitate transcription factor binding immediately following nuclear import and coordinate transcription with subsequent nuclear export.363,364 Multiple studies have shown that nucleoporins can induce promoter-enhancer interactions, activating transcription.362,365 These nucleoporins are mainly from the nuclear outer ring and the nuclear basket.366 For example, Nup93 and Nup153 bind transcription factor-rich super-enhancers and drive the expression of key genes that specify cell identity.367 The nucleoporin Seh1 promotes transcription of proteins essential for oligodendrocyte differentiation through assembly of an Olig2-dependent transcription complex.368

Nucleoporins have been found to play a role in transcriptional activation not only at the nuclear pore complex but also in the nucleoplasm.359 Insides the nucleoplasm of Drosophila, several nucleoporins (Nup98, Nup62, and Nup50) interacts with development and cell cycle genes and activates their transcription.369 Similarly, Nup88 also binds to silent loci off-pore, and these nucleoporin-binding loci are often distinct from those NE contact sites.370 Nup98 can promote transcription by stimulating the ATPase activity of the DExH/D-box helicase DHX9.371 In leukemia, Nup98 is frequently fused to other DNA-binding homeodomain proteins, such as HOXA9, leading to the expression of oncogenes to drive leukemogenesis.372 The phase separation property of fusion nucleoporins seems critical for the transcription regulation activity. Interestingly, their condensation to chromatin depends on the chromatin-bound XPO1 that has formed a complex with RanGTP and a chromatin-bound NES-containing protein.373 Inhibition of XPO1 by leptomycin B disrupts the interaction of these nucleoporins with chromatin and reverses transcriptional activation mediated by these nucleoporins.373

Transcription repression

Less frequently transcribed heterochromatin is usually enriched at the nuclear periphery.374 Nup93 is associated with polycomb-silenced genes and physically interacts with a group of polycomb proteins, and polycomb repressive complexes containing Nup93 are more stable and localized to the nuclear periphery.375 Therefore, Nup93 may repress transcription by promoting heterochromatin formation.375 Similarly, Nup153 associates with the transcriptional start site of developmental genes and recruits polycomb-repressive complex 1, maintaining stem cell pluripotency in mammalian cells.376 Nup88 binds specifically to silenced genes; however, the regulatory mechanism is unclear.370

Genes near telomeres are less frequently transcribed due to the ‘positional effect’.377 Telomeres are localized at the nuclear periphery and bind silencing factors, such as Sir2, Sir3, and Sir4.378 In yeast, the Y complex component Nup170 (human Nup155), as well as the nuclear basket components Mlp1/2 (human Tpr), are critical for maintenance of the correct localization of telomeres.379,380 Furthermore, these nucleoporins can recruit silencing factors to telomeres.381 Depletion of these nucleoporins results in defective telomere silencing.382

Bimodal regulation

Actively transcribing genes are usually grouped into distinct topologically associated domains (TADs) with boundaries on both sides of the domain that insulate transcription within a TAD.383 The nuclear basket protein Nup153 interacts with key boundary proteins CTCF and cohesion to stabilize TADs.365 Therefore, Nup153 depletion leads to improper TAD boundaries as well as differential gene expression.365 Another study demonstrated that promoter binding by Nup153 increased gene expression, while transcriptional end site binding reduced gene expression.384 While it is conclusive that many nucleoporins can regulate transcription, whether phase-separation is involved in all these interactions and whether other NTPs regulate the process are largely unclear.

Diseases involving defects in nuclear transport proteins

Due to their high functional importance and relatively low gene redundancy, many NTPs are key players in different diseases. In particular, cancer cells often upregulate the expression of many karyopherins to alter the localization of cargoes or promote oncogenic transcription by creating nucleoporin fusion proteins.4,385,386 Defects in different NTPs downregulate nuclear transport and improperly localize key RNA-binding proteins such as TDP-43 in different neurodegenerative diseases.83 Many viruses exploit nuclear transport machinery to complete their life cycle in hosts and/or suppress host immune responses through impairment of nuclear transport.387,388 Inhibitors targeting various NTPs are being actively developed and clinically tested in relevant diseases.

Cancer

In the mitosis section, we showed that NTP dysfunction can result in improper mitosis, genetic instability and cancers. Cancer cells also frequently overexpress karyopherins or employ mutations to manipulate the localization of key proteins and RNAs to promote proliferation and evade tumor suppression. The most prominent example is overexpression or mutation of XPO1, which localizes many tumor suppressors to the cytoplasm to render them inactive. In addition, the transcriptional regulation function of several NTPs is also implicated in cancers. In leukemia patients, fragments of Nup98 and Nup214 are frequently fused to other proteins, resulting in fusion proteins that promote oncogenic transcription.

Overexpression of NTPs in cancer

Cancer cells often exhibit increased nuclear translocation velocity and capacity in response to faster signaling and metabolic stress, and many NTP proteins are overexpressed in cancer.98,389 XPO1 overexpression in many types of cancer correlates with disease severity and prognostic outcome in various studies.390 Mislocalization and inactivation of tumor suppressor proteins, such as P53, P21, and Rb, in the cytoplasm have been linked to XPO1 overexpression (Fig. 8a).391 Since overexpression of XPO1 is required to sustain multiple hallmark features of cancer,392 genetic or pharmacological inhibition of XPO1 is effective in a broad spectrum of cancer cells.131 XPO1 frequently mediates drug resistance, and XPO1 inhibitors were reported to enhance the efficacy of many clinically used drugs.115,393 However, the first-generation XPO1 inhibitor leptomycin B failed clinical trials due to high toxicity.394 Leptomycin B covalently binds to XPO1 and permanently inhibits its nuclear export function, but XPO1 is essential for the survival of all eukaryotic cells.16,395Fig. 8 Role of nuclear transport proteins in cancer. a Overexpression of XPO1 leads to mislocalization and subsequent inactivation of many tumor suppressors, such as P53. Inhibition of XPO1, for example, by the FDA-approved drug selinexor, correctly repositions the tumor suppressors in the nucleus and inhibits cancer cell growth. b In several hematopoietic cancers, nucleoporin fusion proteins cocondensate with other transcription factors around chromatin, induce aberrant chromatin looping and activate HOXA cluster oncogenes

Several reversible second-generation XPO1 inhibitors have been subsequently developed with significantly reduced toxicity.396–398 Among them, selinexor (KPT-330) was approved by the FDA in 2019 for the treatment of relapsed and refractory diffuse large B-cell lymphoma as well as multiple myeloma.115 Dozens of selinexor clinical trials are underway, either as a single agent or in combination with other therapies (Table 3).399–401 Eltanexor (KPT-8602), a next-generation inhibitor that is fast reversible and less permeable to the blood-brain barrier, is also being investigated in several clinical trials.402 These studies clearly demonstrate the efficacy of XPO1 inhibitors in patients with advanced and refractory human cancers, especially hematological cancers, either alone or in combination with pre-existing therapies. The adverse effects are mostly gastrointestinal and hematological, such as nausea, vomiting, anemia, and thrombocytopenia. In elderly patients with acute myeloid leukemia, reduced survival with selinexor was observed, but the reasons were unclear.403 See these reviews for earlier clinical trials.115,126,131Table 3 Recently completed clinical trials involving XPO1 inhibitors

Studies	Treatments	Efficacy (total number of patients)	High grade (>3) AEs	References	
Advanced soft tissue sarcomas, phase I	Selinexor 60 or 80 mg weekly plus 75 mg/m2 doxorubicin	Partial response 21% and stable disease 63% (24)	Neutropenia (56%), febrile neutropenia (28%) and anemia (24%)	494	
Advanced or metastatic malignancies, phase I	Selinexor 40 mg/m2 twice a week given 2 out of 3 weeks	Complete response 2.7% (74)	Hyponatremia (23%), fatigue (8%), vomiting (5%), thrombocytopenia (5%), and anemia (2%)	495	
Relapsed or refractory multiple myeloma, phase I	Eltanexor (KPT-8602) 5, 10, 20, 30, and 40 mg, given once daily for 5 days per week or 60 mg at days 1, 3, 5 of each week	ORR 33% (39)	Thrombocytopenia (54%), neutropenia (33%), and anemia (18%)	496	
Refractory/relapsed adult acute myeloid leukemia, phase I	Selinexor 60 mg (3 patients), 80 mg (3 patients), and 100 mg (7 patients) weekly	Complete remission 42% (12)	Non-hematologic AEs in 78.6% of patients	497	
Patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma, phase I	Weekly oral selinexor and daily oral ibrutinib	ORR 32% (34)	Thrombocytopenia (24%), anemia (18%), and neutropenia (12%)	498	
Recurrent metastatic solid tumors, phase Ib	Selinexor (60 mg or 80 mg twice weekly orally) and weekly paclitaxel (80 mg IV 2 week on, 1 week off)	ORR 17% (24)	Neutropenia (46%), anemia (31%), and nausea (21%)	499	
Advanced or metastatic solid tumors, phase 1b	Selinexor 40 or 60 mg combined with different standard chemotherapy	Disease control rate 14% (19)	Neutropenia (42%), leukopenia (26%), and hyponatremia (21%)	500	
Previously treated multiple myeloma, phase I/II	Selinexor (100 mg once per week), bortezomib (1·3 mg/m2 once per week), and dexamethasone (20 mg twice per week)	Median PFS 13.93 months (195)	Thrombocytopenia (39%), fatigue (13%), anemia (16%), and pneumonia (11%)	501	
Hypomethylating agents refractory myelodysplastic syndromes, phase I/II	Eltanexor 20 mg or 10 mg, days 1–5 each week	ORR 53% (15)	Infrequent	502	
Relapsed/refractory multiple myeloma, phase II	Selinexor 80 mg combined with dexamethasone 20 mg	ORR 29.3% (82)	Anemia (57.3%), thrombocytopenia (51.2%), lymphopenia (42.7%), neutropenia (40.2%), hyponatremia (29.3%), and lung infection (26.8%).	503	
Elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome, phase II	Standard chemotherapy with or without oral selinexor 60 mg twice weekly	Event-free survival without selinexor 45% (51) versus with selinexor 26% (51)	With selinexor, cardiac AEs (11%), gastrointestinal AEs (43%), infectious AEs (57%), metabolic and nutritional disorders AEs (46%)	403	
Heavily pre-treated Chinese patients with relapsed/refractory multiple myeloma, phase II	Oral selinexor 80 mg combined with dexamethasone 20 mg, twice a week	ORR 29.3% (82)	Anemia (57.3%), thrombocytopenia (51.2%), lymphopenia (42.7%), neutropenia (40.2%), hyponatremia (29.3%), and lung infection (26.8%)	503	
Recurrent glioblastoma, phase II	Selinexor 50 mg/m2 or 60 mg twice weekly, or 80 mg once weekly	Six-month PFS 12.6% (68)	Serious AEs in 34% patients; 1.3% fatal	400	
Refractory diffuse large B-cell lymphoma, phase IIb	Selinexor, 60 mg and 100 mg, twice weekly	ORR 29.1% (134)	Thrombocytopenia, lymphopenia, neutropenia, anemia, or hyponatremia in ≥15%	504	
Advanced, refractory dedifferentiated liposarcoma, phase II/III	Selinexor 60 mg twice weekly	PFS medians 2.8 months (188)	Nausea (80.7%), decreased appetite (60.4%), and fatigue (51.3%)	505	
Previously treated multiple myeloma, phase III	Oral selinexor (100 mg) and subcutaneous bortezomib (1.3 mg) once weekly and dexamethasone 40 mg per week	PFS median 11.76 for 2–3 prior lines (108)	Manageable and generally reversible AEs	506	
PFS progression-free survival, ORR objective response rate, AE adverse effect

Canonical nuclear import factors Impβ1 and Impα1 are overexpressed in multiple cancers, albeit less frequently than XPO1.87 Overexpression of these proteins may lead to nuclear entry of many oncogenic transcription factors (such as PDL1 and β-catenin) to promote tumorigenesis.98,404 The overexpression of other Impα isoforms and other karyopherins, such as XPO5, XPO6, and Imp8, has been reported in a few specific cancer types.140,184,405–407 In addition to karyopherins, other NTPs, such as Ran, Nup93, and POM121, have also been reported to be overexpressed in cancers, playing a role in cancer initiation and/or progression.356,408,409 Mechanistically, overexpression of nucleoporins and Ran is unlikely to cause cancer via promoting nuclear transport, but rather through their other functions such as mitotic and transcriptional regulation functions.

Mutations that change protein localization

Mutation also plays a role in altering cellular localization of key proteins in cancers. Notably, the XPO1 E571K mutation is present in a quarter of patients with Hodgkin lymphoma and primary mediastinal B-cell lymphoma.410 Moreover, E571K accelerated leukemogenesis in a mouse model of chronic lymphocytic leukemia.389 This mutation altered XPO1 localization and the interactome of XPO1 in B-cell lymphoma.411 Structurally, E571 is located proximal to the NES groove, and the E571K mutation can increase the affinity for XPO1 cargoes that have more acidic residues in the NES sequence.412

Many studies have identified pathogenic mutations occurring within cargoes rather than karyopherins.87 For example, the tumor potential of cyclin D1 depends on its nuclear retention.413 T286 mutations, which specifically disrupts cyclin D1 phosphorylation and XPO1-mediated nuclear export, have been found in primary esophageal carcinoma samples.413 Moreover, nucleophosmin (NPM), which is localized in the nucleus of normal cells, is cytoplasmic in approximately one-third of acute myeloid leukemia samples and plays a key role in leukemogenesis.414 This cytoplasmic localization of NPM occurred because of a frameshift in its last exon generated a new NES sequence that promoted its nuclear export.414 Understanding these different pathogenic mechanisms can help guide the development of precise medicines which specifically correct the localization of a particular cargo.

RNA export dysregulation and cancer

Similar to protein nuclear transport, RNA export is altered in many cancers. Human mRNA can be exported via XPO1/RanGTP-dependent pathways and NXT1/NXF1-dependent bulk export pathway.415 Multiple factors within these pathways are dysregulated across various cancers, such as XPO1, THO1, HuR, and eIF4E.415–417 In particular, ~ 30% of human cancers upregulate eIF4E levels, exporting a set of mRNAs containing eIF4E-sensitive elements through the XPO1 pathway.418 Many of these mRNAs encode oncogenes, including cyclin D1, NBS1, cMyc, and MDM2, leading to activation of proliferation pathways such as Akt.419 There are over a dozen clinical trials using the eIF4E inhibitor ribavirin on different cancers.420 The bulk mRNA export factor NXT1 was also identified as a genetic dependency in neuroblastoma and several pediatric cancers.421

Defects in pre-miRNA export are also observed across many cancers. Mature miRNAs are often downregulated in cancer, and several mechanisms are known to reduce miRNA levels.422 In a subset of human tumors with microsatellite instability, several XPO5-inactivating mutations trapped pre-miRNAs within the nucleus and reduced miRNA-target inhibition.423 In another study, ERK phosphorylation of XPO5 induces a conformational change in XPO5, making it unable to load pre-miRNA appropriately.424 XPO5 phosphorylation is associated with poor prognosis in liver cancer patients.424 Epigenetic change and abnormal XPO5 expression levels also impact miRNA expression and have profound effects on tumorigenesis.132

Nucleoporin fusions that alter transcription

In a wide array of hematopoietic malignancies, chromosome translocations often result in Nup98 oncogenic fusion proteins associated with poor prognosis.425,426 Fusion proteins typically include the N-terminal FG domain of Nup98 and the C-terminal domain of a partner protein such as HOXA9.427 Many fusion proteins physically interact with mixed lineage leukemia 1 (MLL1) and nonspecific lethal (NSL) histone-modifying complexes, an interaction that is critical for its leukemogenesis ability.428,429 These fusion proteins can upregulate the HOXA cluster gene and inhibit hematopoietic precursor differentiation (Fig. 8b).385,425 In acute myeloid leukemia, the loss of the direct transcriptional target CDK6 severely attenuated fusion-driven leukemogenesis.430 In addition to Nup98 fusions, fusions containing fragments of Nup214 or Tpr have also been observed in several cancers and can similarly drive cancer progression.431–433

The oncogenic property of fusions depends not only on fused domains that bind DNA or modify histones but also on the FG domain of Nup98.385,434 The FG domain is capable of liquid-liquid phase separation and is critical for puncta formation on chromatin.354,372 This property promotes binding between the fused domain and chromatin, generating a broad superenhancer-like binding pattern that potentiates transcriptional activation of proto-oncogenes.354

Neurodegenerative diseases

Unlike cancers, nuclear transport is often impaired in neurodegenerative diseases (NDDs), including amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer’s disease, and Huntington’s disease.435 Cytoplasmic aggregation of RBP proteins such as TDP-43 and FUS is a hallmark of NDD.436 The microtubule-associated protein Tau is not known as an RBP but it is also capable of binding RNA and other RBPs, especially in disease.437,438 These RBP proteins are normally nuclear but are predominantly aggregated in the cytoplasm of diseased neurons.439 For example, mislocalization and aggregation of TAR-DNA binding protein 43 (TDP-43) is observed in ~98% of ALS cases.440 Similarly, cytoplasmic FUS aggregates are a pathological hallmark in a subset of patients with FTD or ALS. The loss of RBP nuclear function and gain of RBP cytoplasmic function are critical for the pathogenesis of NDD.439 Many studies indicate that impaired nuclear transport is responsible for RBP pathology and is a common factor in many NDDs,350 highlighting a promising area of research that could lead to the discovery of new therapies for NDDs.

The vicious cycle between nuclear transport impairment and RBP pathology

Impaired nuclear transport of RBP proteins is a major cause of RBP mislocalization. Some RBP cargo mutations that occur in neurodegenerative diseases promote accumulation and aggregation in the cytoplasm.278 For example, many FUS-NLS mutations impair TNPO1 binding, promoting cytoplasmic phase separation and stress granule partitioning of FUS.343 Phosphorylation or mutation of the NLS of TDP-43 disrupts the nuclear import and chaperone activity of Impα1/β1.441 Furthermore, many NTPs, including karyopherins and nucleoporins, are downregulated in NDD cells. Therefore, impaired nuclear transport is increasingly recognized as a pathogenic driver of neurodegeneration.442

The cytoplasmic aggregation of RBPs is not only a consequence of impaired nuclear transport but may in turn lead to defective nuclear transport. For example, cytoplasmic TDP-43 droplets may recruit and mislocalize importin-α, Nup62, RanGAP1, Ran, and Nup107, leading to inhibition of nuclear transport and eventual neuronal cell death.443 Likewise, pathogenic Tau can lead to NPC dysfunction by directly interacting with NPC components, causing their mislocalization.444 Therefore, current studies support the existence of a vicious cycle in NDD, i.e., the progressive deterioration of RBP localization and nuclear transport (Fig. 9).Fig. 9 Vicious cycle between cytoplasmic condensation of RNA binding proteins (RBPs) and defective nuclear transport. Cytoplasmic condensation of RBPs (such as FUS and TDP-43) recruits many nuclear transport proteins (such as importins, nucleoporins, and Ran system proteins) into the condensates and disrupts normal nuclear transport (especially import). Impaired nuclear transport further leads to cytoplasmic accumulation of RBPs and excessive condensation. The vicious cycle can be triggered by genetic factors such as mutations or external factors such as chronic stress

Nuclear transport protein abnormalities in NDD

Karyopherins, especially importins, play an important role in the nuclear import of RBPs. For example, upregulation of Impα3 reduces the cytoplasmic accumulation of TDP-43 and mitigates behavioral deficits in mice.445 Alternatively, inhibition of protein nuclear export also suppresses neurodegeneration.446 In addition to their canonical role in nuclear import, importins sculpt cytoplasmic membraneless organelles and dissolve the ‘irreversible’ precipitates or beta-amyloid-like fibers formed by RBPs, as explained in section 4.2.2.103 Therefore, karyopherins exhibit two distinct roles in NDD, as mediators of RBP nuclear localization and as molecular chaperones that inhibit RBP aggregation, and karyopherin abnormalities can trigger the onset and progression of NDD.

Karyopherin abnormalities are widely observed in NDD.83 For example, protein levels of Impα1 and XPO2 are reduced in the frontal cortex of FTD patients, and Impβ1 is reduced in the spinal cord of ALS patients.447,448 Furthermore, karyopherins are often sequestered into stress granules and TDP-43 droplets in diseased neuron cells.351,449 Several patient-derived TNPO2 variants that impair RanGTP or cargo binding have been shown to be responsible for neurodevelopmental abnormalities.450 These observations are consistent with genetic perturbation studies, suggesting that karyopherin abnormalities may mediate NDD pathogenesis. Upregulating the expression levels of several aforementioned importins in neuronal cells of patients is a promising strategy for the treatment of those NDDs without RBP NLS mutations.

In addition to karyopherin abnormalities, loss of nuclear pores, nucleoporin aggregation, and altered nuclear morphology are some of the most prominent features across a variety of NDD cells and animal models.451,452 Through phase separation, aggregated TDP-43, FUS, and Tau mislocalize FG nucleoporins and trigger the structural and functional impairment of NPCs.444,453 For example, the nucleoporin Nup62 colocalizes with TDP-43 granules in diseased brain cells.351,454 Although importins can reduce these cytoplasmic condensates formed by RBPs and nucleoporins, they may be overwhelmed and trapped by these excessive biocondensates in diseased cells.455 Impaired mRNA export is often observed in NDD cells, as many FG nucleoporins are critical for mRNA export.452,456 Furthermore, specific nucleoporin mutations may lead to cell type-specific neurological disorders.350 For example, a homozygous splicing mutation in Nup133 causes Galloway-Mowat syndrome, highlighting the importance of nuclear transport in NDD.457 Nucleoporin alterations and the consequential loss of NPC function may lie upstream of TDP-43 mislocalization in NDD.458 Abnormalities in nucleoporins (such as Nup62, Nup93, Tpr, and Nup153) also impact non-neuron cells, contribute to aging and premature aging at the organism level.459

Other factors that may initiate the vicious cycle

Many studies have demonstrated that C9ORF72 hexanucleotide (GGGGCC) repeat expansion (HRE, either familial or sporadic) may act as an initiator of the vicious cycle. HRE, the most common genetic cause of ALS and FD, encodes proteins containing extra intrinsically disordered regions. One of the encoded poly-GR proteins tightly binds to Impα1, directly disrupting the nuclear import of endogenous cargoes.460 A mutant C9ORF72 can induce proteasome-mediated degradation of select nucleoporins.461 Mutations that generate extra intrinsically disordered regions in proteins such as huntingtin and ataxin1 can similarly initiate the vicious cycle.462,463 In addition to the protein, HRE RNA initiates a decrease in POM121, which may further lead to downregulation of seven additional nucleoporins.464 The HRE RNA can also sequester RanGAP1 and distort the RanGTP gradient, disrupting nuclear integrity and transport.465 Several components of nuclear transport can also effectively combat the toxicity of C9ORF72 HRE by means of nuclear import and anti-aggregation.466

In addition to genetic factors, external factors may initiate the vicious cycle. The formation of stress granules is a typical response of cells to a broad range of stresses. However, stress granule formation may sequester critical NTPs, like RBP biocondensates, thereby inhibiting nuclear transport.467 Therefore, constitutive oxidative stress throughout aging may persistently impair nuclear transport and lead to irreversible NDD. Likewise, a recent study using Drosophila demonstrated that traumatic injury leads to NPC defects, impairing the RanGTP gradient, and leading to cytoplasmic aggregation of Nup62 and TDP-43.454 This may explain why traumatic brain injury is a predisposing factor for several neurodegenerative diseases. Since cellular localization of a protein is determined by both its nuclear import and nuclear export, nuclear export inhibitors may be applied after a traumatic injury to prevent NDD. Based on two encouraging preclinical studies,468,469 it is worth further testing whether XPO1 inhibitors can clinically slow down or even reverse some of the discussed NDDs.

Viral infection

Many viruses replicate in the nucleus of host cells and rely on the nuclear transport system for their nuclear entry. In addition, nuclear transport plays a role in other stages of the viral life cycle, such as uncoating and viral RNA export. Viruses have developed specific strategies to suppress host immune responses by targeting karyopherins, thereby avoiding clearance by the host. In addition to targeting karyopherins, viruses may inhibit or distort host nuclear transport by altering NPC integrity.

Exploitation of nuclear transport proteins to complete the viral infection cycle

Several RNA viruses and nearly all DNA viruses require access to the host cell nucleoplasm for replication.470 Following virus-cell fusion, a core consisting of capsid proteins (CA) surrounding the viral genomic DNA/RNA enters the cytoplasm of host cells.471 The NPC filament proteins Nup214 and Nup358 can bind to capsid proteins and are critical for NPC docking.472 Prior to genome import and replication in the nucleus, the core of most viruses must be uncoated by cytosolic host proteins such as karyopherins.473 TNPO1, which promotes the removal of M1 from the core by binding to a PY-NLS sequence in the matrix protein M1, is a common uncoating factor for influenza A virus (IAV) and human immunodeficiency virus type 1 (HIV-1).107

Most of these viruses utilize cellular nuclear import machinery for their nuclear entry.474 For example, IAV vRNP uses Impα7 for its nuclear import.475 Although viral mechanisms for crossing NPCs are complex and diverse, interaction with Impα/β1 is absolutely critical for nuclear entry of many viruses.476 The macrocyclic lactone ivermectin, which is reported to target IMPα/β1, has broad-spectrum activity against a variety of viruses, including HIV-1, DENV, ZIKV, West Nile virus (WNV), and SARS-CoV-2 (COVID-19).387 Our group, however, have observed no direct binding between ivermectin to IMPα1 or β1, nor inhibition of classical nuclear import using physiological relevant concentrations of ivermectin (unpublished). Through inhibition of the binding of NS5 and Impα1, N-(4-hydroxyphenyl) retinamide (4-HPR) has anti-ZIKV activity at low μM concentrations.387

Human retroviruses such as HIV and human T-cell leukemia virus type 1 (HTLV-1) require export of their intron-containing RNAs from the nucleus to the cytoplasm for translation and packaging. Two viral proteins, Rev and Rex, act as export adaptors to facilitate export of viral RNA through simultaneous binding of the viral RNA and the export factor XPO1.477 Inhibition of XPO1 thus results in sequestration of key viral accessory proteins and genomic materials in the host cell nucleus, thereby reducing the replication of viruses such as influenza, respiratory syncytial virus (RSV), and SARS-CoV.478 Clinical studies using the XPO1 inhibitor selinexor are currently in progress.388 Since XPO1 suppress inflammation and immune activation through the NFκB pathway, the application of XPO1 inhibitors in different cancers may also result in bacterial infection, a major cause of poor clinical outcomes.478,479 Therefore, combination with antibiotics should probably be considered in the treatment of cancers or viral infections.

Evasion of immune clearance by inhibiting protein nuclear import or mRNA nuclear export

As a defense mechanism, human cells upregulate the interferon response to combat viral infections. Typically, upon viral stimulation, IRF and STAT transcription factors are imported into the nucleus, subsequently transcribing and exporting an array of mRNAs encoding immune factors.480 Viruses have evolved different strategies to inhibit this process. Open reading frame 6 (ORF6) of SARS-CoV-2 binds to Impα1 to inhibit IRF3 nuclear import and the type I interferon response.481 Similarly, Ebola virus VP24 binds importin alpha proteins and inhibits STAT1 nuclear import, rendering cells refractory to IFNs.187 Zika virus NS2A protein induces degradation of Impα1 through chaperone-mediated autophagy.482 In contrast, the influenza virus NS1 protein blocks host mRNA nuclear export by directly interacting with the NXF1-NXT1 export machinery.483

Viruses can also disrupt the host immune response by targeting nucleoporins. For example, the 2Apro protease of poliovirus and rhinovirus cleaves Nup62, Nup98, and Nup153.484,485 Alternatively, mengovirus and cardioviruses can inhibit nuclear transport through induction of hyperphosphorylation of nucleoporins such as Nup162, Nup35, and Nup214.486,487 Cytoplasmic mislocalization of NPC parts, such as Nup214, Nup358, and Nup62, is frequently observed in cells infected with different viruses.472,488,489 Moreover, ORF10 and ORF6 from several viruses repress host mRNA export by interacting with RAE1 and Nup98.490,491 These actions inhibit antiviral responses and may also prevent cell death to allow viral replication or induce NE leakage to permit viral genome entry into the nucleus.472 While the above findings are well documented, actual infections are often more complex and dependent on the specific virus and the infection stage.492

Conclusion and perspectives

Due to the complexity and structural dynamics of NPCs, a complete atomic model has not been achieved thus far, despite enormous efforts. It is expected that with continuous improvements in resolution power and artificial intelligence, an almost complete atomic NPC structure will soon be obtained. Different conformations of NPCs may be obtained to illustrate how NPCs transit from one to another. While atomic models cannot be established for disordered regions, it should be possible to correctly understand their function in the broader context of structured regions. Such structural information is crucial for understanding the canonical function of NPCs, interpreting the pathogenic mechanisms of disease mutations, and developing targeted drugs for related diseases.

A few karyopherins, including XPO1 and classical nuclear import factors, are well studied; however, little is known about many other karyopherins. While some karyopherins (especially importins) are redundant in transporting certain cargoes, they do vary widely in terms of function and spatiotemporal expression. Furthermore, often selected karyopherins are reported to play key roles in different diseases. Therefore, it is important to study the structures, cargo recognition mechanisms, and affiliated pathways of each karyopherin. Furthermore, the development of potent and selective inhibitors has been limited to only a few karyopherins.493 The development of specific inhibitors is not only beneficial to basic research but may also provide new therapies for imminently threatening diseases.

In addition to their role in nuclear transport, nuclear transport proteins play roles in other cellular processes, such as mitosis, biomolecular condensate regulation, and transcription regulation. These functions share common fundamental principles with the nuclear transport function, including the interaction network and assembly principle, but can be completely distinguished from nuclear transport. For example, nuclear transport, mitosis, and gene transcriptional regulation of NTPs are important for tumorigenesis, while the nuclear transport and regulation of biomolecular condensate functions of NTPs are clearly involved in NDDs. Future studies involving NTPs should try to clarify which specific functions of an NTP are important for the phenotype or disease in question.

The nuclear transport system is a double-edged sword that keeps cells functioning properly. Generally, upregulation of nuclear transport may lead to cancer, and downregulation may lead to NDD. Viruses may either use nuclear transport to facilitate their replication or inhibit nuclear transport to evade immune surveillance. Therefore, while treating one disease, care must be taken to avoid causing another. For example, when treating tumors through inhibition of highly expressed NTPs, it is important to avoid triggering NDD development. Likewise, when upregulating importins to treat different NDDs, the risk of carcinogenesis should be considered. Tissue-specific targeting or delivery may be helpful in this regard.

Supplementary information

Supplemental text

Supplementary information

The online version contains supplementary material available at 10.1038/s41392-023-01649-4.

Acknowledgements

This work was funded by the National Natural Science Foundation of China (NSFC # 82273850).

Author contributions

Q.S. wrote the draft. Y.Y., L.G., C.L., B.G., and D.J. provided relevant resources and revised the manuscript. All authors have read and approved the article.

Competing interests

The authors declare no competing interests.

These authors contributed equally: Yang Yang, Lu Guo, Lin Chen, Bo Gong.
==== Refs
References

1. Macara IG Transport into and out of the nucleus Microbiol Mol. Biol. Rev. 2001 65 570 594 11729264
Macara, I. G. Transport into and out of the nucleus. Microbiol Mol. Biol. Rev. 65, 570–594 (2001). table of contents.11729264
2. Cautain B Hill R de Pedro N Link W Components and regulation of nuclear transport processes FEBS J. 2015 282 445 462 25429850
Cautain, B., Hill, R., de Pedro, N. & Link, W. Components and regulation of nuclear transport processes. FEBS J. 282, 445–462 (2015).25429850
3. Beck M Hurt E The nuclear pore complex: understanding its function through structural insight Nat. Rev. Mol. Cell Biol. 2017 18 73 89 27999437
Beck, M. & Hurt, E. The nuclear pore complex: understanding its function through structural insight. Nat. Rev. Mol. Cell Biol. 18, 73–89 (2017).27999437
4. Wing CE Fung HYJ Chook YM Karyopherin-mediated nucleocytoplasmic transport Nat. Rev. Mol. Cell Biol. 2022 23 307 328 35058649
Wing, C. E., Fung, H. Y. J. & Chook, Y. M. Karyopherin-mediated nucleocytoplasmic transport. Nat. Rev. Mol. Cell Biol. 23, 307–328 (2022).35058649
5. Izaurralde E The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus EMBO J. 1997 16 6535 6547 9351834
Izaurralde, E. et al. The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus. EMBO J. 16, 6535–6547 (1997).9351834
6. Oka M Yoneda Y Importin alpha: functions as a nuclear transport factor and beyond Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2018 94 259 274 30078827
Oka, M. & Yoneda, Y. Importin alpha: functions as a nuclear transport factor and beyond. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 94, 259–274 (2018).30078827
7. Damizia M Altieri L Lavia P Non-transport roles of nuclear import receptors: In need of the right balance Front Cell Dev Biol. 2022 10 1041938 36438555
Damizia, M., Altieri, L. & Lavia, P. Non-transport roles of nuclear import receptors: In need of the right balance. Front Cell Dev Biol. 10, 1041938 (2022).36438555
8. Zhang ZM SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7 Cell Death Dis. 2022 13 174 35197448
Zhang, Z. M. et al. SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7. Cell Death Dis. 13, 174 (2022).35197448
9. Maik-Rachline G The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer Sci Signal. 2018 11 eaao3428 29636389
Maik-Rachline, G. et al. The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer. Sci Signal. 11, eaao3428 (2018).29636389
10. Watson ML Further observations on the nuclear envelope of the animal cell J. Biophys. Biochem. Cytol. 1959 6 147 156 13843146
Watson, M. L. Further observations on the nuclear envelope of the animal cell. J. Biophys. Biochem. Cytol. 6, 147–156 (1959).13843146
11. Stevens BJ Swift H RNA transport from nucleus to cytoplasm in Chironomus salivary glands J. Cell Biol. 1966 31 55 77 5971975
Stevens, B. J. & Swift, H. RNA transport from nucleus to cytoplasm in Chironomus salivary glands. J. Cell Biol. 31, 55–77 (1966).5971975
12. Moreland RB Nam HG Hereford LM Fried HM Identification of a nuclear localization signal of a yeast ribosomal protein Proc. Natl. Acad. Sci. USA. 1985 82 6561 6565 3931077
Moreland, R. B., Nam, H. G., Hereford, L. M. & Fried, H. M. Identification of a nuclear localization signal of a yeast ribosomal protein. Proc. Natl. Acad. Sci. USA. 82, 6561–6565 (1985).3931077
13. Chi NC Adam EJ Adam SA Sequence and characterization of cytoplasmic nuclear protein import factor p97 J. Cell Biol. 1995 130 265 274 7615630
Chi, N. C., Adam, E. J. & Adam, S. A. Sequence and characterization of cytoplasmic nuclear protein import factor p97. J. Cell Biol. 130, 265–274 (1995).7615630
14. Goldfarb DS Gariepy J Schoolnik G Kornberg RD Synthetic peptides as nuclear localization signals Nature. 1986 322 641 644 3638500
Goldfarb, D. S., Gariepy, J., Schoolnik, G. & Kornberg, R. D. Synthetic peptides as nuclear localization signals. Nature. 322, 641–644 (1986).3638500
15. Fornerod M Ohno M Yoshida M Mattaj IW CRM1 is an export receptor for leucine-rich nuclear export signals Cell. 1997 90 1051 1060 9323133
Fornerod, M., Ohno, M., Yoshida, M. & Mattaj, I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90, 1051–1060 (1997).9323133
16. Stade K Ford CS Guthrie C Weis K Exportin 1 (Crm1p) is an essential nuclear export factor Cell. 1997 90 1041 1050 9323132
Stade, K., Ford, C. S., Guthrie, C. & Weis, K. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell. 90, 1041–1050 (1997).9323132
17. Wen W Meinkoth JL Tsien RY Taylor SS Identification of a signal for rapid export of proteins from the nucleus Cell. 1995 82 463 473 7634336
Wen, W., Meinkoth, J. L., Tsien, R. Y. & Taylor, S. S. Identification of a signal for rapid export of proteins from the nucleus. Cell. 82, 463–473 (1995).7634336
18. Gorlich D Kutay U Transport between the cell nucleus and the cytoplasm Annu. Rev. Cell Dev. Biol. 1999 15 607 660 10611974
Gorlich, D. & Kutay, U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15, 607–660 (1999).10611974
19. Vetter IR Structural view of the Ran-Importin beta interaction at 2.3 A resolution Cell. 1999 97 635 646 10367892
Vetter, I. R. et al. Structural view of the Ran-Importin beta interaction at 2.3 A resolution. Cell. 97, 635–646 (1999).10367892
20. Chook YM Blobel G Structure of the nuclear transport complex karyopherin-beta2-Ran x GppNHp Nature. 1999 399 230 237 10353245
Chook, Y. M. & Blobel, G. Structure of the nuclear transport complex karyopherin-beta2-Ran x GppNHp. Nature. 399, 230–237 (1999).10353245
21. Alber F The molecular architecture of the nuclear pore complex Nature. 2007 450 695 701 18046406
Alber, F. et al. The molecular architecture of the nuclear pore complex. Nature. 450, 695–701 (2007).18046406
22. Cowburn D Rout M Improving the hole picture: towards a consensus on the mechanism of nuclear transport Biochem. Soc. Trans. 2023 51 871 886 37099395
Cowburn, D. & Rout, M. Improving the hole picture: towards a consensus on the mechanism of nuclear transport. Biochem. Soc. Trans. 51, 871–886 (2023).37099395
23. Tai L Yin G Sun F Zhu Y Cryo-electron microscopy reveals the structure of the nuclear pore complex J. Mol. Biol. 2023 435 168051 36933820
Tai, L., Yin, G., Sun, F. & Zhu, Y. Cryo-electron microscopy reveals the structure of the nuclear pore complex. J. Mol. Biol. 435, 168051 (2023).36933820
24. Akhtar A Gasser SM The nuclear envelope and transcriptional control Nat. Rev. Genet. 2007 8 507 517 17549064
Akhtar, A. & Gasser, S. M. The nuclear envelope and transcriptional control. Nat. Rev. Genet. 8, 507–517 (2007).17549064
25. Jakel S Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains EMBO J. 2002 21 377 386 11823430
Jakel, S. et al. Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains. EMBO J. 21, 377–386 (2002).11823430
26. Pennisi E Nuclear transport protein does double duty in mitosis Science. 1999 284 1260 1261 10383302
Pennisi, E. Nuclear transport protein does double duty in mitosis. Science. 284, 1260–1261 (1999).10383302
27. Chahine MN Pierce GN Therapeutic targeting of nuclear protein import in pathological cell conditions Pharmacol Rev. 2009 61 358 372 19805478
Chahine, M. N. & Pierce, G. N. Therapeutic targeting of nuclear protein import in pathological cell conditions. Pharmacol Rev. 61, 358–372 (2009).19805478
28. Syed YY Selinexor: First global approval Drugs. 2019 79 1485 1494 31429063
Syed, Y. Y. Selinexor: First global approval. Drugs. 79, 1485–1494 (2019).31429063
29. Maul GG Deaven L Quantitative determination of nuclear pore complexes in cycling cells with differing DNA content J. Cell Biol. 1977 73 748 760 406262
Maul, G. G. & Deaven, L. Quantitative determination of nuclear pore complexes in cycling cells with differing DNA content. J. Cell Biol. 73, 748–760 (1977).406262
30. Lin DH Architecture of the symmetric core of the nuclear pore Science. 2016 352 aaf1015 27081075
Lin, D. H. et al. Architecture of the symmetric core of the nuclear pore. Science. 352, aaf1015 (2016).27081075
31. Reichelt R Correlation between structure and mass distribution of the nuclear pore complex and of distinct pore complex components J. Cell Biol. 1990 110 883 894 2324201
Reichelt, R. et al. Correlation between structure and mass distribution of the nuclear pore complex and of distinct pore complex components. J. Cell Biol. 110, 883–894 (1990).2324201
32. Hampoelz B Andres-Pons A Kastritis P Beck M Structure and assembly of the nuclear pore complex Annu. Rev. Biophys. 2019 48 515 536 30943044
Hampoelz, B., Andres-Pons, A., Kastritis, P. & Beck, M. Structure and assembly of the nuclear pore complex. Annu. Rev. Biophys. 48, 515–536 (2019).30943044
33. Lin DH Hoelz A The structure of the nuclear pore complex (an update) Annu. Rev. Biochem. 2019 88 725 783 30883195
Lin, D. H. & Hoelz, A. The structure of the nuclear pore complex (an update). Annu. Rev. Biochem. 88, 725–783 (2019).30883195
34. Akey CW Comprehensive structure and functional adaptations of the yeast nuclear pore complex Cell. 2022 185 361 378.e325 34982960
Akey, C. W. et al. Comprehensive structure and functional adaptations of the yeast nuclear pore complex. Cell. 185, 361–378.e325 (2022).34982960
35. Kosinski J Molecular architecture of the inner ring scaffold of the human nuclear pore complex Science. 2016 352 363 365 27081072
Kosinski, J. et al. Molecular architecture of the inner ring scaffold of the human nuclear pore complex. Science. 352, 363–365 (2016).27081072
36. Li Z Near-atomic structure of the inner ring of the Saccharomyces cerevisiae nuclear pore complex Cell Res. 2022 32 437 450 35301440
Li, Z. et al. Near-atomic structure of the inner ring of the Saccharomyces cerevisiae nuclear pore complex. Cell Res. 32, 437–450 (2022).35301440
37. Zimmerli CE Nuclear pores dilate and constrict in cellulo Science. 2021 374 eabd9776 34762489
Zimmerli, C. E. et al. Nuclear pores dilate and constrict in cellulo. Science. 374, eabd9776 (2021).34762489
38. Petrovic S Architecture of the linker-scaffold in the nuclear pore Science. 2022 376 eabm9798 35679425
Petrovic, S. et al. Architecture of the linker-scaffold in the nuclear pore. Science. 376, eabm9798 (2022).35679425
39. Eisenhardt N Redolfi J Antonin W Interaction of Nup53 with Ndc1 and Nup155 is required for nuclear pore complex assembly J. Cell Sci. 2014 127 908 921 24363447
Eisenhardt, N., Redolfi, J. & Antonin, W. Interaction of Nup53 with Ndc1 and Nup155 is required for nuclear pore complex assembly. J. Cell Sci. 127, 908–921 (2014).24363447
40. Mauro MS Ndc1 drives nuclear pore complex assembly independent of membrane biogenesis to promote nuclear formation and growth Elife. 2022 11 e75513 35852146
Mauro, M. S. et al. Ndc1 drives nuclear pore complex assembly independent of membrane biogenesis to promote nuclear formation and growth. Elife. 11, e75513 (2022).35852146
41. Huang G Cryo-EM structure of the inner ring from the Xenopus laevis nuclear pore complex Cell Res. 2022 32 451 460 35301439
Huang, G. et al. Cryo-EM structure of the inner ring from the Xenopus laevis nuclear pore complex. Cell Res. 32, 451–460 (2022).35301439
42. Mosalaganti S AI-based structure prediction empowers integrative structural analysis of human nuclear pores Science. 2022 376 eabm9506 35679397
Mosalaganti, S. et al. AI-based structure prediction empowers integrative structural analysis of human nuclear pores. Science. 376, eabm9506 (2022).35679397
43. Wong RW Nuclear pore complex: From structural view to chemical tools Chem Biol. 2015 22 1285 1287 26496682
Wong, R. W. Nuclear pore complex: From structural view to chemical tools. Chem Biol. 22, 1285–1287 (2015).26496682
44. Fischer J Linker Nups connect the nuclear pore complex inner ring with the outer ring and transport channel Nat. Struct. Mol. Biol. 2015 22 774 781 26344569
Fischer, J. et al. Linker Nups connect the nuclear pore complex inner ring with the outer ring and transport channel. Nat. Struct. Mol. Biol. 22, 774–781 (2015).26344569
45. Ng SC Guttler T Gorlich D Recapitulation of selective nuclear import and export with a perfectly repeated 12mer GLFG peptide Nat. Commun. 2021 12 4047 34193851
Ng, S. C., Guttler, T. & Gorlich, D. Recapitulation of selective nuclear import and export with a perfectly repeated 12mer GLFG peptide. Nat. Commun. 12, 4047 (2021).34193851
46. Celetti G The liquid state of FG-nucleoporins mimics permeability barrier properties of nuclear pore complexes J. Cell Biol. 2020 219 e201907157 31723007
Celetti, G. et al. The liquid state of FG-nucleoporins mimics permeability barrier properties of nuclear pore complexes. J. Cell Biol. 219, e201907157 (2020).31723007
47. Stuwe T Evidence for an evolutionary relationship between the large adaptor nucleoporin Nup192 and karyopherins Proc. Natl. Acad. Sci. USA. 2014 111 2530 2535 24505056
Stuwe, T. et al. Evidence for an evolutionary relationship between the large adaptor nucleoporin Nup192 and karyopherins. Proc. Natl. Acad. Sci. USA. 111, 2530–2535 (2014).24505056
48. Onischenko E Natively unfolded FG repeats stabilize the structure of the nuclear pore complex Cell. 2017 171 904 917.e919 29033133
Onischenko, E. et al. Natively unfolded FG repeats stabilize the structure of the nuclear pore complex. Cell. 171, 904–917.e919 (2017).29033133
49. Huang G Cryo-EM structure of the nuclear ring from Xenopus laevis nuclear pore complex Cell Res. 2022 32 349 358 35177819
Huang, G. et al. Cryo-EM structure of the nuclear ring from Xenopus laevis nuclear pore complex. Cell Res. 32, 349–358 (2022).35177819
50. Tai L 8 A structure of the outer rings of the Xenopus laevis nuclear pore complex obtained by cryo-EM and AI Protein Cell. 2022 13 760 777 35015240
Tai, L. et al. 8 A structure of the outer rings of the Xenopus laevis nuclear pore complex obtained by cryo-EM and AI. Protein Cell. 13, 760–777 (2022).35015240
51. Bley CJ Architecture of the cytoplasmic face of the nuclear pore Science. 2022 376 eabm9129 35679405
Bley, C. J. et al. Architecture of the cytoplasmic face of the nuclear pore. Science. 376, eabm9129 (2022).35679405
52. Fontana P Structure of cytoplasmic ring of nuclear pore complex by integrative cryo-EM and AlphaFold Science. 2022 376 eabm9326 35679401
Fontana, P. et al. Structure of cytoplasmic ring of nuclear pore complex by integrative cryo-EM and AlphaFold. Science. 376, eabm9326 (2022).35679401
53. Nordeen SA Turman DL Schwartz TU Yeast Nup84-Nup133 complex structure details flexibility and reveals conservation of the membrane anchoring ALPS motif Nat Commun. 2020 11 6060 33247142
Nordeen, S. A., Turman, D. L. & Schwartz, T. U. Yeast Nup84-Nup133 complex structure details flexibility and reveals conservation of the membrane anchoring ALPS motif. Nat Commun. 11, 6060 (2020).33247142
54. Richards L Nucleoporins facilitate ORC loading onto chromatin Cell Rep. 2022 41 111590 36351393
Richards, L. et al. Nucleoporins facilitate ORC loading onto chromatin. Cell Rep. 41, 111590 (2022).36351393
55. Kuhn TM Chromatin targeting of nuclear pore proteins induces chromatin decondensation J. Cell Biol. 2019 218 2945 2961 31366666
Kuhn, T. M. et al. Chromatin targeting of nuclear pore proteins induces chromatin decondensation. J. Cell Biol. 218, 2945–2961 (2019).31366666
56. Zhu X Structure of the cytoplasmic ring of the Xenopus laevis nuclear pore complex Science. 2022 376 eabl8280 35679404
Zhu, X. et al. Structure of the cytoplasmic ring of the Xenopus laevis nuclear pore complex. Science. 376, eabl8280 (2022).35679404
57. Upla P Molecular architecture of the major membrane ring component of the nuclear pore complex Structure. 2017 25 434 445 28162953
Upla, P. et al. Molecular architecture of the major membrane ring component of the nuclear pore complex. Structure. 25, 434–445 (2017).28162953
58. Zhang Y Molecular architecture of the luminal ring of the Xenopus laevis nuclear pore complex Cell Res. 2020 30 532 540 32367042
Zhang, Y. et al. Molecular architecture of the luminal ring of the Xenopus laevis nuclear pore complex. Cell Res. 30, 532–540 (2020).32367042
59. Kim SJ Integrative structure and functional anatomy of a nuclear pore complex Nature. 2018 555 475 482 29539637
Kim, S. J. et al. Integrative structure and functional anatomy of a nuclear pore complex. Nature. 555, 475–482 (2018).29539637
60. Stavru F Nautrup-Pedersen G Cordes VC Gorlich D Nuclear pore complex assembly and maintenance in POM121- and gp210-deficient cells J. Cell Biol. 2006 173 477 483 16702234
Stavru, F., Nautrup-Pedersen, G., Cordes, V. C. & Gorlich, D. Nuclear pore complex assembly and maintenance in POM121- and gp210-deficient cells. J. Cell Biol. 173, 477–483 (2006).16702234
61. Mitchell JM Pom121 links two essential subcomplexes of the nuclear pore complex core to the membrane J. Cell Biol. 2010 191 505 521 20974814
Mitchell, J. M. et al. Pom121 links two essential subcomplexes of the nuclear pore complex core to the membrane. J. Cell Biol. 191, 505–521 (2010).20974814
62. Chen S Association of RanGAP to nuclear pore complex component, RanBP2/Nup358, is required for pupal development in Drosophila Cell Rep. 2021 37 110151 34965423
Chen, S. et al. Association of RanGAP to nuclear pore complex component, RanBP2/Nup358, is required for pupal development in Drosophila. Cell Rep. 37, 110151 (2021).34965423
63. Fernandez-Martinez J Rout MP One ring to rule them all? structural and functional diversity in the nuclear pore complex Trends Biochem Sci. 2021 46 595 607 33563541
Fernandez-Martinez, J. & Rout, M. P. One ring to rule them all? structural and functional diversity in the nuclear pore complex. Trends Biochem Sci. 46, 595–607 (2021).33563541
64. Gray S Cao W Montpetit B De La Cruz EM The nucleoporin Gle1 activates DEAD-box protein 5 (Dbp5) by promoting ATP binding and accelerating rate limiting phosphate release Nucleic Acids Res. 2022 50 3998 4011 35286399
Gray, S., Cao, W., Montpetit, B. & De La Cruz, E. M. The nucleoporin Gle1 activates DEAD-box protein 5 (Dbp5) by promoting ATP binding and accelerating rate limiting phosphate release. Nucleic Acids Res. 50, 3998–4011 (2022).35286399
65. von Appen A In situ structural analysis of the human nuclear pore complex Nature. 2015 526 140 143 26416747
von Appen, A. et al. In situ structural analysis of the human nuclear pore complex. Nature. 526, 140–143 (2015).26416747
66. Huang G Structure of the cytoplasmic ring of the Xenopus laevis nuclear pore complex by cryo-electron microscopy single particle analysis Cell Res. 2020 30 520 531 32376910
Huang, G. et al. Structure of the cytoplasmic ring of the Xenopus laevis nuclear pore complex by cryo-electron microscopy single particle analysis. Cell Res. 30, 520–531 (2020).32376910
67. Ritterhoff T The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes Nat Commun. 2016 7 11482 27160050
Ritterhoff, T. et al. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes. Nat Commun. 7, 11482 (2016).27160050
68. Port SA Structural and functional characterization of CRM1-Nup214 interactions reveals multiple FG-binding sites involved in nuclear export Cell Rep. 2015 13 690 702 26489467
Port, S. A. et al. Structural and functional characterization of CRM1-Nup214 interactions reveals multiple FG-binding sites involved in nuclear export. Cell Rep. 13, 690–702 (2015).26489467
69. Mahajan R A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2 Cell. 1997 88 97 107 9019411
Mahajan, R. et al. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 88, 97–107 (1997).9019411
70. Yokoyama N A giant nucleopore protein that binds Ran/TC4 Nature. 1995 376 184 188 7603572
Yokoyama, N. et al. A giant nucleopore protein that binds Ran/TC4. Nature. 376, 184–188 (1995).7603572
71. Partridge JR Schwartz TU Crystallographic and biochemical analysis of the Ran-binding zinc finger domain J. Mol. Biol. 2009 391 375 389 19505478
Partridge, J. R. & Schwartz, T. U. Crystallographic and biochemical analysis of the Ran-binding zinc finger domain. J. Mol. Biol. 391, 375–389 (2009).19505478
72. Bernad R van der Velde H Fornerod M Pickersgill H Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export Mol. Cell Biol. 2004 24 2373 2384 14993277
Bernad, R., van der Velde, H., Fornerod, M. & Pickersgill, H. Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol. Cell Biol. 24, 2373–2384 (2004).14993277
73. Lin DH Structural and functional analysis of mRNA export regulation by the nuclear pore complex Nat Commun. 2018 9 2319 29899397
Lin, D. H. et al. Structural and functional analysis of mRNA export regulation by the nuclear pore complex. Nat Commun. 9, 2319 (2018).29899397
74. Krull S Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket Mol. Biol. Cell. 2004 15 4261 4277 15229283
Krull, S. et al. Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket. Mol. Biol. Cell. 15, 4261–4277 (2004).15229283
75. Aksenova V Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway Nat Commun. 2020 11 4577 32917881
Aksenova, V. et al. Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway. Nat Commun. 11, 4577 (2020).32917881
76. Duheron V Structural characterization of altered nucleoporin Nup153 expression in human cells by thin-section electron microscopy Nucleus. 2014 5 601 612 25485891
Duheron, V. et al. Structural characterization of altered nucleoporin Nup153 expression in human cells by thin-section electron microscopy. Nucleus. 5, 601–612 (2014).25485891
77. Mackay DR Makise M Ullman KS Defects in nuclear pore assembly lead to activation of an Aurora B-mediated abscission checkpoint J. Cell Biol. 2010 191 923 931 21098116
Mackay, D. R., Makise, M. & Ullman, K. S. Defects in nuclear pore assembly lead to activation of an Aurora B-mediated abscission checkpoint. J. Cell Biol. 191, 923–931 (2010).21098116
78. Cibulka J Assembly principle of a membrane-anchored nuclear pore basket scaffold Sci. Adv. 2022 8 eabl6863 35148185
Cibulka, J. et al. Assembly principle of a membrane-anchored nuclear pore basket scaffold. Sci. Adv. 8, eabl6863 (2022).35148185
79. Souquet B Nup133 is required for proper nuclear pore basket assembly and dynamics in embryonic stem cells Cell Rep. 2018 23 2443 2454 29791854
Souquet, B. et al. Nup133 is required for proper nuclear pore basket assembly and dynamics in embryonic stem cells. Cell Rep. 23, 2443–2454 (2018).29791854
80. Meszaros N Nuclear pore basket proteins are tethered to the nuclear envelope and can regulate membrane curvature Dev Cell. 2015 33 285 298 25942622
Meszaros, N. et al. Nuclear pore basket proteins are tethered to the nuclear envelope and can regulate membrane curvature. Dev Cell. 33, 285–298 (2015).25942622
81. Petrovic, S. et al. Structure and function of the nuclear pore complex. Cold Spring Harb. Perspect. Biol. 14:a041264 (2022).
82. Gallardo P Salas-Pino S Daga RR A new role for the nuclear basket network Microb Cell. 2017 4 423 425 29234671
Gallardo, P., Salas-Pino, S. & Daga, R. R. A new role for the nuclear basket network. Microb Cell. 4, 423–425 (2017).29234671
83. Pasha T Karyopherin abnormalities in neurodegenerative proteinopathies Brain. 2021 144 2915 2932 34019093
Pasha, T. et al. Karyopherin abnormalities in neurodegenerative proteinopathies. Brain. 144, 2915–2932 (2021).34019093
84. Koepp DM Silver PA A GTPase controlling nuclear trafficking: running the right way or walking RANdomly? Cell. 1996 87 1 4 8858141
Koepp, D. M. & Silver, P. A. A GTPase controlling nuclear trafficking: running the right way or walking RANdomly? Cell. 87, 1–4 (1996).8858141
85. Stewart M Insights into the molecular mechanism of nuclear trafficking using nuclear transport factor 2 (NTF2) Cell Struct. Funct. 2000 25 217 225 11129791
Stewart, M. Insights into the molecular mechanism of nuclear trafficking using nuclear transport factor 2 (NTF2). Cell Struct. Funct. 25, 217–225 (2000).11129791
86. Goldfarb DS Importin alpha: a multipurpose nuclear-transport receptor Trends Cell Biol. 2004 14 505 514 15350979
Goldfarb, D. S. et al. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 14, 505–514 (2004).15350979
87. Cagatay T Chook YM Karyopherins in cancer Curr Opin Cell Biol. 2018 52 30 42 29414591
Cagatay, T. & Chook, Y. M. Karyopherins in cancer. Curr Opin Cell Biol. 52, 30–42 (2018).29414591
88. Kimura M Extensive cargo identification reveals distinct biological roles of the 12 importin pathways Elife. 2017 6 e21184 28117667
Kimura, M. et al. Extensive cargo identification reveals distinct biological roles of the 12 importin pathways. Elife. 6, e21184 (2017).28117667
89. Baade I The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors J. Biol. Chem. 2021 296 100659 33857479
Baade, I. et al. The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors. J. Biol. Chem. 296, 100659 (2021).33857479
90. Zhang ZC Satterly N Fontoura BM Chook YM Evolutionary development of redundant nuclear localization signals in the mRNA export factor NXF1 Mol. Biol. Cell. 2011 22 4657 4668 21965294
Zhang, Z. C., Satterly, N., Fontoura, B. M. & Chook, Y. M. Evolutionary development of redundant nuclear localization signals in the mRNA export factor NXF1. Mol. Biol. Cell. 22, 4657–4668 (2011).21965294
91. Gorlich D Henklein P Laskey RA Hartmann E A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus EMBO J. 1996 15 1810 1817 8617226
Gorlich, D., Henklein, P., Laskey, R. A. & Hartmann, E. A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus. EMBO J. 15, 1810–1817 (1996).8617226
92. Huber J Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain structure EMBO J. 1998 17 4114 4126 9670026
Huber, J. et al. Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain structure. EMBO J. 17, 4114–4126 (1998).9670026
93. Lott K Cingolani G The importin beta binding domain as a master regulator of nucleocytoplasmic transport Biochim. Biophys. Acta. 2011 1813 1578 1592 21029753
Lott, K. & Cingolani, G. The importin beta binding domain as a master regulator of nucleocytoplasmic transport. Biochim. Biophys. Acta. 1813, 1578–1592 (2011).21029753
94. Lee SJ The structure of importin-beta bound to SREBP-2: nuclear import of a transcription factor Science. 2003 302 1571 1575 14645851
Lee, S. J. et al. The structure of importin-beta bound to SREBP-2: nuclear import of a transcription factor. Science. 302, 1571–1575 (2003).14645851
95. Ye Z PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-kappaB signalling by interacting with KPNB1 Cell Death Dis. 2022 13 633 35864095
Ye, Z. et al. PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-kappaB signalling by interacting with KPNB1. Cell Death Dis. 13, 633 (2022).35864095
96. Wang, S. M. et al. Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine. Autophagy, 1-26, (2022).
97. Du W KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway Cell Death Differ. 2021 28 1284 1300 33139930
Du, W. et al. KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway. Cell Death Differ. 28, 1284–1300 (2021).33139930
98. Mahipal A Malafa M Importins and exportins as therapeutic targets in cancer Pharmacol Ther. 2016 164 135 143 27113410
Mahipal, A. & Malafa, M. Importins and exportins as therapeutic targets in cancer. Pharmacol Ther. 164, 135–143 (2016).27113410
99. Twyffels L Gueydan C Kruys V Transportin-1 and Transportin-2: protein nuclear import and beyond FEBS Lett. 2014 588 1857 1868 24780099
Twyffels, L., Gueydan, C. & Kruys, V. Transportin-1 and Transportin-2: protein nuclear import and beyond. FEBS Lett. 588, 1857–1868 (2014).24780099
100. Nanaura H C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers Nat Commun. 2021 12 5301 34489423
Nanaura, H. et al. C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers. Nat Commun. 12, 5301 (2021).34489423
101. Bourgeois B Nonclassical nuclear localization signals mediate nuclear import of CIRBP Proc. Natl. Acad. Sci. USA. 2020 117 8503 8514 32234784
Bourgeois, B. et al. Nonclassical nuclear localization signals mediate nuclear import of CIRBP. Proc. Natl. Acad. Sci. USA. 117, 8503–8514 (2020).32234784
102. Niaki AG Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-linked FUS mutations Mol Cell. 2020 77 82 94.e84 31630970
Niaki, A. G. et al. Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-linked FUS mutations. Mol Cell. 77, 82–94.e84 (2020).31630970
103. Guo L Fare CM Shorter J Therapeutic dissolution of aberrant phases by nuclear-import receptors Trends Cell Biol. 2019 29 308 322 30660504
Guo, L., Fare, C. M. & Shorter, J. Therapeutic dissolution of aberrant phases by nuclear-import receptors. Trends Cell Biol. 29, 308–322 (2019).30660504
104. Yang TJ Tumor suppressor BAP1 nuclear import is governed by transportin-1 J. Cell Biol. 2022 221 e202201094 35446349
Yang, T. J. et al. Tumor suppressor BAP1 nuclear import is governed by transportin-1. J. Cell Biol. 221, e202201094 (2022).35446349
105. Hwang WY Kap-beta2/Transportin mediates beta-catenin nuclear transport in Wnt signaling Elife. 2022 11 e70495 36300792
Hwang, W. Y. et al. Kap-beta2/Transportin mediates beta-catenin nuclear transport in Wnt signaling. Elife. 11, e70495 (2022).36300792
106. Fernandez J Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating Nat Microbiol. 2019 4 1840 1850 31611641
Fernandez, J. et al. Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating. Nat Microbiol. 4, 1840–1850 (2019).31611641
107. Miyake Y Influenza virus uses transportin 1 for vRNP debundling during cell entry Nat Microbiol. 2019 4 578 586 30692667
Miyake, Y. et al. Influenza virus uses transportin 1 for vRNP debundling during cell entry. Nat Microbiol. 4, 578–586 (2019).30692667
108. Shamsher MK Ploski J Radu A Karyopherin beta 2B participates in mRNA export from the nucleus Proc. Natl. Acad. Sci. USA. 2002 99 14195 14199 12384575
Shamsher, M. K., Ploski, J. & Radu, A. Karyopherin beta 2B participates in mRNA export from the nucleus. Proc. Natl. Acad. Sci. USA. 99, 14195–14199 (2002).12384575
109. Kataoka N Bachorik JL Dreyfuss G Transportin-SR, a nuclear import receptor for SR proteins J. Cell Biol. 1999 145 1145 1152 10366588
Kataoka, N., Bachorik, J. L. & Dreyfuss, G. Transportin-SR, a nuclear import receptor for SR proteins. J. Cell Biol. 145, 1145–1152 (1999).10366588
110. Lai MC Lin RI Tarn WY Transportin-SR2 mediates nuclear import of phosphorylated SR proteins Proc. Natl. Acad. Sci. USA. 2001 98 10154 10159 11517331
Lai, M. C., Lin, R. I. & Tarn, W. Y. Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proc. Natl. Acad. Sci. USA. 98, 10154–10159 (2001).11517331
111. Maertens GN Structural basis for nuclear import of splicing factors by human Transportin 3 Proc. Natl. Acad. Sci. USA. 2014 111 2728 2733 24449914
Maertens, G. N. et al. Structural basis for nuclear import of splicing factors by human Transportin 3. Proc. Natl. Acad. Sci. USA. 111, 2728–2733 (2014).24449914
112. Janssens J CRISPR/Cas9-induced mutagenesis corroborates the role of transportin-SR2 in HIV-1 nuclear import Microbiol Spectr. 2021 9 e0133621 34612665
Janssens, J. et al. CRISPR/Cas9-induced mutagenesis corroborates the role of transportin-SR2 in HIV-1 nuclear import. Microbiol Spectr. 9, e0133621 (2021).34612665
113. Rodriguez-Mora S The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1 F induces protection against HIV-1 infection PLoS Pathog. 2019 15 e1007958 31465518
Rodriguez-Mora, S. et al. The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1 F induces protection against HIV-1 infection. PLoS Pathog. 15, e1007958 (2019).31465518
114. Kalab P Solc P Motlik J The role of RanGTP gradient in vertebrate oocyte maturation Results Probl. Cell Differ. 2011 53 235 267 21630149
Kalab, P., Solc, P. & Motlik, J. The role of RanGTP gradient in vertebrate oocyte maturation. Results Probl. Cell Differ. 53, 235–267 (2011).21630149
115. Azmi AS Uddin MH Mohammad RM The nuclear export protein XPO1 - from biology to targeted therapy Nat. Rev. Clin. Oncol. 2021 18 152 169 33173198
Azmi, A. S., Uddin, M. H. & Mohammad, R. M. The nuclear export protein XPO1 - from biology to targeted therapy. Nat. Rev. Clin. Oncol. 18, 152–169 (2021).33173198
116. Sun H A nuclear export signal is required for cGAS to sense cytosolic DNA Cell Rep. 2021 34 108586 33406424
Sun, H. et al. A nuclear export signal is required for cGAS to sense cytosolic DNA. Cell Rep. 34, 108586 (2021).33406424
117. Napolitano G mTOR-dependent phosphorylation controls TFEB nuclear export Nat Commun. 2018 9 3312 30120233
Napolitano, G. et al. mTOR-dependent phosphorylation controls TFEB nuclear export. Nat Commun. 9, 3312 (2018).30120233
118. Camus V XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy J. Hematol Oncol. 2017 10 47 28196522
Camus, V. et al. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy. J. Hematol Oncol. 10, 47 (2017).28196522
119. Kirli K A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning Elife. 2015 4 e11466 26673895
Kirli, K. et al. A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. Elife. 4, e11466 (2015).26673895
120. Thakar K Identification of CRM1-dependent nuclear export cargos using quantitative mass spectrometry Mol. Cell Proteomics. 2013 12 664 678 23242554
Thakar, K. et al. Identification of CRM1-dependent nuclear export cargos using quantitative mass spectrometry. Mol. Cell Proteomics. 12, 664–678 (2013).23242554
121. Fung HY Fu SC Chook YM Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals Elife. 2017 6 e23961 28282025
Fung, H. Y., Fu, S. C. & Chook, Y. M. Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals. Elife. 6, e23961 (2017).28282025
122. Dong X Biswas A Chook YM Structural basis for assembly and disassembly of the CRM1 nuclear export complex Nat. Struct. Mol. Biol. 2009 16 558 560 19339972
Dong, X., Biswas, A. & Chook, Y. M. Structural basis for assembly and disassembly of the CRM1 nuclear export complex. Nat. Struct. Mol. Biol. 16, 558–560 (2009).19339972
123. Koyama M Matsuura Y Mechanistic insights from the recent structures of the CRM1 nuclear export complex and its disassembly intermediate Biophys. (Nagoya-shi). 2012 8 145 150
Koyama, M. & Matsuura, Y. Mechanistic insights from the recent structures of the CRM1 nuclear export complex and its disassembly intermediate. Biophys. (Nagoya-shi). 8, 145–150 (2012).
124. Okamura M Inose H Masuda S RNA export through the NPC in eukaryotes Genes (Basel). 2015 6 124 149 25802992
Okamura, M., Inose, H. & Masuda, S. RNA export through the NPC in eukaryotes. Genes (Basel). 6, 124–149 (2015).25802992
125. ElMaghraby MF A heterochromatin-specific RNA export pathway facilitates piRNA production Cell. 2019 178 964 979 e920 31398345
ElMaghraby, M. F. et al. A heterochromatin-specific RNA export pathway facilitates piRNA production. Cell. 178, 964–979 e920 (2019).31398345
126. Azizian NG Li Y XPO1-dependent nuclear export as a target for cancer therapy J. Hematol Oncol. 2020 13 61 32487143
Azizian, N. G. & Li, Y. XPO1-dependent nuclear export as a target for cancer therapy. J. Hematol Oncol. 13, 61 (2020).32487143
127. Kutay U Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor Cell. 1997 90 1061 1071 9323134
Kutay, U. et al. Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell. 90, 1061–1071 (1997).9323134
128. Matsuura Y Stewart M Structural basis for the assembly of a nuclear export complex Nature. 2004 432 872 877 15602554
Matsuura, Y. & Stewart, M. Structural basis for the assembly of a nuclear export complex. Nature. 432, 872–877 (2004).15602554
129. Dong Q Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing Proc. Natl. Acad. Sci. USA. 2018 115 E4013 E4022 29636421
Dong, Q. et al. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing. Proc. Natl. Acad. Sci. USA. 115, E4013–E4022 (2018).29636421
130. Zhang X CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway J. Cancer. 2021 12 2797 2806 33854580
Zhang, X. et al. CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway. J. Cancer. 12, 2797–2806 (2021).33854580
131. Nachmias B Schimmer AD Targeting nuclear import and export in hematological malignancies Leukemia. 2020 34 2875 2886 32624581
Nachmias, B. & Schimmer, A. D. Targeting nuclear import and export in hematological malignancies. Leukemia. 34, 2875–2886 (2020).32624581
132. Wu K He J Pu W Peng Y The role of exportin-5 in MicroRNA biogenesis and cancer Genomics Proteomics Bioinformatics. 2018 16 120 126 29723684
Wu, K., He, J., Pu, W. & Peng, Y. The role of exportin-5 in MicroRNA biogenesis and cancer. Genomics Proteomics Bioinformatics. 16, 120–126 (2018).29723684
133. Lund E Nuclear export of microRNA precursors Science. 2004 303 95 98 14631048
Lund, E. et al. Nuclear export of microRNA precursors. Science. 303, 95–98 (2004).14631048
134. Okada C A high-resolution structure of the pre-microRNA nuclear export machinery Science. 2009 326 1275 1279 19965479
Okada, C. et al. A high-resolution structure of the pre-microRNA nuclear export machinery. Science. 326, 1275–1279 (2009).19965479
135. Wild T A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60 S subunit export PLoS Biol. 2010 8 e1000522 21048991
Wild, T. et al. A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60 S subunit export. PLoS Biol. 8, e1000522 (2010).21048991
136. Yi R Qin Y Macara IG Cullen BR Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Genes Dev. 2003 17 3011 3016 14681208
Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–3016 (2003).14681208
137. Calado A Exportin-5-mediated nuclear export of eukaryotic elongation factor 1 A and tRNA EMBO J. 2002 21 6216 6224 12426393
Calado, A. et al. Exportin-5-mediated nuclear export of eukaryotic elongation factor 1 A and tRNA. EMBO J. 21, 6216–6224 (2002).12426393
138. Bohnsack MT Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm EMBO J. 2002 21 6205 6215 12426392
Bohnsack, M. T. et al. Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm. EMBO J. 21, 6205–6215 (2002).12426392
139. Li J Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma Cell Death Differ. 2018 25 1612 1624 29445125
Li, J. et al. Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma. Cell Death Differ. 25, 1612–1624 (2018).29445125
140. Shigeyasu K Exportin-5 functions as an oncogene and a potential therapeutic target in colorectal cancer Clin. Cancer Res. 2017 23 1312 1322 27553833
Shigeyasu, K. et al. Exportin-5 functions as an oncogene and a potential therapeutic target in colorectal cancer. Clin. Cancer Res. 23, 1312–1322 (2017).27553833
141. Choi HK Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response Nat Commun. 2015 6 7390 26077467
Choi, H. K. et al. Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response. Nat Commun. 6, 7390 (2015).26077467
142. Grunwald M Lazzaretti D Bono F Structural basis for the nuclear export activity of Importin13 EMBO J. 2013 32 899 913 23435562
Grunwald, M., Lazzaretti, D. & Bono, F. Structural basis for the nuclear export activity of Importin13. EMBO J. 32, 899–913 (2013).23435562
143. Tao T Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells Am. J. Respir Cell Mol. Biol. 2006 35 668 680 16809634
Tao, T. et al. Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. Am. J. Respir Cell Mol. Biol. 35, 668–680 (2006).16809634
144. Baade I Extensive identification and in-depth validation of importin 13 cargoes Mol. Cell Proteomics. 2018 17 1337 1353 29666159
Baade, I. et al. Extensive identification and in-depth validation of importin 13 cargoes. Mol. Cell Proteomics. 17, 1337–1353 (2018).29666159
145. Grunwald M Bono F Structure of Importin13-Ubc9 complex: nuclear import and release of a key regulator of sumoylation EMBO J. 2011 30 427 438 21139563
Grunwald, M. & Bono, F. Structure of Importin13-Ubc9 complex: nuclear import and release of a key regulator of sumoylation. EMBO J. 30, 427–438 (2011).21139563
146. Zohud BA Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation Cell Death Dis. 2020 11 879 33082305
Zohud, B. A. et al. Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation. Cell Death Dis. 11, 879 (2020).33082305
147. Viswanathan SR Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer Nat Genet. 2018 50 937 943 29955178
Viswanathan, S. R. et al. Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer. Nat Genet. 50, 937–943 (2018).29955178
148. Huang XF Mutation of IPO13 causes recessive ocular coloboma, microphthalmia, and cataract Exp Mol Med. 2018 50 1 11 30420619
Huang, X. F. et al. Mutation of IPO13 causes recessive ocular coloboma, microphthalmia, and cataract. Exp Mol Med. 50, 1–11 (2018).30420619
149. Bhardwaj A Das S SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions Proc. Natl. Acad. Sci. USA. 2016 113 E538 E547 26787900
Bhardwaj, A. & Das, S. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. Proc. Natl. Acad. Sci. USA. 113, E538–E547 (2016).26787900
150. Chen YS Racca JD Phillips NB Weiss MA Inherited human sex reversal due to impaired nucleocytoplasmic trafficking of SRY defines a male transcriptional threshold Proc. Natl. Acad. Sci. USA. 2013 110 E3567 E3576 24003159
Chen, Y. S., Racca, J. D., Phillips, N. B. & Weiss, M. A. Inherited human sex reversal due to impaired nucleocytoplasmic trafficking of SRY defines a male transcriptional threshold. Proc. Natl. Acad. Sci. USA. 110, E3567–E3576 (2013).24003159
151. Chen L Exportin 4 depletion leads to nuclear accumulation of a subset of circular RNAs Nat Commun. 2022 13 5769 36182935
Chen, L. et al. Exportin 4 depletion leads to nuclear accumulation of a subset of circular RNAs. Nat Commun. 13, 5769 (2022).36182935
152. Aksu M Trakhanov S Gorlich D Structure of the exportin Xpo4 in complex with RanGTP and the hypusine-containing translation factor eIF5A Nat Commun. 2016 7 11952 27306458
Aksu, M., Trakhanov, S. & Gorlich, D. Structure of the exportin Xpo4 in complex with RanGTP and the hypusine-containing translation factor eIF5A. Nat Commun. 7, 11952 (2016).27306458
153. Metwally M Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease EBioMedicine. 2021 70 103521 34388518
Metwally, M. et al. Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease. EBioMedicine. 70, 103521 (2021).34388518
154. Mingot JM Bohnsack MT Jakle U Gorlich D Exportin 7 defines a novel general nuclear export pathway EMBO J. 2004 23 3227 3236 15282546
Mingot, J. M., Bohnsack, M. T., Jakle, U. & Gorlich, D. Exportin 7 defines a novel general nuclear export pathway. EMBO J. 23, 3227–3236 (2004).15282546
155. Liang P KPNB1, XPO7 and IPO8 mediate the translocation ofNF-kappaB/p65 into the nucleus Traffic. 2013 14 1132 1143 23906023
Liang, P. et al. KPNB1, XPO7 and IPO8 mediate the translocation ofNF-kappaB/p65 into the nucleus. Traffic. 14, 1132–1143 (2013).23906023
156. Aksu M Xpo7 is a broad-spectrum exportin and a nuclear import receptor J. Cell Biol. 2018 217 2329 2340 29748336
Aksu, M. et al. Xpo7 is a broad-spectrum exportin and a nuclear import receptor. J. Cell Biol. 217, 2329–2340 (2018).29748336
157. Innes AJ XPO7 is a tumor suppressor regulating p21(CIP1)-dependent senescence Genes Dev. 2021 35 379 391 33602872
Innes, A. J. et al. XPO7 is a tumor suppressor regulating p21(CIP1)-dependent senescence. Genes Dev. 35, 379–391 (2021).33602872
158. Bayliss R Structural basis for the interaction between NTF2 and nucleoporin FxFG repeats EMBO J. 2002 21 2843 2853 12065398
Bayliss, R. et al. Structural basis for the interaction between NTF2 and nucleoporin FxFG repeats. EMBO J. 21, 2843–2853 (2002).12065398
159. Clouse KN Luo MJ Zhou Z Reed R A Ran-independent pathway for export of spliced mRNA Nat Cell Biol. 2001 3 97 99 11146633
Clouse, K. N., Luo, M. J., Zhou, Z. & Reed, R. A Ran-independent pathway for export of spliced mRNA. Nat Cell Biol. 3, 97–99 (2001).11146633
160. Ribbeck K NTF2 mediates nuclear import of Ran EMBO J. 1998 17 6587 6598 9822603
Ribbeck, K. et al. NTF2 mediates nuclear import of Ran. EMBO J. 17, 6587–6598 (1998).9822603
161. Stewart M Kent HM McCoy AJ Structural basis for molecular recognition between nuclear transport factor 2 (NTF2) and the GDP-bound form of the Ras-family GTPase Ran J. Mol. Biol. 1998 277 635 646 9533885
Stewart, M., Kent, H. M. & McCoy, A. J. Structural basis for molecular recognition between nuclear transport factor 2 (NTF2) and the GDP-bound form of the Ras-family GTPase Ran. J. Mol. Biol. 277, 635–646 (1998).9533885
162. Bullock TL Clarkson WD Kent HM Stewart M The 1.6 angstroms resolution crystal structure of nuclear transport factor 2 (NTF2) J. Mol. Biol. 1996 260 422 431 8757804
Bullock, T. L., Clarkson, W. D., Kent, H. M. & Stewart, M. The 1.6 angstroms resolution crystal structure of nuclear transport factor 2 (NTF2). J. Mol. Biol. 260, 422–431 (1996).8757804
163. Yamada M Tachibana T Imamoto N Yoneda Y Nuclear transport factor p10/NTF2 functions as a Ran-GDP dissociation inhibitor (Ran-GDI) Curr. Biol. 1998 8 1339 1342 9843686
Yamada, M., Tachibana, T., Imamoto, N. & Yoneda, Y. Nuclear transport factor p10/NTF2 functions as a Ran-GDP dissociation inhibitor (Ran-GDI). Curr. Biol. 8, 1339–1342 (1998).9843686
164. Van Impe K A new role for nuclear transport factor 2 and Ran: nuclear import of CapG Traffic. 2008 9 695 707 18266911
Van Impe, K. et al. A new role for nuclear transport factor 2 and Ran: nuclear import of CapG. Traffic. 9, 695–707 (2008).18266911
165. Lu M A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway Cell. 2014 157 1130 1145 24855949
Lu, M. et al. A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway. Cell. 157, 1130–1145 (2014).24855949
166. Fribourg S Braun IC Izaurralde E Conti E Structural basis for the recognition of a nucleoporin FG repeat by the NTF2-like domain of the TAP/p15 mRNA nuclear export factor Mol. Cell. 2001 8 645 656 11583626
Fribourg, S., Braun, I. C., Izaurralde, E. & Conti, E. Structural basis for the recognition of a nucleoporin FG repeat by the NTF2-like domain of the TAP/p15 mRNA nuclear export factor. Mol. Cell. 8, 645–656 (2001).11583626
167. Aibara S Katahira J Valkov E Stewart M The principal mRNA nuclear export factor NXF1:NXT1 forms a symmetric binding platform that facilitates export of retroviral CTE-RNA Nucleic Acids Res. 2015 43 1883 1893 25628361
Aibara, S., Katahira, J., Valkov, E. & Stewart, M. The principal mRNA nuclear export factor NXF1:NXT1 forms a symmetric binding platform that facilitates export of retroviral CTE-RNA. Nucleic Acids Res. 43, 1883–1893 (2015).25628361
168. Dimitrova L Structural characterization of the chaetomium thermophilum TREX-2 complex and its interaction with the mRNA nuclear export factor Mex67:Mtr2 Structure. 2015 23 1246 1257 26051714
Dimitrova, L. et al. Structural characterization of the chaetomium thermophilum TREX-2 complex and its interaction with the mRNA nuclear export factor Mex67:Mtr2. Structure. 23, 1246–1257 (2015).26051714
169. Pasquinelli AE The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway EMBO J. 1997 16 7500 7510 9405378
Pasquinelli, A. E. et al. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 16, 7500–7510 (1997).9405378
170. Kerkow DE The structure of the NXF2/NXT1 heterodimeric complex reveals the combined specificity and versatility of the NTF2-like fold J. Mol Biol. 2012 415 649 665 22123199
Kerkow, D. E. et al. The structure of the NXF2/NXT1 heterodimeric complex reveals the combined specificity and versatility of the NTF2-like fold. J. Mol Biol. 415, 649–665 (2012).22123199
171. Tan W Identification and characterization of the mouse nuclear export factor (Nxf) family members Nucleic Acids Res. 2005 33 3855 3865 16027110
Tan, W. et al. Identification and characterization of the mouse nuclear export factor (Nxf) family members. Nucleic Acids Res. 33, 3855–3865 (2005).16027110
172. Sasaki M Molecular cloning and functional characterization of mouse Nxf family gene products Genomics. 2005 85 641 653 15820316
Sasaki, M. et al. Molecular cloning and functional characterization of mouse Nxf family gene products. Genomics. 85, 641–653 (2005).15820316
173. Kose S Furuta M Imamoto N Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage Cell. 2012 149 578 589 22541429
Kose, S., Furuta, M. & Imamoto, N. Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage. Cell. 149, 578–589 (2012).22541429
174. Song J Structural and functional analysis of Hikeshi, a new nuclear transport receptor of Hsp70s Acta Crystallogr D Biol Crystallogr. 2015 71 473 483 25760597
Song, J. et al. Structural and functional analysis of Hikeshi, a new nuclear transport receptor of Hsp70s. Acta Crystallogr D Biol Crystallogr. 71, 473–483 (2015).25760597
175. Imamoto N Heat stress-induced nuclear transport mediated by Hikeshi confers nuclear function of Hsp70s Curr. Opin. Cell Biol. 2018 52 82 87 29490261
Imamoto, N. Heat stress-induced nuclear transport mediated by Hikeshi confers nuclear function of Hsp70s. Curr. Opin. Cell Biol. 52, 82–87 (2018).29490261
176. Jullien D Gorlich D Laemmli UK Adachi Y Nuclear import of RPA in Xenopus egg extracts requires a novel protein XRIPalpha but not importin alpha EMBO J. 1999 18 4348 4358 10428972
Jullien, D., Gorlich, D., Laemmli, U. K. & Adachi, Y. Nuclear import of RPA in Xenopus egg extracts requires a novel protein XRIPalpha but not importin alpha. EMBO J. 18, 4348–4358 (1999).10428972
177. Kosugi S Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling Chem. Biol. 2008 15 940 949 18804031
Kosugi, S. et al. Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling. Chem. Biol. 15, 940–949 (2008).18804031
178. Catimel B Biophysical characterization of interactions involving importin-alpha during nuclear import J. Biol. Chem. 2001 276 34189 34198 11448961
Catimel, B. et al. Biophysical characterization of interactions involving importin-alpha during nuclear import. J. Biol. Chem. 276, 34189–34198 (2001).11448961
179. Kobe B Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin alpha Nat Struct. Biol. 1999 6 388 397 10201409
Kobe, B. Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin alpha. Nat Struct. Biol. 6, 388–397 (1999).10201409
180. Pumroy RA Cingolani G Diversification of importin-alpha isoforms in cellular trafficking and disease states Biochem. J. 2015 466 13 28 25656054
Pumroy, R. A. & Cingolani, G. Diversification of importin-alpha isoforms in cellular trafficking and disease states. Biochem. J. 466, 13–28 (2015).25656054
181. Panayotis N Importin alpha5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1 Cell Rep. 2018 25 3169 3179 e3167 30540948
Panayotis, N. et al. Importin alpha5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1. Cell Rep. 25, 3169–3179 e3167 (2018).30540948
182. Sankhala RS Three-dimensional context rather than NLS amino acid sequence determines importin alpha subtype specificity for RCC1 Nat Commun. 2017 8 979 29042532
Sankhala, R. S. et al. Three-dimensional context rather than NLS amino acid sequence determines importin alpha subtype specificity for RCC1. Nat Commun. 8, 979 (2017).29042532
183. Smith KM Structural basis for importin alpha 3 specificity of W proteins in Hendra and Nipah viruses Nat Commun. 2018 9 3703 30209309
Smith, K. M. et al. Structural basis for importin alpha 3 specificity of W proteins in Hendra and Nipah viruses. Nat Commun. 9, 3703 (2018).30209309
184. Hazawa M Disease-specific alteration of karyopherin-alpha subtype establishes feed-forward oncogenic signaling in head and neck squamous cell carcinoma Oncogene. 2020 39 2212 2223 31822798
Hazawa, M. et al. Disease-specific alteration of karyopherin-alpha subtype establishes feed-forward oncogenic signaling in head and neck squamous cell carcinoma. Oncogene. 39, 2212–2223 (2020).31822798
185. Florio TJ Differential recognition of canonical NF-kappaB dimers by Importin alpha3 Nat Commun. 2022 13 1207 35260573
Florio, T. J. et al. Differential recognition of canonical NF-kappaB dimers by Importin alpha3. Nat Commun. 13, 1207 (2022).35260573
186. Delaforge E Large-Scale Conformational Dynamics Control H5N1 Influenza Polymerase PB2 Binding to Importin alpha J. Am. Chem. Soc. 2015 137 15122 15134 26424125
Delaforge, E. et al. Large-Scale Conformational Dynamics Control H5N1 Influenza Polymerase PB2 Binding to Importin alpha. J. Am. Chem. Soc. 137, 15122–15134 (2015).26424125
187. Xu W Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1 Cell Host Microbe. 2014 16 187 200 25121748
Xu, W. et al. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe. 16, 187–200 (2014).25121748
188. Kawashima T Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors J. Cell Biol. 2006 175 937 946 17178910
Kawashima, T. et al. Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J. Cell Biol. 175, 937–946 (2006).17178910
189. Mitrousis G Olia AS Walker-Kopp N Cingolani G Molecular basis for the recognition of snurportin 1 by importin beta J. Biol. Chem. 2008 283 7877 7884 18187419
Mitrousis, G., Olia, A. S., Walker-Kopp, N. & Cingolani, G. Molecular basis for the recognition of snurportin 1 by importin beta. J. Biol. Chem. 283, 7877–7884 (2008).18187419
190. Paraskeva E CRM1-mediated recycling of snurportin 1 to the cytoplasm J. Cell Biol. 1999 145 255 264 10209022
Paraskeva, E. et al. CRM1-mediated recycling of snurportin 1 to the cytoplasm. J. Cell Biol. 145, 255–264 (1999).10209022
191. Dong X Structural basis for leucine-rich nuclear export signal recognition by CRM1 Nature. 2009 458 1136 1141 19339969
Dong, X. et al. Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature. 458, 1136–1141 (2009).19339969
192. Dumont J Verlhac MH Using FRET to study RanGTP gradients in live mouse oocytes Methods Mol. Biol. 2013 957 107 120 23138947
Dumont, J. & Verlhac, M. H. Using FRET to study RanGTP gradients in live mouse oocytes. Methods Mol. Biol. 957, 107–120 (2013).23138947
193. Cole CN Hammell CM Nucleocytoplasmic transport: driving and directing transport Curr. Biol. 1998 8 R368 R372 9635180
Cole, C. N. & Hammell, C. M. Nucleocytoplasmic transport: driving and directing transport. Curr. Biol. 8, R368–R372 (1998).9635180
194. Langer K Insights into the function of the CRM1 cofactor RanBP3 from the structure of its Ran-binding domain PLoS One. 2011 6 e17011 21364925
Langer, K. et al. Insights into the function of the CRM1 cofactor RanBP3 from the structure of its Ran-binding domain. PLoS One. 6, e17011 (2011).21364925
195. Bischoff FR Ponstingl H Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1 Nature. 1991 354 80 82 1944575
Bischoff, F. R. & Ponstingl, H. Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature. 354, 80–82 (1991).1944575
196. Cingolani G Petosa C Weis K Muller CW Structure of importin-beta bound to the IBB domain of importin-alpha Nature. 1999 399 221 229 10353244
Cingolani, G., Petosa, C., Weis, K. & Muller, C. W. Structure of importin-beta bound to the IBB domain of importin-alpha. Nature. 399, 221–229 (1999).10353244
197. Moroianu J Blobel G Radu A Nuclear protein import: Ran-GTP dissociates the karyopherin alphabeta heterodimer by displacing alpha from an overlapping binding site on beta Proc. Natl. Acad. Sci. USA. 1996 93 7059 7062 8692944
Moroianu, J., Blobel, G. & Radu, A. Nuclear protein import: Ran-GTP dissociates the karyopherin alphabeta heterodimer by displacing alpha from an overlapping binding site on beta. Proc. Natl. Acad. Sci. USA. 93, 7059–7062 (1996).8692944
198. Fu SC Correlation of CRM1-NES affinity with nuclear export activity Mol. Biol. Cell. 2018 29 2037 2044 29927350
Fu, S. C. et al. Correlation of CRM1-NES affinity with nuclear export activity. Mol. Biol. Cell. 29, 2037–2044 (2018).29927350
199. Clarke PR Zhang C Spatial and temporal coordination of mitosis by Ran GTPase Nat. Rev. Mol. Cell Biol. 2008 9 464 477 18478030
Clarke, P. R. & Zhang, C. Spatial and temporal coordination of mitosis by Ran GTPase. Nat. Rev. Mol. Cell Biol. 9, 464–477 (2008).18478030
200. Kalab P Weis K Heald R Visualization of a Ran-GTP gradient in interphase and mitotic Xenopus egg extracts Science. 2002 295 2452 2456 11923538
Kalab, P., Weis, K. & Heald, R. Visualization of a Ran-GTP gradient in interphase and mitotic Xenopus egg extracts. Science. 295, 2452–2456 (2002).11923538
201. Dasso M The Ran GTPase: theme and variations Curr. Biol. 2002 12 R502 R508 12176353
Dasso, M. The Ran GTPase: theme and variations. Curr. Biol. 12, R502–R508 (2002).12176353
202. Nemergut ME Chromatin docking and exchange activity enhancement of RCC1 by histones H2A and H2B Science. 2001 292 1540 1543 11375490
Nemergut, M. E. et al. Chromatin docking and exchange activity enhancement of RCC1 by histones H2A and H2B. Science. 292, 1540–1543 (2001).11375490
203. Makde RD England JR Yennawar HP Tan S Structure of RCC1 chromatin factor bound to the nucleosome core particle Nature. 2010 467 562 566 20739938
Makde, R. D., England, J. R., Yennawar, H. P. & Tan, S. Structure of RCC1 chromatin factor bound to the nucleosome core particle. Nature. 467, 562–566 (2010).20739938
204. Chen T N-terminal alpha-methylation of RCC1 is necessary for stable chromatin association and normal mitosis Nat Cell Biol. 2007 9 596 603 17435751
Chen, T. et al. N-terminal alpha-methylation of RCC1 is necessary for stable chromatin association and normal mitosis. Nat Cell Biol. 9, 596–603 (2007).17435751
205. Klebe C Prinz H Wittinghofer A Goody RS The kinetic mechanism of Ran–nucleotide exchange catalyzed by RCC1 Biochemistry. 1995 34 12543 12552 7548002
Klebe, C., Prinz, H., Wittinghofer, A. & Goody, R. S. The kinetic mechanism of Ran–nucleotide exchange catalyzed by RCC1. Biochemistry. 34, 12543–12552 (1995).7548002
206. Renault L Kuhlmann J Henkel A Wittinghofer A Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1) Cell. 2001 105 245 255 11336674
Renault, L., Kuhlmann, J., Henkel, A. & Wittinghofer, A. Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1). Cell. 105, 245–255 (2001).11336674
207. Yamada M Mattaj IW Yoneda Y An ATP-dependent activity that releases RanGDP from NTF2 J. Biol. Chem. 2004 279 36228 36234 15155737
Yamada, M., Mattaj, I. W. & Yoneda, Y. An ATP-dependent activity that releases RanGDP from NTF2. J. Biol. Chem. 279, 36228–36234 (2004).15155737
208. Matunis MJ Coutavas E Blobel G A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex J. Cell Biol. 1996 135 1457 1470 8978815
Matunis, M. J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457–1470 (1996).8978815
209. Bischoff FR RanGAP1 induces GTPase activity of nuclear Ras-related Ran Proc. Natl. Acad. Sci. USA. 1994 91 2587 2591 8146159
Bischoff, F. R. et al. RanGAP1 induces GTPase activity of nuclear Ras-related Ran. Proc. Natl. Acad. Sci. USA. 91, 2587–2591 (1994).8146159
210. Seewald MJ Korner C Wittinghofer A Vetter IR RanGAP mediates GTP hydrolysis without an arginine finger Nature. 2002 415 662 666 11832950
Seewald, M. J., Korner, C., Wittinghofer, A. & Vetter, I. R. RanGAP mediates GTP hydrolysis without an arginine finger. Nature. 415, 662–666 (2002).11832950
211. Gong Y Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma Dev Cell. 2023 58 192 210.e111 36696903
Gong, Y. et al. Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma. Dev Cell. 58, 192–210.e111 (2023).36696903
212. Roscioli E Importin-beta negatively regulates multiple aspects of mitosis including RANGAP1 recruitment to kinetochores J. Cell Biol. 2012 196 435 450 22331847
Roscioli, E. et al. Importin-beta negatively regulates multiple aspects of mitosis including RANGAP1 recruitment to kinetochores. J. Cell Biol. 196, 435–450 (2012).22331847
213. Li Y Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals Elife. 2019 8 e41331 31021318
Li, Y. et al. Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals. Elife. 8, e41331 (2019).31021318
214. Kehlenbach RH A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export J. Cell Biol. 1999 145 645 657 10330396
Kehlenbach, R. H. et al. A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. J. Cell Biol. 145, 645–657 (1999).10330396
215. Bischoff FR Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1 EMBO J. 1995 14 705 715 7882974
Bischoff, F. R. et al. Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1. EMBO J. 14, 705–715 (1995).7882974
216. Kuhlmann J Macara I Wittinghofer A Dynamic and equilibrium studies on the interaction of Ran with its effector, RanBP1 Biochemistry. 1997 36 12027 12035 9315840
Kuhlmann, J., Macara, I. & Wittinghofer, A. Dynamic and equilibrium studies on the interaction of Ran with its effector, RanBP1. Biochemistry. 36, 12027–12035 (1997).9315840
217. Richards SA Lounsbury KM Carey KL Macara IG A nuclear export signal is essential for the cytosolic localization of the Ran binding protein, RanBP1 J Cell Biol. 1996 134 1157 1168 8794858
Richards, S. A., Lounsbury, K. M., Carey, K. L. & Macara, I. G. A nuclear export signal is essential for the cytosolic localization of the Ran binding protein, RanBP1. J Cell Biol. 134, 1157–1168 (1996).8794858
218. Vetter IR Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport Nature. 1999 398 39 46 10078529
Vetter, I. R. et al. Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport. Nature. 398, 39–46 (1999).10078529
219. Lindsay ME Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export J. Cell Biol. 2001 153 1391 1402 11425870
Lindsay, M. E. et al. Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export. J. Cell Biol. 153, 1391–1402 (2001).11425870
220. Koyama M Shirai N Matsuura Y Structural insights into how Yrb2p accelerates the assembly of the Xpo1p nuclear export complex Cell Rep. 2014 9 983 995 25437554
Koyama, M., Shirai, N. & Matsuura, Y. Structural insights into how Yrb2p accelerates the assembly of the Xpo1p nuclear export complex. Cell Rep. 9, 983–995 (2014).25437554
221. Guttler T Gorlich D Ran-dependent nuclear export mediators: a structural perspective EMBO J. 2011 30 3457 3474 21878989
Guttler, T. & Gorlich, D. Ran-dependent nuclear export mediators: a structural perspective. EMBO J. 30, 3457–3474 (2011).21878989
222. Nemergut ME Lindsay ME Brownawell AM Macara IG Ran-binding protein 3 links Crm1 to the Ran guanine nucleotide exchange factor J. Biol. Chem. 2002 277 17385 17388 11932251
Nemergut, M. E., Lindsay, M. E., Brownawell, A. M. & Macara, I. G. Ran-binding protein 3 links Crm1 to the Ran guanine nucleotide exchange factor. J. Biol. Chem. 277, 17385–17388 (2002).11932251
223. Holzer G The nucleoporin Nup50 activates the Ran guanine nucleotide exchange factor RCC1 to promote NPC assembly at the end of mitosis EMBO J. 2021 40 e108788 34725842
Holzer, G. et al. The nucleoporin Nup50 activates the Ran guanine nucleotide exchange factor RCC1 to promote NPC assembly at the end of mitosis. EMBO J. 40, e108788 (2021).34725842
224. Lindsay ME Npap60/Nup50 is a tri-stable switch that stimulates importin-alpha:beta-mediated nuclear protein import Cell. 2002 110 349 360 12176322
Lindsay, M. E. et al. Npap60/Nup50 is a tri-stable switch that stimulates importin-alpha:beta-mediated nuclear protein import. Cell. 110, 349–360 (2002).12176322
225. Werner A Flotho A Melchior F The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase Mol. Cell. 2012 46 287 298 22464730
Werner, A., Flotho, A. & Melchior, F. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase. Mol. Cell. 46, 287–298 (2012).22464730
226. Pichler A Melchior F Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport Traffic. 2002 3 381 387 12010456
Pichler, A. & Melchior, F. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic. 3, 381–387 (2002).12010456
227. Pichler A The nucleoporin RanBP2 has SUMO1 E3 ligase activity Cell. 2002 108 109 120 11792325
Pichler, A. et al. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 108, 109–120 (2002).11792325
228. Du JX Bialkowska AB McConnell BB Yang VW SUMOylation regulates nuclear localization of Kruppel-like factor 5 J. Biol. Chem. 2008 283 31991 32002 18782761
Du, J. X., Bialkowska, A. B., McConnell, B. B. & Yang, V. W. SUMOylation regulates nuclear localization of Kruppel-like factor 5. J. Biol. Chem. 283, 31991–32002 (2008).18782761
229. Terui Y Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1 J. Biol. Chem. 2004 279 28257 28265 15117942
Terui, Y. et al. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279, 28257–28265 (2004).15117942
230. Ptak C Wozniak RW SUMO and nucleocytoplasmic transport Adv. Exp. Med. Biol. 2017 963 111 126 28197909
Ptak, C. & Wozniak, R. W. SUMO and nucleocytoplasmic transport. Adv. Exp. Med. Biol. 963, 111–126 (2017).28197909
231. Rodriguez MS Dargemont C Hay RT SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting J. Biol. Chem. 2001 276 12654 12659 11124955
Rodriguez, M. S., Dargemont, C. & Hay, R. T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654–12659 (2001).11124955
232. Sternsdorf T Jensen K Reich B Will H The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers J. Biol. Chem. 1999 274 12555 12566 10212234
Sternsdorf, T., Jensen, K., Reich, B. & Will, H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555–12566 (1999).10212234
233. Panse VG A proteome-wide approach identifies sumoylated substrate proteins in yeast J. Biol. Chem. 2004 279 41346 41351 15292183
Panse, V. G. et al. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279, 41346–41351 (2004).15292183
234. Melchior F Schergaut M Pichler A SUMO: ligases, isopeptidases and nuclear pores Trends Biochem Sci. 2003 28 612 618 14607092
Melchior, F., Schergaut, M. & Pichler, A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci. 28, 612–618 (2003).14607092
235. Di Cesare E Aurora B SUMOylation is restricted to centromeres in early mitosis and requires RANBP2 Cells. 2023 12 372 36766713
Di Cesare, E. et al. Aurora B SUMOylation is restricted to centromeres in early mitosis and requires RANBP2. Cells. 12, 372 (2023).36766713
236. Panse VG Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway Traffic. 2006 7 1311 1321 16978391
Panse, V. G. et al. Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway. Traffic. 7, 1311–1321 (2006).16978391
237. Zhang H Saitoh H Matunis MJ Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex Mol. Cell Biol. 2002 22 6498 6508 12192048
Zhang, H., Saitoh, H. & Matunis, M. J. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell Biol. 22, 6498–6508 (2002).12192048
238. Vertegaal ACO Signalling mechanisms and cellular functions of SUMO Nat. Rev. Mol. Cell Biol. 2022 23 715 731 35750927
Vertegaal, A. C. O. Signalling mechanisms and cellular functions of SUMO. Nat. Rev. Mol. Cell Biol. 23, 715–731 (2022).35750927
239. Chang HM Yeh ETH SUMO: From bench to bedside Physiol Rev. 2020 100 1599 1619 32666886
Chang, H. M. & Yeh, E. T. H. SUMO: From bench to bedside. Physiol Rev. 100, 1599–1619 (2020).32666886
240. Jamali T Jamali Y Mehrbod M Mofrad MR Nuclear pore complex: biochemistry and biophysics of nucleocytoplasmic transport in health and disease Int Rev Cell Mol Biol. 2011 287 233 286 21414590
Jamali, T., Jamali, Y., Mehrbod, M. & Mofrad, M. R. Nuclear pore complex: biochemistry and biophysics of nucleocytoplasmic transport in health and disease. Int Rev Cell Mol Biol. 287, 233–286 (2011).21414590
241. Timney BL Simple rules for passive diffusion through the nuclear pore complex J. Cell Biol. 2016 215 57 76 27697925
Timney, B. L. et al. Simple rules for passive diffusion through the nuclear pore complex. J. Cell Biol. 215, 57–76 (2016).27697925
242. Huang K Szleifer I Modeling the nucleoporins that form the hairy pores Biochem. Soc. Trans. 2020 48 1447 1461 32794558
Huang, K. & Szleifer, I. Modeling the nucleoporins that form the hairy pores. Biochem. Soc. Trans. 48, 1447–1461 (2020).32794558
243. Donnaloja F Jacchetti E Soncini M Raimondi MT Mechanosensing at the nuclear envelope by nuclear pore complex stretch activation and its effect in physiology and pathology Front Physiol. 2019 10 896 31354529
Donnaloja, F., Jacchetti, E., Soncini, M. & Raimondi, M. T. Mechanosensing at the nuclear envelope by nuclear pore complex stretch activation and its effect in physiology and pathology. Front Physiol. 10, 896 (2019).31354529
244. Frey S Richter RP Gorlich D FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties Science. 2006 314 815 817 17082456
Frey, S., Richter, R. P. & Gorlich, D. FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties. Science. 314, 815–817 (2006).17082456
245. Peters R Translocation through the nuclear pore complex: selectivity and speed by reduction-of-dimensionality Traffic. 2005 6 421 427 15813752
Peters, R. Translocation through the nuclear pore complex: selectivity and speed by reduction-of-dimensionality. Traffic. 6, 421–427 (2005).15813752
246. Lim RY Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transport Proc Natl. Acad. Sci. USA. 2006 103 9512 9517 16769882
Lim, R. Y. et al. Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transport. Proc Natl. Acad. Sci. USA. 103, 9512–9517 (2006).16769882
247. Milles S Facilitated aggregation of FG nucleoporins under molecular crowding conditions EMBO Rep. 2013 14 178 183 23238392
Milles, S. et al. Facilitated aggregation of FG nucleoporins under molecular crowding conditions. EMBO Rep. 14, 178–183 (2013).23238392
248. Schmidt HB Gorlich D Nup98 FG domains from diverse species spontaneously phase-separate into particles with nuclear pore-like permselectivity Elife. 2015 4 e04251 25562883
Schmidt, H. B. & Gorlich, D. Nup98 FG domains from diverse species spontaneously phase-separate into particles with nuclear pore-like permselectivity. Elife. 4, e04251 (2015).25562883
249. Lim RY Nanomechanical basis of selective gating by the nuclear pore complex Science. 2007 318 640 643 17916694
Lim, R. Y. et al. Nanomechanical basis of selective gating by the nuclear pore complex. Science. 318, 640–643 (2007).17916694
250. Hoogenboom BW Physics of the nuclear pore complex: Theory, modeling and experiment Phys Rep. 2021 921 1 53 35892075
Hoogenboom, B. W. et al. Physics of the nuclear pore complex: Theory, modeling and experiment. Phys Rep. 921, 1–53 (2021).35892075
251. Frey S Gorlich D FG/FxFG as well as GLFG repeats form a selective permeability barrier with self-healing properties EMBO J. 2009 28 2554 2567 19680227
Frey, S. & Gorlich, D. FG/FxFG as well as GLFG repeats form a selective permeability barrier with self-healing properties. EMBO J. 28, 2554–2567 (2009).19680227
252. Frey S Gorlich D A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes Cell. 2007 130 512 523 17693259
Frey, S. & Gorlich, D. A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes. Cell. 130, 512–523 (2007).17693259
253. Ghavami A Veenhoff LM van der Giessen E Onck PR Probing the disordered domain of the nuclear pore complex through coarse-grained molecular dynamics simulations Biophys. J. 2014 107 1393 1402 25229147
Ghavami, A., Veenhoff, L. M., van der Giessen, E. & Onck, P. R. Probing the disordered domain of the nuclear pore complex through coarse-grained molecular dynamics simulations. Biophys. J. 107, 1393–1402 (2014).25229147
254. Ng SC Gorlich D A simple thermodynamic description of phase separation of Nup98 FG domains Nat Commun. 2022 13 6172 36257947
Ng, S. C. & Gorlich, D. A simple thermodynamic description of phase separation of Nup98 FG domains. Nat Commun. 13, 6172 (2022).36257947
255. Sakiyama Y Mazur A Kapinos LE Lim RY Spatiotemporal dynamics of the nuclear pore complex transport barrier resolved by high-speed atomic force microscopy Nat. Nanotechnol. 2016 11 719 723 27136131
Sakiyama, Y., Mazur, A., Kapinos, L. E. & Lim, R. Y. Spatiotemporal dynamics of the nuclear pore complex transport barrier resolved by high-speed atomic force microscopy. Nat. Nanotechnol. 11, 719–723 (2016).27136131
256. Rout MP Aitchison JD Magnasco MO Chait BT Virtual gating and nuclear transport: the hole picture Trends Cell Biol. 2003 13 622 628 14624840
Rout, M. P., Aitchison, J. D., Magnasco, M. O. & Chait, B. T. Virtual gating and nuclear transport: the hole picture. Trends Cell Biol. 13, 622–628 (2003).14624840
257. Zheng T Zilman A Self-regulation of the nuclear pore complex enables clogging-free crowded transport Proc. Natl. Acad. Sci. USA. 2023 120 e2212874120 36757893
Zheng, T. & Zilman, A. Self-regulation of the nuclear pore complex enables clogging-free crowded transport. Proc. Natl. Acad. Sci. USA. 120, e2212874120 (2023).36757893
258. Kalita J Karyopherin enrichment and compensation fortifies the nuclear pore complex against nucleocytoplasmic leakage J. Cell Biol. 2022 221 e202108107 35089308
Kalita, J. et al. Karyopherin enrichment and compensation fortifies the nuclear pore complex against nucleocytoplasmic leakage. J. Cell Biol. 221, e202108107 (2022).35089308
259. Kapinos LE Huang B Rencurel C Lim RYH Karyopherins regulate nuclear pore complex barrier and transport function J. Cell Biol. 2017 216 3609 3624 28864541
Kapinos, L. E., Huang, B., Rencurel, C. & Lim, R. Y. H. Karyopherins regulate nuclear pore complex barrier and transport function. J. Cell Biol. 216, 3609–3624 (2017).28864541
260. Kapinos LE Karyopherin-centric control of nuclear pores based on molecular occupancy and kinetic analysis of multivalent binding with FG nucleoporins Biophys. J. 2014 106 1751 1762 24739174
Kapinos, L. E. et al. Karyopherin-centric control of nuclear pores based on molecular occupancy and kinetic analysis of multivalent binding with FG nucleoporins. Biophys. J. 106, 1751–1762 (2014).24739174
261. Lennon KM Characterizing binding interactions that are essential for selective transport through the nuclear pore complex Int. J. Mol. Sci. 2021 22 10898 34639238
Lennon, K. M. et al. Characterizing binding interactions that are essential for selective transport through the nuclear pore complex. Int. J. Mol. Sci. 22, 10898 (2021).34639238
262. Stanley GJ Fassati A Hoogenboom BW Biomechanics of the transport barrier in the nuclear pore complex Semin Cell Dev Biol. 2017 68 42 51 28506890
Stanley, G. J., Fassati, A. & Hoogenboom, B. W. Biomechanics of the transport barrier in the nuclear pore complex. Semin Cell Dev Biol. 68, 42–51 (2017).28506890
263. Yang W ‘Natively unfolded’ nucleoporins in nucleocytoplasmic transport: clustered or evenly distributed? Nucleus. 2011 2 10 16 21647294
Yang, W. ‘Natively unfolded’ nucleoporins in nucleocytoplasmic transport: clustered or evenly distributed? Nucleus. 2, 10–16 (2011).21647294
264. Moore MS Npap60: a new player in nuclear protein import Trends Cell Biol. 2003 13 61 64 12559755
Moore, M. S. Npap60: a new player in nuclear protein import. Trends Cell Biol. 13, 61–64 (2003).12559755
265. Milles S Plasticity of an ultrafast interaction between nucleoporins and nuclear transport receptors Cell. 2015 163 734 745 26456112
Milles, S. et al. Plasticity of an ultrafast interaction between nucleoporins and nuclear transport receptors. Cell. 163, 734–745 (2015).26456112
266. Raveh B Slide-and-exchange mechanism for rapid and selective transport through the nuclear pore complex Proc. Natl. Acad. Sci. USA. 2016 113 E2489 E2497 27091992
Raveh, B. et al. Slide-and-exchange mechanism for rapid and selective transport through the nuclear pore complex. Proc. Natl. Acad. Sci. USA. 113, E2489–E2497 (2016).27091992
267. Herrmann M Near-field optical study of protein transport kinetics at a single nuclear pore Nano Lett. 2009 9 3330 3336 19591452
Herrmann, M. et al. Near-field optical study of protein transport kinetics at a single nuclear pore. Nano Lett. 9, 3330–3336 (2009).19591452
268. Yang W Gelles J Musser SM Imaging of single-molecule translocation through nuclear pore complexes Proc. Natl. Acad. Sci. USA. 2004 101 12887 12892 15306682
Yang, W., Gelles, J. & Musser, S. M. Imaging of single-molecule translocation through nuclear pore complexes. Proc. Natl. Acad. Sci. USA. 101, 12887–12892 (2004).15306682
269. Nachury MV Weis K The direction of transport through the nuclear pore can be inverted Proc. Natl. Acad. Sci. USA. 1999 96 9622 9627 10449743
Nachury, M. V. & Weis, K. The direction of transport through the nuclear pore can be inverted. Proc. Natl. Acad. Sci. USA. 96, 9622–9627 (1999).10449743
270. Huang K Nanocompartmentalization of the nuclear pore lumen Biophys. J. 2020 118 219 231 31839259
Huang, K. et al. Nanocompartmentalization of the nuclear pore lumen. Biophys. J. 118, 219–231 (2020).31839259
271. Strawn LA Minimal nuclear pore complexes define FG repeat domains essential for transport Nat Cell Biol. 2004 6 197 206 15039779
Strawn, L. A. et al. Minimal nuclear pore complexes define FG repeat domains essential for transport. Nat Cell Biol. 6, 197–206 (2004).15039779
272. Forler D RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export Mol Cell Biol. 2004 24 1155 1167 14729961
Forler, D. et al. RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export. Mol Cell Biol. 24, 1155–1167 (2004).14729961
273. Pyhtila B Rexach M A gradient of affinity for the karyopherin Kap95p along the yeast nuclear pore complex J. Biol. Chem. 2003 278 42699 42709 12917401
Pyhtila, B. & Rexach, M. A gradient of affinity for the karyopherin Kap95p along the yeast nuclear pore complex. J. Biol. Chem. 278, 42699–42709 (2003).12917401
274. Ben-Efraim I Gerace L Gradient of increasing affinity of importin beta for nucleoporins along the pathway of nuclear import J. Cell Biol. 2001 152 411 417 11266456
Ben-Efraim, I. & Gerace, L. Gradient of increasing affinity of importin beta for nucleoporins along the pathway of nuclear import. J. Cell Biol. 152, 411–417 (2001).11266456
275. Floer M Blobel G Putative reaction intermediates in Crm1-mediated nuclear protein export J. Biol. Chem. 1999 274 16279 16286 10347184
Floer, M. & Blobel, G. Putative reaction intermediates in Crm1-mediated nuclear protein export. J. Biol. Chem. 274, 16279–16286 (1999).10347184
276. Paci G Molecular determinants of large cargo transport into the nucleus Elife. 2020 9 e55963 32692309
Paci, G. et al. Molecular determinants of large cargo transport into the nucleus. Elife. 9, e55963 (2020).32692309
277. Forbes DJ Travesa A Nord MS Bernis C Nuclear transport factors: global regulation of mitosis Curr. Opin. Cell Biol. 2015 35 78 90 25982429
Forbes, D. J., Travesa, A., Nord, M. S. & Bernis, C. Nuclear transport factors: global regulation of mitosis. Curr. Opin. Cell Biol. 35, 78–90 (2015).25982429
278. Springhower CE Rosen MK Chook YM Karyopherins and condensates Curr. Opin. Cell Biol. 2020 64 112 123 32474299
Springhower, C. E., Rosen, M. K. & Chook, Y. M. Karyopherins and condensates. Curr. Opin. Cell Biol. 64, 112–123 (2020).32474299
279. Sumner MC Brickner J The nuclear pore complex as a transcription regulator Cold Spring Harb. Perspect. Biol. 2022 14 a039438 34127448
Sumner, M. C. & Brickner, J. The nuclear pore complex as a transcription regulator. Cold Spring Harb. Perspect. Biol. 14, a039438 (2022).34127448
280. Endicott SJ Brueckner M NUP98 sets the size-exclusion diffusion limit through the ciliary base Curr. Biol. 2018 28 1643 1650 e1643 29731308
Endicott, S. J. & Brueckner, M. NUP98 sets the size-exclusion diffusion limit through the ciliary base. Curr. Biol. 28, 1643–1650 e1643 (2018).29731308
281. Del Viso F Congenital heart disease genetics uncovers context-dependent organization and function of nucleoporins at cilia Dev Cell. 2016 38 478 492 27593162
Del Viso, F. et al. Congenital heart disease genetics uncovers context-dependent organization and function of nucleoporins at cilia. Dev Cell. 38, 478–492 (2016).27593162
282. Jevtic P The nucleoporin ELYS regulates nuclear size by controlling NPC number and nuclear import capacity EMBO Rep. 2019 20 e47283 31085625
Jevtic, P. et al. The nucleoporin ELYS regulates nuclear size by controlling NPC number and nuclear import capacity. EMBO Rep. 20, e47283 (2019).31085625
283. Brownlee C Heald R Importin alpha partitioning to the plasma membrane regulates intracellular scaling Cell. 2019 176 805 815.e808 30639102
Brownlee, C. & Heald, R. Importin alpha partitioning to the plasma membrane regulates intracellular scaling. Cell. 176, 805–815.e808 (2019).30639102
284. Bonner AM Hawley RS A nucleoporin at the meiotic kinetochore Dev Cell. 2016 38 447 448 27623378
Bonner, A. M. & Hawley, R. S. A nucleoporin at the meiotic kinetochore. Dev Cell. 38, 447–448 (2016).27623378
285. Hattersley N MEL-28/ELYS and CENP-C coordinately control outer kinetochore assembly and meiotic chromosome-microtubule interactions Curr. Biol. 2022 32 2563 2571.e2564 35609608
Hattersley, N. et al. MEL-28/ELYS and CENP-C coordinately control outer kinetochore assembly and meiotic chromosome-microtubule interactions. Curr. Biol. 32, 2563–2571.e2564 (2022).35609608
286. Drutovic D RanGTP and importin beta regulate meiosis I spindle assembly and function in mouse oocytes EMBO J. 2020 39 e101689 31617608
Drutovic, D. et al. RanGTP and importin beta regulate meiosis I spindle assembly and function in mouse oocytes. EMBO J. 39, e101689 (2020).31617608
287. Moore W Zhang C Clarke PR Targeting of RCC1 to chromosomes is required for proper mitotic spindle assembly in human cells Curr. Biol. 2002 12 1442 1447 12194828
Moore, W., Zhang, C. & Clarke, P. R. Targeting of RCC1 to chromosomes is required for proper mitotic spindle assembly in human cells. Curr. Biol. 12, 1442–1447 (2002).12194828
288. Zhang MS Arnaoutov A Dasso M RanBP1 governs spindle assembly by defining mitotic Ran-GTP production Dev Cell. 2014 31 393 404 25458009
Zhang, M. S., Arnaoutov, A. & Dasso, M. RanBP1 governs spindle assembly by defining mitotic Ran-GTP production. Dev Cell. 31, 393–404 (2014).25458009
289. Cavazza T Vernos I The RanGTP pathway: From nucleo-cytoplasmic transport to spindle assembly and beyond Front Cell Dev Biol. 2015 3 82 26793706
Cavazza, T. & Vernos, I. The RanGTP pathway: From nucleo-cytoplasmic transport to spindle assembly and beyond. Front Cell Dev Biol. 3, 82 (2015).26793706
290. Chang CC Regulation of mitotic spindle assembly factor NuMA by importin-beta J Cell Biol. 2017 216 3453 3462 28939615
Chang, C. C. et al. Regulation of mitotic spindle assembly factor NuMA by importin-beta. J Cell Biol. 216, 3453–3462 (2017).28939615
291. Ems-McClung SC RanGTP induces an effector gradient of XCTK2 and importin alpha/beta for spindle microtubule cross-linking J. Cell Biol. 2020 219 e201906045 31865374
Ems-McClung, S. C. et al. RanGTP induces an effector gradient of XCTK2 and importin alpha/beta for spindle microtubule cross-linking. J. Cell Biol. 219, e201906045 (2020).31865374
292. Chang CC Ran pathway-independent regulation of mitotic Golgi disassembly by Importin-alpha Nat Commun. 2019 10 4307 31541088
Chang, C. C. et al. Ran pathway-independent regulation of mitotic Golgi disassembly by Importin-alpha. Nat Commun. 10, 4307 (2019).31541088
293. Eibes S Nek9 phosphorylation defines a new role for TPX2 in Eg5-dependent centrosome separation before nuclear envelope breakdown Curr. Biol. 2018 28 121 129.e124 29276125
Eibes, S. et al. Nek9 phosphorylation defines a new role for TPX2 in Eg5-dependent centrosome separation before nuclear envelope breakdown. Curr. Biol. 28, 121–129.e124 (2018).29276125
294. Lu X Requirement for lamin B receptor and its regulation by importin beta and phosphorylation in nuclear envelope assembly during mitotic exit J. Biol. Chem. 2010 285 33281 33293 20576617
Lu, X. et al. Requirement for lamin B receptor and its regulation by importin beta and phosphorylation in nuclear envelope assembly during mitotic exit. J. Biol. Chem. 285, 33281–33293 (2010).20576617
295. Wandke C Kutay U Enclosing chromatin: reassembly of the nucleus after open mitosis Cell. 2013 152 1222 1225 23498932
Wandke, C. & Kutay, U. Enclosing chromatin: reassembly of the nucleus after open mitosis. Cell. 152, 1222–1225 (2013).23498932
296. Walther TC RanGTP mediates nuclear pore complex assembly Nature. 2003 424 689 694 12894213
Walther, T. C. et al. RanGTP mediates nuclear pore complex assembly. Nature. 424, 689–694 (2003).12894213
297. Lau CK Transportin regulates major mitotic assembly events: from spindle to nuclear pore assembly Mol. Biol. Cell. 2009 20 4043 4058 19641022
Lau, C. K. et al. Transportin regulates major mitotic assembly events: from spindle to nuclear pore assembly. Mol. Biol. Cell. 20, 4043–4058 (2009).19641022
298. Bernis C Transportin acts to regulate mitotic assembly events by target binding rather than Ran sequestration Mol. Biol. Cell. 2014 25 992 1009 24478460
Bernis, C. et al. Transportin acts to regulate mitotic assembly events by target binding rather than Ran sequestration. Mol. Biol. Cell. 25, 992–1009 (2014).24478460
299. Arnaoutov A Crm1 is a mitotic effector of Ran-GTP in somatic cells Nat Cell Biol. 2005 7 626 632 15908946
Arnaoutov, A. et al. Crm1 is a mitotic effector of Ran-GTP in somatic cells. Nat Cell Biol. 7, 626–632 (2005).15908946
300. Bao XX Exportin Crm1 is repurposed as a docking protein to generate microtubule organizing centers at the nuclear pore Elife. 2018 7 e33465 29809148
Bao, X. X. et al. Exportin Crm1 is repurposed as a docking protein to generate microtubule organizing centers at the nuclear pore. Elife. 7, e33465 (2018).29809148
301. Budhu AS Wang XW Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1 Cell Cycle. 2005 4 1510 1514 16294017
Budhu, A. S. & Wang, X. W. Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1. Cell Cycle. 4, 1510–1514 (2005).16294017
302. Wang W Budhu A Forgues M Wang XW Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication Nat Cell Biol. 2005 7 823 830 16041368
Wang, W., Budhu, A., Forgues, M. & Wang, X. W. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol. 7, 823–830 (2005).16041368
303. Dawlaty MM Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha Cell. 2008 133 103 115 18394993
Dawlaty, M. M. et al. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell. 133, 103–115 (2008).18394993
304. Wozniak R Burke B Doye V Nuclear transport and the mitotic apparatus: an evolving relationship Cell Mol. Life Sci. 2010 67 2215 2230 20372967
Wozniak, R., Burke, B. & Doye, V. Nuclear transport and the mitotic apparatus: an evolving relationship. Cell Mol. Life Sci. 67, 2215–2230 (2010).20372967
305. Yokoyama H The nucleoporin MEL-28 promotes RanGTP-dependent gamma-tubulin recruitment and microtubule nucleation in mitotic spindle formation Nat Commun. 2014 5 3270 24509916
Yokoyama, H. et al. The nucleoporin MEL-28 promotes RanGTP-dependent gamma-tubulin recruitment and microtubule nucleation in mitotic spindle formation. Nat Commun. 5, 3270 (2014).24509916
306. Mishra RK The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores Nat Cell Biol. 2010 12 164 169 20081840
Mishra, R. K. et al. The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores. Nat Cell Biol. 12, 164–169 (2010).20081840
307. Zuccolo M The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions EMBO J. 2007 26 1853 1864 17363900
Zuccolo, M. et al. The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions. EMBO J. 26, 1853–1864 (2007).17363900
308. Platani M The Nup107-160 nucleoporin complex promotes mitotic events via control of the localization state of the chromosome passenger complex Mol Biol Cell. 2009 20 5260 5275 19864462
Platani, M. et al. The Nup107-160 nucleoporin complex promotes mitotic events via control of the localization state of the chromosome passenger complex. Mol Biol Cell. 20, 5260–5275 (2009).19864462
309. Hashizume C Nakano H Yoshida K Wong RW Characterization of the role of the tumor marker Nup88 in mitosis Mol Cancer. 2010 9 119 20497554
Hashizume, C., Nakano, H., Yoshida, K. & Wong, R. W. Characterization of the role of the tumor marker Nup88 in mitosis. Mol Cancer. 9, 119 (2010).20497554
310. Jeganathan KB Malureanu L van Deursen JM The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation Nature. 2005 438 1036 1039 16355229
Jeganathan, K. B., Malureanu, L. & van Deursen, J. M. The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. Nature. 438, 1036–1039 (2005).16355229
311. Naylor RM Jeganathan KB Cao X van Deursen JM Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy J. Clin. Invest. 2016 126 543 559 26731471
Naylor, R. M., Jeganathan, K. B., Cao, X. & van Deursen, J. M. Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. J. Clin. Invest. 126, 543–559 (2016).26731471
312. Rodriguez-Bravo V Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor Cell. 2014 156 1017 1031 24581499
Rodriguez-Bravo, V. et al. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell. 156, 1017–1031 (2014).24581499
313. Mossaid I Fahrenkrog B Complex commingling: Nucleoporins and the spindle assembly checkpoint Cells. 2015 4 706 725 26540075
Mossaid, I. & Fahrenkrog, B. Complex commingling: Nucleoporins and the spindle assembly checkpoint. Cells. 4, 706–725 (2015).26540075
314. Jackman M Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint J. Cell Biol. 2020 219 e201907082 32236513
Jackman, M. et al. Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint. J. Cell Biol. 219, e201907082 (2020).32236513
315. Schweizer N Spindle assembly checkpoint robustness requires Tpr-mediated regulation of Mad1/Mad2 proteostasis J. Cell Biol. 2013 203 883 893 24344181
Schweizer, N. et al. Spindle assembly checkpoint robustness requires Tpr-mediated regulation of Mad1/Mad2 proteostasis. J. Cell Biol. 203, 883–893 (2013).24344181
316. Dultz E Systematic kinetic analysis of mitotic dis- and reassembly of the nuclear pore in living cells J. Cell Biol. 2008 180 857 865 18316408
Dultz, E. et al. Systematic kinetic analysis of mitotic dis- and reassembly of the nuclear pore in living cells. J. Cell Biol. 180, 857–865 (2008).18316408
317. Laurell E Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry Cell. 2011 144 539 550 21335236
Laurell, E. et al. Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry. Cell. 144, 539–550 (2011).21335236
318. Linder MI Mitotic disassembly of nuclear pore complexes involves CDK1- and PLK1-mediated phosphorylation of key interconnecting nucleoporins Dev Cell. 2017 43 141 156.e147 29065306
Linder, M. I. et al. Mitotic disassembly of nuclear pore complexes involves CDK1- and PLK1-mediated phosphorylation of key interconnecting nucleoporins. Dev Cell. 43, 141–156.e147 (2017).29065306
319. Martino L Channel nucleoporins recruit PLK-1 to nuclear pore complexes to direct nuclear envelope breakdown in C. elegans Dev Cell. 2017 43 157 171 e157 29065307
Martino, L. et al. Channel nucleoporins recruit PLK-1 to nuclear pore complexes to direct nuclear envelope breakdown in C. elegans. Dev Cell. 43, 157–171 e157 (2017).29065307
320. Chou YY Inherited nuclear pore substructures template post-mitotic pore assembly Dev Cell. 2021 56 1786 1803.e1789 34129835
Chou, Y. Y. et al. Inherited nuclear pore substructures template post-mitotic pore assembly. Dev Cell. 56, 1786–1803.e1789 (2021).34129835
321. Dultz E Huet S Ellenberg J Formation of the nuclear envelope permeability barrier studied by sequential photoswitching and flux analysis Biophys. J. 2009 97 1891 1897 19804719
Dultz, E., Huet, S. & Ellenberg, J. Formation of the nuclear envelope permeability barrier studied by sequential photoswitching and flux analysis. Biophys. J. 97, 1891–1897 (2009).19804719
322. Bilokapic S Schwartz TU Structural and functional studies of the 252 kDa nucleoporin ELYS reveal distinct roles for its three tethered domains Structure. 2013 21 572 580 23499022
Bilokapic, S. & Schwartz, T. U. Structural and functional studies of the 252 kDa nucleoporin ELYS reveal distinct roles for its three tethered domains. Structure. 21, 572–580 (2013).23499022
323. Hattersley N A nucleoporin docks protein phosphatase 1 to direct meiotic chromosome segregation and nuclear assembly Dev Cell. 2016 38 463 477 27623381
Hattersley, N. et al. A nucleoporin docks protein phosphatase 1 to direct meiotic chromosome segregation and nuclear assembly. Dev Cell. 38, 463–477 (2016).27623381
324. Vagnarelli P Repo-Man coordinates chromosomal reorganization with nuclear envelope reassembly during mitotic exit Dev Cell. 2011 21 328 342 21820363
Vagnarelli, P. et al. Repo-Man coordinates chromosomal reorganization with nuclear envelope reassembly during mitotic exit. Dev Cell. 21, 328–342 (2011).21820363
325. Hawryluk-Gara LA Nup53 is required for nuclear envelope and nuclear pore complex assembly Mol. Biol. Cell. 2008 19 1753 1762 18256286
Hawryluk-Gara, L. A. et al. Nup53 is required for nuclear envelope and nuclear pore complex assembly. Mol. Biol. Cell. 19, 1753–1762 (2008).18256286
326. Walther TC The conserved Nup107-160 complex is critical for nuclear pore complex assembly Cell. 2003 113 195 206 12705868
Walther, T. C. et al. The conserved Nup107-160 complex is critical for nuclear pore complex assembly. Cell. 113, 195–206 (2003).12705868
327. Bodoor K Sequential recruitment of NPC proteins to the nuclear periphery at the end of mitosis J. Cell Sci. 1999 112 2253 2264 10362555
Bodoor, K. et al. Sequential recruitment of NPC proteins to the nuclear periphery at the end of mitosis. J. Cell Sci. 112, 2253–2264 (1999).10362555
328. Mansfeld J The conserved transmembrane nucleoporin NDC1 is required for nuclear pore complex assembly in vertebrate cells Mol. Cell. 2006 22 93 103 16600873
Mansfeld, J. et al. The conserved transmembrane nucleoporin NDC1 is required for nuclear pore complex assembly in vertebrate cells. Mol. Cell. 22, 93–103 (2006).16600873
329. Otsuka S Postmitotic nuclear pore assembly proceeds by radial dilation of small membrane openings Nat. Struct. Mol. Biol. 2018 25 21 28 29323269
Otsuka, S. et al. Postmitotic nuclear pore assembly proceeds by radial dilation of small membrane openings. Nat. Struct. Mol. Biol. 25, 21–28 (2018).29323269
330. Kutay U Juhlen R Antonin W Mitotic disassembly and reassembly of nuclear pore complexes Trends Cell Biol. 2021 31 1019 1033 34294532
Kutay, U., Juhlen, R. & Antonin, W. Mitotic disassembly and reassembly of nuclear pore complexes. Trends Cell Biol. 31, 1019–1033 (2021).34294532
331. Ren H Postmitotic annulate lamellae assembly contributes to nuclear envelope reconstitution in daughter cells J. Biol. Chem. 2019 294 10383 10391 31152066
Ren, H. et al. Postmitotic annulate lamellae assembly contributes to nuclear envelope reconstitution in daughter cells. J. Biol. Chem. 294, 10383–10391 (2019).31152066
332. Hampoelz B Pre-assembled nuclear pores insert into the nuclear envelope during early development Cell. 2016 166 664 678 27397507
Hampoelz, B. et al. Pre-assembled nuclear pores insert into the nuclear envelope during early development. Cell. 166, 664–678 (2016).27397507
333. Harel A Forbes DJ Importin beta: conducting a much larger cellular symphony Mol Cell. 2004 16 319 330 15525506
Harel, A. & Forbes, D. J. Importin beta: conducting a much larger cellular symphony. Mol Cell. 16, 319–330 (2004).15525506
334. Ganguly A Importin-beta directly regulates the motor activity and turnover of a kinesin-4 Dev Cell. 2018 44 642 651.e645 29503159
Ganguly, A. et al. Importin-beta directly regulates the motor activity and turnover of a kinesin-4. Dev Cell. 44, 642–651.e645 (2018).29503159
335. Chen M The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein J. Cell Biol. 2017 216 641 656 28193700
Chen, M. et al. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. J. Cell Biol. 216, 641–656 (2017).28193700
336. Bernardes NE Structure of IMPORTIN-4 bound to the H3-H4-ASF1 histone-histone chaperone complex Proc. Natl. Acad. Sci. USA. 2022 119 e2207177119 36103578
Bernardes, N. E. et al. Structure of IMPORTIN-4 bound to the H3-H4-ASF1 histone-histone chaperone complex. Proc. Natl. Acad. Sci. USA. 119, e2207177119 (2022).36103578
337. Pardal AJ Bowman AJ A specific role for importin-5 and NASP in the import and nuclear hand-off of monomeric H3 Elife. 2022 11 e81755 36066346
Pardal, A. J. & Bowman, A. J. A specific role for importin-5 and NASP in the import and nuclear hand-off of monomeric H3. Elife. 11, e81755 (2022).36066346
338. Padavannil A Importin-9 wraps around the H2A-H2B core to act as nuclear importer and histone chaperone Elife. 2019 8 e43630 30855230
Padavannil, A. et al. Importin-9 wraps around the H2A-H2B core to act as nuclear importer and histone chaperone. Elife. 8, e43630 (2019).30855230
339. Kato M Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels Cell. 2012 149 753 767 22579281
Kato, M. et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 149, 753–767 (2012).22579281
340. Qamar S FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions Cell. 2018 173 720 734 e715 29677515
Qamar, S. et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions. Cell. 173, 720–734 e715 (2018).29677515
341. Hutten S Nuclear import receptors directly bind to arginine-rich dipeptide repeat proteins and suppress their pathological interactions Cell Rep. 2020 33 108538 33357437
Hutten, S. et al. Nuclear import receptors directly bind to arginine-rich dipeptide repeat proteins and suppress their pathological interactions. Cell Rep. 33, 108538 (2020).33357437
342. Guo L Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains Cell. 2018 173 677 692.e620 29677512
Guo, L. et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell. 173, 677–692.e620 (2018).29677512
343. Hofweber M Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation Cell. 2018 173 706 719.e713 29677514
Hofweber, M. et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 173, 706–719.e713 (2018).29677514
344. Yoshizawa T Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites Cell. 2018 173 693 705.e622 29677513
Yoshizawa, T. et al. Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites. Cell. 173, 693–705.e622 (2018).29677513
345. Wang J A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins Cell. 2018 174 688 699.e616 29961577
Wang, J. et al. A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell. 174, 688–699.e616 (2018).29961577
346. Ibanez de Opakua A Molecular interactions of FG nucleoporin repeats at high resolution Nat Chem. 2022 14 1278 1285 36138110
Ibanez de Opakua, A. et al. Molecular interactions of FG nucleoporin repeats at high resolution. Nat Chem. 14, 1278–1285 (2022).36138110
347. Danilov LG The human NUP58 nucleoporin can form amyloids in vitro and in vivo Biomedicines. 2021 9 1451 34680573
Danilov, L. G. et al. The human NUP58 nucleoporin can form amyloids in vitro and in vivo. Biomedicines. 9, 1451 (2021).34680573
348. Najbauer EE Atomic resolution dynamics of cohesive interactions in phase-separated Nup98 FG domains Nat Commun. 2022 13 1494 35314668
Najbauer, E. E. et al. Atomic resolution dynamics of cohesive interactions in phase-separated Nup98 FG domains. Nat Commun. 13, 1494 (2022).35314668
349. Davis LK Ford IJ Saric A Hoogenboom BW Intrinsically disordered nuclear pore proteins show ideal-polymer morphologies and dynamics Phys. Rev. E. 2020 101 022420 32168597
Davis, L. K., Ford, I. J., Saric, A. & Hoogenboom, B. W. Intrinsically disordered nuclear pore proteins show ideal-polymer morphologies and dynamics. Phys. Rev. E. 101, 022420 (2020).32168597
350. Coyne AN Rothstein JD Nuclear pore complexes—a doorway to neural injury in neurodegeneration Nat Rev. Neurol. 2022 18 348 362 35488039
Coyne, A. N. & Rothstein, J. D. Nuclear pore complexes—a doorway to neural injury in neurodegeneration. Nat Rev. Neurol. 18, 348–362 (2022).35488039
351. Chou CC TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD Nat Neurosci. 2018 21 228 239 29311743
Chou, C. C. et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci. 21, 228–239 (2018).29311743
352. Diez L Phosphorylation but not oligomerization drives the accumulation of tau with nucleoporin Nup98 Int. J. Mol. Sci. 2022 23 3495 35408855
Diez, L. et al. Phosphorylation but not oligomerization drives the accumulation of tau with nucleoporin Nup98. Int. J. Mol. Sci. 23, 3495 (2022).35408855
353. Eftekharzadeh B Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease Neuron. 2018 99 925 940.e927 30189209
Eftekharzadeh, B. et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease. Neuron. 99, 925–940.e927 (2018).30189209
354. Ahn JH Phase separation drives aberrant chromatin looping and cancer development Nature. 2021 595 591 595 34163069
Ahn, J. H. et al. Phase separation drives aberrant chromatin looping and cancer development. Nature. 595, 591–595 (2021).34163069
355. Mendes A Fahrenkrog B NUP214 in leukemia: It’s more than transport Cells. 2019 8 76 30669574
Mendes, A. & Fahrenkrog, B. NUP214 in leukemia: It’s more than transport. Cells. 8, 76 (2019).30669574
356. Rodriguez-Bravo V Nuclear pores promote lethal prostate cancer by increasing POM121-driven E2F1, MYC, and AR nuclear import Cell. 2018 174 1200 1215.e1220 30100187
Rodriguez-Bravo, V. et al. Nuclear pores promote lethal prostate cancer by increasing POM121-driven E2F1, MYC, and AR nuclear import. Cell. 174, 1200–1215.e1220 (2018).30100187
357. Raices M D’Angelo MA Nuclear pore complexes and regulation of gene expression Curr. Opin. Cell Biol. 2017 46 26 32 28088069
Raices, M. & D’Angelo, M. A. Nuclear pore complexes and regulation of gene expression. Curr. Opin. Cell Biol. 46, 26–32 (2017).28088069
358. Pascual-Garcia P Capelson M Nuclear pores in genome architecture and enhancer function Curr. Opin. Cell Biol. 2019 58 126 133 31063899
Pascual-Garcia, P. & Capelson, M. Nuclear pores in genome architecture and enhancer function. Curr. Opin. Cell Biol. 58, 126–133 (2019).31063899
359. Ibarra A Hetzer MW Nuclear pore proteins and the control of genome functions Genes Dev. 2015 29 337 349 25691464
Ibarra, A. & Hetzer, M. W. Nuclear pore proteins and the control of genome functions. Genes Dev. 29, 337–349 (2015).25691464
360. Kohler A Hurt E Gene regulation by nucleoporins and links to cancer Mol Cell. 2010 38 6 15 20385085
Kohler, A. & Hurt, E. Gene regulation by nucleoporins and links to cancer. Mol Cell. 38, 6–15 (2010).20385085
361. Sun J Shi Y Yildirim E The nuclear pore complex in cell type-specific chromatin structure and gene regulation Trends Genet. 2019 35 579 588 31213386
Sun, J., Shi, Y. & Yildirim, E. The nuclear pore complex in cell type-specific chromatin structure and gene regulation. Trends Genet. 35, 579–588 (2019).31213386
362. Pascual-Garcia P Metazoan nuclear pores provide a scaffold for poised genes and mediate induced enhancer-promoter contacts Mol. Cell. 2017 66 63 76 e66 28366641
Pascual-Garcia, P. et al. Metazoan nuclear pores provide a scaffold for poised genes and mediate induced enhancer-promoter contacts. Mol. Cell. 66, 63–76 e66 (2017).28366641
363. Blobel G Gene gating: a hypothesis Proc. Natl. Acad. Sci. USA. 1985 82 8527 8529 3866238
Blobel, G. Gene gating: a hypothesis. Proc. Natl. Acad. Sci. USA. 82, 8527–8529 (1985).3866238
364. Jani D Functional and structural characterization of the mammalian TREX-2 complex that links transcription with nuclear messenger RNA export Nucleic Acids Res. 2012 40 4562 4573 22307388
Jani, D. et al. Functional and structural characterization of the mammalian TREX-2 complex that links transcription with nuclear messenger RNA export. Nucleic Acids Res. 40, 4562–4573 (2012).22307388
365. Kadota S Nucleoporin 153 links nuclear pore complex to chromatin architecture by mediating CTCF and cohesin binding Nat Commun. 2020 11 2606 32451376
Kadota, S. et al. Nucleoporin 153 links nuclear pore complex to chromatin architecture by mediating CTCF and cohesin binding. Nat Commun. 11, 2606 (2020).32451376
366. Aleman JR Correct dosage of X chromosome transcription is controlled by a nuclear pore component Cell Rep. 2021 35 109236 34133927
Aleman, J. R. et al. Correct dosage of X chromosome transcription is controlled by a nuclear pore component. Cell Rep. 35, 109236 (2021).34133927
367. Ibarra A Nucleoporin-mediated regulation of cell identity genes Genes Dev. 2016 30 2253 2258 27807035
Ibarra, A. et al. Nucleoporin-mediated regulation of cell identity genes. Genes Dev. 30, 2253–2258 (2016).27807035
368. Liu Z Nucleoporin Seh1 interacts with Olig2/Brd7 to promote oligodendrocyte differentiation and myelination Neuron. 2019 102 587 601 e587 30876848
Liu, Z. et al. Nucleoporin Seh1 interacts with Olig2/Brd7 to promote oligodendrocyte differentiation and myelination. Neuron. 102, 587–601 e587 (2019).30876848
369. Kalverda B Pickersgill H Shloma VV Fornerod M Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm Cell. 2010 140 360 371 20144760
Kalverda, B., Pickersgill, H., Shloma, V. V. & Fornerod, M. Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm. Cell. 140, 360–371 (2010).20144760
370. Capelson M Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes Cell. 2010 140 372 383 20144761
Capelson, M. et al. Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes. Cell. 140, 372–383 (2010).20144761
371. Capitanio JS Montpetit B Wozniak RW Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9 Elife. 2017 6 e18825 28221134
Capitanio, J. S., Montpetit, B. & Wozniak, R. W. Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9. Elife. 6, e18825 (2017).28221134
372. Chandra B Phase separation mediates NUP98 fusion oncoprotein leukemic transformation Cancer Discov. 2022 12 1152 1169 34903620
Chandra, B. et al. Phase separation mediates NUP98 fusion oncoprotein leukemic transformation. Cancer Discov. 12, 1152–1169 (2022).34903620
373. Oka M Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes Elife. 2016 5 e09540 26740045
Oka, M. et al. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes. Elife. 5, e09540 (2016).26740045
374. Jost KL Bertulat B Cardoso MC Heterochromatin and gene positioning: inside, outside, any side? Chromosoma. 2012 121 555 563 23090282
Jost, K. L., Bertulat, B. & Cardoso, M. C. Heterochromatin and gene positioning: inside, outside, any side? Chromosoma. 121, 555–563 (2012).23090282
375. Gozalo A Core components of the nuclear pore bind distinct states of chromatin and contribute to polycomb repression Mol. Cell. 2020 77 67 81 e67 31784359
Gozalo, A. et al. Core components of the nuclear pore bind distinct states of chromatin and contribute to polycomb repression. Mol. Cell. 77, 67–81 e67 (2020).31784359
376. Jacinto FV Benner C Hetzer MW The nucleoporin Nup153 regulates embryonic stem cell pluripotency through gene silencing Genes Dev. 2015 29 1224 1238 26080816
Jacinto, F. V., Benner, C. & Hetzer, M. W. The nucleoporin Nup153 regulates embryonic stem cell pluripotency through gene silencing. Genes Dev. 29, 1224–1238 (2015).26080816
377. Weiler KS Wakimoto BT Heterochromatin and gene expression in Drosophila Annu. Rev. Genet. 1995 29 577 605 8825487
Weiler, K. S. & Wakimoto, B. T. Heterochromatin and gene expression in Drosophila. Annu. Rev. Genet. 29, 577–605 (1995).8825487
378. Gotta M The clustering of telomeres and colocalization with Rap1, Sir3, and Sir4 proteins in wild-type Saccharomyces cerevisiae J. Cell Biol. 1996 134 1349 1363 8830766
Gotta, M. et al. The clustering of telomeres and colocalization with Rap1, Sir3, and Sir4 proteins in wild-type Saccharomyces cerevisiae. J. Cell Biol. 134, 1349–1363 (1996).8830766
379. Van de Vosse DW A role for the nucleoporin Nup170p in chromatin structure and gene silencing Cell. 2013 152 969 983 23452847
Van de Vosse, D. W. et al. A role for the nucleoporin Nup170p in chromatin structure and gene silencing. Cell. 152, 969–983 (2013).23452847
380. Galy V Nuclear pore complexes in the organization of silent telomeric chromatin Nature. 2000 403 108 112 10638763
Galy, V. et al. Nuclear pore complexes in the organization of silent telomeric chromatin. Nature. 403, 108–112 (2000).10638763
381. Lapetina DL Ptak C Roesner UK Wozniak RW Yeast silencing factor Sir4 and a subset of nucleoporins form a complex distinct from nuclear pore complexes J. Cell Biol. 2017 216 3145 3159 28883038
Lapetina, D. L., Ptak, C., Roesner, U. K. & Wozniak, R. W. Yeast silencing factor Sir4 and a subset of nucleoporins form a complex distinct from nuclear pore complexes. J. Cell Biol. 216, 3145–3159 (2017).28883038
382. Feuerbach F Nuclear architecture and spatial positioning help establish transcriptional states of telomeres in yeast Nat Cell Biol. 2002 4 214 221 11862215
Feuerbach, F. et al. Nuclear architecture and spatial positioning help establish transcriptional states of telomeres in yeast. Nat Cell Biol. 4, 214–221 (2002).11862215
383. Pombo A Dillon N Three-dimensional genome architecture: players and mechanisms Nat. Rev. Mol. Cell Biol. 2015 16 245 257 25757416
Pombo, A. & Dillon, N. Three-dimensional genome architecture: players and mechanisms. Nat. Rev. Mol. Cell Biol. 16, 245–257 (2015).25757416
384. Toda T Nup153 interacts with Sox2 to enable bimodal gene regulation and maintenance of neural progenitor cells Cell Stem Cell. 2017 21 618 634 e617 28919367
Toda, T. et al. Nup153 interacts with Sox2 to enable bimodal gene regulation and maintenance of neural progenitor cells. Cell Stem Cell. 21, 618–634 e617 (2017).28919367
385. Michmerhuizen NL Klco JM Mullighan CG Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies Blood. 2020 136 2275 2289 32766874
Michmerhuizen, N. L., Klco, J. M. & Mullighan, C. G. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies. Blood. 136, 2275–2289 (2020).32766874
386. Xu S Powers MA Nuclear pore proteins and cancer Semin Cell Dev Biol. 2009 20 620 630 19577736
Xu, S. & Powers, M. A. Nuclear pore proteins and cancer. Semin Cell Dev Biol. 20, 620–630 (2009).19577736
387. Martin AJ Jans DA Antivirals that target the host IMPalpha/beta1-virus interface Biochem. Soc. Trans. 2021 49 281 295 33439253
Martin, A. J. & Jans, D. A. Antivirals that target the host IMPalpha/beta1-virus interface. Biochem. Soc. Trans. 49, 281–295 (2021).33439253
388. Uddin MH Zonder JA Azmi AS Exportin 1 inhibition as antiviral therapy Drug Discov. Today. 2020 25 1775 1781 32569833
Uddin, M. H., Zonder, J. A. & Azmi, A. S. Exportin 1 inhibition as antiviral therapy. Drug Discov. Today. 25, 1775–1781 (2020).32569833
389. Walker JS Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia J. Hematol. Oncol. 2021 14 17 33451349
Walker, J. S. et al. Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia. J. Hematol. Oncol. 14, 17 (2021).33451349
390. Ishizawa J Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein Pharmacol Ther. 2015 153 25 35 26048327
Ishizawa, J. et al. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein. Pharmacol Ther. 153, 25–35 (2015).26048327
391. Gravina GL Nucleo-cytoplasmic transport as a therapeutic target of cancer J. Hematol Oncol. 2014 7 85 25476752
Gravina, G. L. et al. Nucleo-cytoplasmic transport as a therapeutic target of cancer. J. Hematol Oncol. 7, 85 (2014).25476752
392. Sun Q Inhibiting cancer cell hallmark features through nuclear export inhibition Signal Transduct Target Ther. 2016 1 16010 29263896
Sun, Q. et al. Inhibiting cancer cell hallmark features through nuclear export inhibition. Signal Transduct Target Ther. 1, 16010 (2016).29263896
393. Turner JG Melphalan and exportin 1 inhibitors exert synergistic antitumor effects in preclinical models of human multiple myeloma Cancer Res. 2020 80 5344 5354 33023948
Turner, J. G. et al. Melphalan and exportin 1 inhibitors exert synergistic antitumor effects in preclinical models of human multiple myeloma. Cancer Res. 80, 5344–5354 (2020).33023948
394. Newlands ES Rustin GJ Brampton MH Phase I trial of elactocin Br J Cancer. 1996 74 648 649 8761384
Newlands, E. S., Rustin, G. J. & Brampton, M. H. Phase I trial of elactocin. Br J Cancer. 74, 648–649 (1996).8761384
395. Sun Q Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1 Proc Natl. Acad. Sci USA. 2013 110 1303 1308 23297231
Sun, Q. et al. Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1. Proc Natl. Acad. Sci USA. 110, 1303–1308 (2013).23297231
396. Sakakibara K CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity Blood. 2011 118 3922 3931 21841164
Sakakibara, K. et al. CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity. Blood. 118, 3922–3931 (2011).21841164
397. Tian X Small-molecule antagonist targeting exportin-1 via rational structure-based discovery J Med. Chem. 2020 63 3881 3895 32223194
Tian, X. et al. Small-molecule antagonist targeting exportin-1 via rational structure-based discovery. J Med. Chem. 63, 3881–3895 (2020).32223194
398. Etchin J KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia Br. J. Haematol. 2013 161 117 127 23373539
Etchin, J. et al. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br. J. Haematol. 161, 117–127 (2013).23373539
399. Chari A Oral selinexor-dexamethasone for triple-class refractory multiple myeloma N. Engl. J. Med. 2019 381 727 738 31433920
Chari, A. et al. Oral selinexor-dexamethasone for triple-class refractory multiple myeloma. N. Engl. J. Med. 381, 727–738 (2019).31433920
400. Lassman AB A phase II study of the efficacy and safety of oral selinexor in recurrent glioblastoma Clin. Cancer Res. 2022 28 452 460 34728525
Lassman, A. B. et al. A phase II study of the efficacy and safety of oral selinexor in recurrent glioblastoma. Clin. Cancer Res. 28, 452–460 (2022).34728525
401. Garzon R A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia Blood. 2017 129 3165 3174 28336527
Garzon, R. et al. A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia. Blood. 129, 3165–3174 (2017).28336527
402. Etchin J KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells Leukemia. 2017 31 143 150 27211268
Etchin, J. et al. KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells. Leukemia. 31, 143–150 (2017).27211268
403. Janssen J Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome Leukemia. 2022 36 2189 2195 35869267
Janssen, J. et al. Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome. Leukemia. 36, 2189–2195 (2022).35869267
404. Huang JL Discovery of highly potent daphnane diterpenoids uncovers importin-beta1 as a druggable vulnerability in castration-resistant prostate cancer J. Am. Chem. Soc. 2022 144 17522 17532 36103720
Huang, J. L. et al. Discovery of highly potent daphnane diterpenoids uncovers importin-beta1 as a druggable vulnerability in castration-resistant prostate cancer. J. Am. Chem. Soc. 144, 17522–17532 (2022).36103720
405. Liu T LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3 Mol. Cancer. 2018 17 118 30098595
Liu, T. et al. LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3. Mol. Cancer. 17, 118 (2018).30098595
406. Zhu C Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1 Cell Rep. 2021 34 108749 33596420
Zhu, C. et al. Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1. Cell Rep. 34, 108749 (2021).33596420
407. Volpon L Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E Proc. Natl. Acad. Sci. USA. 2016 113 5263 5268 27114554
Volpon, L. et al. Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E. Proc. Natl. Acad. Sci. USA. 113, 5263–5268 (2016).27114554
408. Nataraj NB Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors Cell Rep. 2022 38 110418 35196484
Nataraj, N. B. et al. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Rep. 38, 110418 (2022).35196484
409. Boudhraa Z Carmona E Provencher D Mes-Masson AM Ran GTPase: A key player in tumor progression and metastasis Front Cell Dev. Biol. 2020 8 345 32528950
Boudhraa, Z., Carmona, E., Provencher, D. & Mes-Masson, A. M. Ran GTPase: A key player in tumor progression and metastasis. Front Cell Dev. Biol. 8, 345 (2020).32528950
410. Camus V Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma Haematologica. 2016 101 1094 1101 27479820
Camus, V. et al. Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma. Haematologica. 101, 1094–1101 (2016).27479820
411. Miloudi H XPO1(E571K) Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma Cancers (Basel). 2020 12 2829 33007990
Miloudi, H. et al. XPO1(E571K) Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma. Cancers (Basel). 12, 2829 (2020).33007990
412. Garcia-Santisteban I A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K Cell Mol. Life Sci. 2016 73 4685 4699 27312238
Garcia-Santisteban, I. et al. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K. Cell Mol. Life Sci. 73, 4685–4699 (2016).27312238
413. Benzeno S Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 Oncogene. 2006 25 6291 6303 16732330
Benzeno, S. et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene. 25, 6291–6303 (2006).16732330
414. Mariano AR Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal Oncogene. 2006 25 4376 4380 16501600
Mariano, A. R. et al. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal. Oncogene. 25, 4376–4380 (2006).16501600
415. Siddiqui N Borden KL mRNA export and cancer Wiley Interdiscip. Rev RNA. 2012 3 13 25 21796793
Siddiqui, N. & Borden, K. L. mRNA export and cancer. Wiley Interdiscip. Rev RNA. 3, 13–25 (2012).21796793
416. Viphakone N Luzp4 defines a new mRNA export pathway in cancer cells Nucleic Acids Res. 2015 43 2353 2366 25662211
Viphakone, N. et al. Luzp4 defines a new mRNA export pathway in cancer cells. Nucleic Acids Res. 43, 2353–2366 (2015).25662211
417. Dominguez-Sanchez MS Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers BMC Cancer. 2011 11 77 21329510
Dominguez-Sanchez, M. S. et al. Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers. BMC Cancer. 11, 77 (2011).21329510
418. Carroll M Borden KL The oncogene eIF4E: using biochemical insights to target cancer J. Interferon Cytokine Res. 2013 33 227 238 23472659
Carroll, M. & Borden, K. L. The oncogene eIF4E: using biochemical insights to target cancer. J. Interferon Cytokine Res. 33, 227–238 (2013).23472659
419. Culjkovic B The eIF4E RNA regulon promotes the Akt signaling pathway J. Cell Biol. 2008 181 51 63 18391071
Culjkovic, B. et al. The eIF4E RNA regulon promotes the Akt signaling pathway. J. Cell Biol. 181, 51–63 (2008).18391071
420. Borden KLB The nuclear pore complex and mRNA export in cancer Cancers (Basel). 2020 13 42 33375634
Borden, K. L. B. The nuclear pore complex and mRNA export in cancer. Cancers (Basel). 13, 42 (2020).33375634
421. Malone CF Selective modulation of a pan-essential protein as a therapeutic strategy in cancer Cancer Discov. 2021 11 2282 2299 33883167
Malone, C. F. et al. Selective modulation of a pan-essential protein as a therapeutic strategy in cancer. Cancer Discov. 11, 2282–2299 (2021).33883167
422. Lu J MicroRNA expression profiles classify human cancers Nature. 2005 435 834 838 15944708
Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature. 435, 834–838 (2005).15944708
423. Melo SA A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells Cancer Cell. 2010 18 303 315 20951941
Melo, S. A. et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell. 18, 303–315 (2010).20951941
424. Sun HL ERK activation globally downregulates mirnas through phosphorylating exportin-5 Cancer Cell. 2016 30 723 736 27846390
Sun, H. L. et al. ERK activation globally downregulates mirnas through phosphorylating exportin-5. Cancer Cell. 30, 723–736 (2016).27846390
425. Gough SM Slape CI Aplan PD NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights Blood. 2011 118 6247 6257 21948299
Gough, S. M., Slape, C. I. & Aplan, P. D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood. 118, 6247–6257 (2011).21948299
426. Struski S NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis Leukemia. 2017 31 565 572 27694926
Struski, S. et al. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia. 31, 565–572 (2017).27694926
427. Lam DH Aplan PD NUP98 gene fusions in hematologic malignancies Leukemia. 2001 15 1689 1695 11681408
Lam, D. H. & Aplan, P. D. NUP98 gene fusions in hematologic malignancies. Leukemia. 15, 1689–1695 (2001).11681408
428. Xu H NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis Cancer Cell. 2016 30 863 878 27889185
Xu, H. et al. NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis. Cancer Cell. 30, 863–878 (2016).27889185
429. Heikamp EB The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML Blood. 2022 139 894 906 34582559
Heikamp, E. B. et al. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Blood. 139, 894–906 (2022).34582559
430. Schmoellerl J CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia Blood. 2020 136 387 400 32344427
Schmoellerl, J. et al. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia. Blood. 136, 387–400 (2020).32344427
431. Oka M Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto HOX clusters causing aberrant HOX expression in leukemia cells Elife. 2019 8 e46667 31755865
Oka, M. et al. Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto HOX clusters causing aberrant HOX expression in leukemia cells. Elife. 8, e46667 (2019).31755865
432. Ben Abdelali R SET-NUP214 is a recurrent gammadelta lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL Blood. 2014 123 1860 1863 24449214
Ben Abdelali, R. et al. SET-NUP214 is a recurrent gammadelta lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL. Blood. 123, 1860–1863 (2014).24449214
433. Vanden Bempt M Cooperative enhancer activation by TLX1 and STAT5 drives development of NUP214-ABL1/TLX1-positive T cell acute lymphoblastic leukemia Cancer Cell. 2018 34 271 285.e277 30107177
Vanden Bempt, M. et al. Cooperative enhancer activation by TLX1 and STAT5 drives development of NUP214-ABL1/TLX1-positive T cell acute lymphoblastic leukemia. Cancer Cell. 34, 271–285.e277 (2018).30107177
434. Gough SM NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function Cancer Discov. 2014 4 564 577 24535671
Gough, S. M. et al. NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function. Cancer Discov. 4, 564–577 (2014).24535671
435. Tziortzouda P Van Den Bosch L Hirth F Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation Nat Rev. Neurosci. 2021 22 197 208 33654312
Tziortzouda, P., Van Den Bosch, L. & Hirth, F. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat Rev. Neurosci. 22, 197–208 (2021).33654312
436. Hutten S Dormann D Nucleocytoplasmic transport defects in neurodegeneration—Cause or consequence? Semin Cell Dev Biol. 2020 99 151 162 31152789
Hutten, S. & Dormann, D. Nucleocytoplasmic transport defects in neurodegeneration—Cause or consequence? Semin Cell Dev Biol. 99, 151–162 (2020).31152789
437. Lester E Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components Neuron. 2021 109 1675 1691.e1679 33848474
Lester, E. et al. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components. Neuron. 109, 1675–1691.e1679 (2021).33848474
438. Kavanagh T Halder A Drummond E Tau interactome and RNA binding proteins in neurodegenerative diseases Mol. Neurodegener. 2022 17 66 36253823
Kavanagh, T., Halder, A. & Drummond, E. Tau interactome and RNA binding proteins in neurodegenerative diseases. Mol. Neurodegener. 17, 66 (2022).36253823
439. Boeynaems S Bogaert E Van Damme P Van Den Bosch L Inside out: the role of nucleocytoplasmic transport in ALS and FTLD Acta Neuropathol. 2016 132 159 173 27271576
Boeynaems, S., Bogaert, E., Van Damme, P. & Van Den Bosch, L. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 132, 159–173 (2016).27271576
440. Tang X Divergence, convergence, and therapeutic implications: A cell biology perspective of C9ORF72-ALS/FTD Mol. Neurodegener. 2020 15 34 32513219
Tang, X. et al. Divergence, convergence, and therapeutic implications: A cell biology perspective of C9ORF72-ALS/FTD. Mol. Neurodegener. 15, 34 (2020).32513219
441. Doll SG Recognition of the TDP-43 nuclear localization signal by importin alpha1/beta Cell Rep. 2022 39 111007 35767952
Doll, S. G. et al. Recognition of the TDP-43 nuclear localization signal by importin alpha1/beta. Cell Rep. 39, 111007 (2022).35767952
442. Ferreira PA The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration Cell Mol. Life Sci. 2019 76 2247 2273 30742233
Ferreira, P. A. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration. Cell Mol. Life Sci. 76, 2247–2273 (2019).30742233
443. Gasset-Rosa F Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death Neuron. 2019 102 339 357.e337 30853299
Gasset-Rosa, F. et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 102, 339–357.e337 (2019).30853299
444. Eftekharzadeh B Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease Neuron. 2019 101 349 30653936
Eftekharzadeh, B. et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease. Neuron. 101, 349 (2019).30653936
445. Park JH Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and Importin alpha3 Elife. 2020 9 e60132 33305734
Park, J. H. et al. Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and Importin alpha3. Elife. 9, e60132 (2020).33305734
446. Zhang K The C9orf72 repeat expansion disrupts nucleocytoplasmic transport Nature. 2015 525 56 61 26308891
Zhang, K. et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 525, 56–61 (2015).26308891
447. Yamashita T Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons Sci. Rep. 2017 7 39994 28045133
Yamashita, T. et al. Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons. Sci. Rep. 7, 39994 (2017).28045133
448. Nishimura AL Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration Brain. 2010 133 1763 1771 20472655
Nishimura, A. L. et al. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain. 133, 1763–1771 (2010).20472655
449. Hock EM Hypertonic stress causes cytoplasmic translocation of neuronal, but not astrocytic, FUS due to impaired transportin function Cell Rep. 2018 24 987 1000.e1007 30044993
Hock, E. M. et al. Hypertonic stress causes cytoplasmic translocation of neuronal, but not astrocytic, FUS due to impaired transportin function. Cell Rep. 24, 987–1000.e1007 (2018).30044993
450. Goodman LD TNPO2 variants associate with human developmental delays, neurologic deficits, and dysmorphic features and alter TNPO2 activity in Drosophila Am. J. Hum. Genet. 2021 108 1669 1691 34314705
Goodman, L. D. et al. TNPO2 variants associate with human developmental delays, neurologic deficits, and dysmorphic features and alter TNPO2 activity in Drosophila. Am. J. Hum. Genet. 108, 1669–1691 (2021).34314705
451. Fallini C Khalil B Smith CL Rossoll W Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD Neurobiol Dis. 2020 140 104835 32179176
Fallini, C., Khalil, B., Smith, C. L. & Rossoll, W. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis. 140, 104835 (2020).32179176
452. Freibaum BD GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport Nature. 2015 525 129 133 26308899
Freibaum, B. D. et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 525, 129–133 (2015).26308899
453. Lin YC Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway Nat Neurosci. 2021 24 1077 1088 34059832
Lin, Y. C. et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat Neurosci. 24, 1077–1088 (2021).34059832
454. Anderson EN Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology Elife. 2021 10 e67587 34060470
Anderson, E. N. et al. Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology. Elife. 10, e67587 (2021).34060470
455. Khalil B Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy Mol. Neurodegener. 2022 17 80 36482422
Khalil, B. et al. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy. Mol. Neurodegener. 17, 80 (2022).36482422
456. Woerner AC Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA Science. 2016 351 173 176 26634439
Woerner, A. C. et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 351, 173–176 (2016).26634439
457. Fujita A Homozygous splicing mutation in NUP133 causes Galloway-Mowat syndrome Ann Neurol. 2018 84 814 828 30427554
Fujita, A. et al. Homozygous splicing mutation in NUP133 causes Galloway-Mowat syndrome. Ann Neurol. 84, 814–828 (2018).30427554
458. Coyne AN Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS Sci. Transl. Med. 2021 13 eabe1923 34321318
Coyne, A. N. et al. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 13, eabe1923 (2021).34321318
459. Martins F Nuclear envelope dysfunction and its contribution to the aging process Aging Cell. 2020 19 e13143 32291910
Martins, F. et al. Nuclear envelope dysfunction and its contribution to the aging process. Aging Cell. 19, e13143 (2020).32291910
460. Hayes LR C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import Elife. 2020 9 e51685 32119645
Hayes, L. R. et al. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife. 9, e51685 (2020).32119645
461. Dubey SK Maulding K Sung H Lloyd TE Nucleoporins are degraded via upregulation of ESCRT-III/Vps4 complex in Drosophila models of C9-ALS/FTD Cell Rep. 2022 40 111379 36130523
Dubey, S. K., Maulding, K., Sung, H. & Lloyd, T. E. Nucleoporins are degraded via upregulation of ESCRT-III/Vps4 complex in Drosophila models of C9-ALS/FTD. Cell Rep. 40, 111379 (2022).36130523
462. Zhang S The ataxin-1 interactome reveals direct connection with multiple disrupted nuclear transport pathways Nat Commun. 2020 11 3343 32620905
Zhang, S. et al. The ataxin-1 interactome reveals direct connection with multiple disrupted nuclear transport pathways. Nat Commun. 11, 3343 (2020).32620905
463. Grima JC Mutant huntingtin disrupts the nuclear pore complex Neuron. 2017 94 93 107.e106 28384479
Grima, J. C. et al. Mutant huntingtin disrupts the nuclear pore complex. Neuron. 94, 93–107.e106 (2017).28384479
464. Coyne AN G(4)C(2) repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD Neuron. 2020 107 1124 1140.e1111 32673563
Coyne, A. N. et al. G(4)C(2) repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron. 107, 1124–1140.e1111 (2020).32673563
465. Gasset-Rosa F Polyglutamine-expanded huntingtin exacerbates age-related disruption of nuclear integrity and nucleocytoplasmic transport Neuron. 2017 94 48 57.e44 28384474
Gasset-Rosa, F. et al. Polyglutamine-expanded huntingtin exacerbates age-related disruption of nuclear integrity and nucleocytoplasmic transport. Neuron. 94, 48–57.e44 (2017).28384474
466. Jovicic A Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS Nat Neurosci. 2015 18 1226 1229 26308983
Jovicic, A. et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 18, 1226–1229 (2015).26308983
467. Zhang K Stress granule assembly disrupts nucleocytoplasmic transport Cell. 2018 173 958 971.e917 29628143
Zhang, K. et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell. 173, 958–971.e917 (2018).29628143
468. Liu S The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-kappaB/NLRP3 Pathway Front Pharmacol. 2022 13 847605 35721113
Liu, S. et al. The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-kappaB/NLRP3 Pathway. Front Pharmacol. 13, 847605 (2022).35721113
469. Haines JD Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination Nat Neurosci. 2015 18 511 520 25706475
Haines, J. D. et al. Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination. Nat Neurosci. 18, 511–520 (2015).25706475
470. Shen Q Wang YE Palazzo AF Crosstalk between nucleocytoplasmic trafficking and the innate immune response to viral infection J. Biol. Chem. 2021 297 100856 34097873
Shen, Q., Wang, Y. E. & Palazzo, A. F. Crosstalk between nucleocytoplasmic trafficking and the innate immune response to viral infection. J. Biol. Chem. 297, 100856 (2021).34097873
471. Francis AC Melikyan GB Single HIV-1 imaging reveals progression of infection through CA-dependent steps of docking at the nuclear pore, uncoating, and nuclear transport Cell Host Microbe. 2018 23 536 548.e536 29649444
Francis, A. C. & Melikyan, G. B. Single HIV-1 imaging reveals progression of infection through CA-dependent steps of docking at the nuclear pore, uncoating, and nuclear transport. Cell Host Microbe. 23, 536–548.e536 (2018).29649444
472. Strunze S Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection Cell Host Microbe. 2011 10 210 223 21925109
Strunze, S. et al. Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection. Cell Host Microbe. 10, 210–223 (2011).21925109
473. Yamauchi Y Influenza A virus uncoating Adv. Virus Res. 2020 106 1 38 32327145
Yamauchi, Y. Influenza A virus uncoating. Adv. Virus Res. 106, 1–38 (2020).32327145
474. Whittaker GR Virus nuclear import Adv. Drug Deliv. Rev. 2003 55 733 747 12788537
Whittaker, G. R. Virus nuclear import. Adv. Drug Deliv. Rev. 55, 733–747 (2003).12788537
475. Wang X Influenza A virus use of BinCARD1 to facilitate the binding of viral NP to importin alpha7 is counteracted by TBK1-p62 axis-mediated autophagy Cell Mol. Immunol. 2022 19 1168 1184 36056146
Wang, X. et al. Influenza A virus use of BinCARD1 to facilitate the binding of viral NP to importin alpha7 is counteracted by TBK1-p62 axis-mediated autophagy. Cell Mol. Immunol. 19, 1168–1184 (2022).36056146
476. Flatt JW Greber UF Viral mechanisms for docking and delivering at nuclear pore complexes Semin Cell Dev Biol. 2017 68 59 71 28506891
Flatt, J. W. & Greber, U. F. Viral mechanisms for docking and delivering at nuclear pore complexes. Semin Cell Dev Biol. 68, 59–71 (2017).28506891
477. Shida H Role of nucleocytoplasmic RNA transport during the life cycle of retroviruses Front Microbiol. 2012 3 179 22783232
Shida, H. Role of nucleocytoplasmic RNA transport during the life cycle of retroviruses. Front Microbiol. 3, 179 (2012).22783232
478. Mostafa-Hedeab G Selinexor and COVID-19: The Neglected Warden Front Pharmacol. 2022 13 884228 35559257
Mostafa-Hedeab, G. et al. Selinexor and COVID-19: The Neglected Warden. Front Pharmacol. 13, 884228 (2022).35559257
479. Abid H Wu JF Abid MB Risk for infections with selinexor in patients with relapsed/refractory multiple myeloma: a systematic review of clinical trials Eur J Cancer. 2021 154 7 10 34217910
Abid, H., Wu, J. F. & Abid, M. B. Risk for infections with selinexor in patients with relapsed/refractory multiple myeloma: a systematic review of clinical trials. Eur J Cancer. 154, 7–10 (2021).34217910
480. Mogensen TH IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies Front Immunol. 2018 9 3047 30671054
Mogensen, T. H. IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies. Front Immunol. 9, 3047 (2018).30671054
481. Xia H Evasion of type I interferon by SARS-CoV-2 Cell Rep. 2020 33 108234 32979938
Xia, H. et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 33, 108234 (2020).32979938
482. He J Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy Autophagy. 2020 16 2238 2251 32924767
He, J. et al. Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy. Autophagy. 16, 2238–2251 (2020).32924767
483. Zhang K Structural basis for influenza virus NS1 protein block of mRNA nuclear export Nat Microbiol. 2019 4 1671 1679 31263181
Zhang, K. et al. Structural basis for influenza virus NS1 protein block of mRNA nuclear export. Nat Microbiol. 4, 1671–1679 (2019).31263181
484. Park N Katikaneni P Skern T Gustin KE Differential targeting of nuclear pore complex proteins in poliovirus-infected cells J. Virol. 2008 82 1647 1655 18045934
Park, N., Katikaneni, P., Skern, T. & Gustin, K. E. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 82, 1647–1655 (2008).18045934
485. Gustin KE Sarnow P Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition EMBO J. 2001 20 240 249 11226174
Gustin, K. E. & Sarnow, P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 20, 240–249 (2001).11226174
486. Bardina MV Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery J. Virol. 2009 83 3150 3161 19144712
Bardina, M. V. et al. Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery. J. Virol. 83, 3150–3161 (2009).19144712
487. Porter FW Palmenberg AC Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses J. Virol. 2009 83 1941 1951 19073724
Porter, F. W. & Palmenberg, A. C. Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses. J. Virol. 83, 1941–1951 (2009).19073724
488. Monette A Ajamian L Lopez-Lastra M Mouland AJ Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression J. Biol. Chem. 2009 284 31350 31362 19737937
Monette, A., Ajamian, L., Lopez-Lastra, M. & Mouland, A. J. Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J. Biol. Chem. 284, 31350–31362 (2009).19737937
489. Simon DN Rout MP Cancer and the nuclear pore complex Adv. Exp. Med. Biol. 2014 773 285 307 24563353
Simon, D. N. & Rout, M. P. Cancer and the nuclear pore complex. Adv. Exp. Med. Biol. 773, 285–307 (2014).24563353
490. Feng H Molecular mechanism underlying selective inhibition of mRNA nuclear export by herpesvirus protein ORF10 Proc. Natl. Acad. Sci. USA. 2020 117 26719 26727 33033226
Feng, H. et al. Molecular mechanism underlying selective inhibition of mRNA nuclear export by herpesvirus protein ORF10. Proc. Natl. Acad. Sci. USA. 117, 26719–26727 (2020).33033226
491. Gao X Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport Nat Commun. 2022 13 4782 35970938
Gao, X. et al. Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport. Nat Commun. 13, 4782 (2022).35970938
492. Le Sage V Mouland AJ Viral subversion of the nuclear pore complex Viruses. 2013 5 2019 2042 23959328
Le Sage, V. & Mouland, A. J. Viral subversion of the nuclear pore complex. Viruses. 5, 2019–2042 (2013).23959328
493. Liu W Identification of a covalent importin-5 inhibitor, goyazensolide, from a collective synthesis of furanoheliangolides ACS Cent Sci. 2021 7 954 962 34235256
Liu, W. et al. Identification of a covalent importin-5 inhibitor, goyazensolide, from a collective synthesis of furanoheliangolides. ACS Cent Sci. 7, 954–962 (2021).34235256
494. Lewin J A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS) Eur. J. Cancer. 2021 144 360 367 33418486
Lewin, J. et al. A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS). Eur. J. Cancer. 144, 360–367 (2021).33418486
495. Ho J A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies Ther. Adv. Med. Oncol. 2022 14 17588359221087555 35432603
Ho, J. et al. A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies. Ther. Adv. Med. Oncol. 14, 17588359221087555 (2022).35432603
496. Cornell RF A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma Am. J. Hematol. 2022 97 E54 E58 34817872
Cornell, R. F. et al. A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. Am. J. Hematol. 97, E54–E58 (2022).34817872
497. Martinez Sanchez MP A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients Ann. Hematol. 2021 100 1497 1508 33914097
Martinez Sanchez, M. P. et al. A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients. Ann. Hematol. 100, 1497–1508 (2021).33914097
498. Stephens DM Selinexor combined with ibrutinib demonstrates tolerability and safety in advanced B-cell malignancies: A phase I study Clin. Cancer Res. 2022 28 3242 3247 35608822
Stephens, D. M. et al. Selinexor combined with ibrutinib demonstrates tolerability and safety in advanced B-cell malignancies: A phase I study. Clin. Cancer Res. 28, 3242–3247 (2022).35608822
499. Westin SN Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer Gynecol Oncol. 2023 168 76 82 36423446
Westin, S. N. et al. Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer. Gynecol Oncol. 168, 76–82 (2023).36423446
500. Thein KZ Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors Exp. Hematol Oncol. 2021 10 59 34965890
Thein, K. Z. et al. Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors. Exp. Hematol Oncol. 10, 59 (2021).34965890
501. Grosicki S Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial Lancet. 2020 396 1563 1573 33189178
Grosicki, S. et al. Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial. Lancet. 396, 1563–1573 (2020).33189178
502. Lee S Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents J. Hematol Oncol. 2022 15 103 35922861
Lee, S. et al. Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents. J. Hematol Oncol. 15, 103 (2022).35922861
503. Qiu L Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study BMC Med. 2022 20 108 35379237
Qiu, L. et al. Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study. BMC Med. 20, 108 (2022).35379237
504. Zijlstra JM The association between patient characteristics and the efficacy and safety of selinexor in diffuse large B-cell lymphoma in the SADAL study Cancers (Basel). 2022 14 791 35159058
Zijlstra, J. M. et al. The association between patient characteristics and the efficacy and safety of selinexor in diffuse large B-cell lymphoma in the SADAL study. Cancers (Basel). 14, 791 (2022).35159058
505. Gounder MM Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial J. Clin. Oncol. 2022 40 2479 2490 35394800
Gounder, M. M. et al. Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 40, 2479–2490 (2022).35394800
506. Mateos MV Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma J. Hematol Oncol. 2021 14 59 33849608
Mateos, M. V. et al. Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. J. Hematol Oncol. 14, 59 (2021).33849608
